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ABSTRACT

Lo, Chiao-Ling. PhD, Purdue University, December 2013. Purdue University,
Notchless Interacts with Multiple Signaling Pathways during Mouse PeriImplantation Development. Major Professor: Amy C. Lossie.

During peri-implantation, the embryo transitions from a suspension environment
in the fallopian tubes to an adherent system within the uterus. Successful
transition requires maternal and fetal signaling cascades that establish maternalfetal boundaries. Failure is common, as ~ 25% of all human pregnancies
terminate during these steps. A large-scale mutation study in mice produced two
mutants (l11Jus1 and l11Jus4) that are excellent models of this transition.
l11Jus1 and l11Jus4 contain missense mutations in the Notchless homolog 1
(Drosophila) (Nle1) gene. NLE1 is thought to signal via the canonical NOTCH
pathway in vertebrates. Although in invertebrates and lower vertebrates, NOTCH
signaling directs cell fate prior to gastrulation, it is dispensable for gastrulation in
mice. Moreover, in yeast and plants, which lack NOTCH signaling, Nle1 is crucial
for ribosome biogenesis. These seemingly contradictory data led me to
hypothesize that mutation of Nle1 causes a lethal trauma to the embryo that
disrupts multiple signaling pathways during peri-implantation development. I
present data that: 1. Refute the presumption that Nle1 functions as a negative
regulator of NOTCH during pre-implantation development; 2. Demonstrate that
mutations in Nle1 lead to mis-expression of several members of the Wnt pathway;
and 3. Show that mutant embryos enter cell cycle arrest; when that fails, they
undergo p53-mediated programmed cell death. To understand the trauma(s) that
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precipitated these lethal cascades, I discovered that Nle1 mutants display delays
in ribosomal RNA processing and nucleogenesis. These results uncover novel
functions for NLE1 in the ribosomal biogenesis, TRP53 and WNT pathways
during mammalian embryonic development.
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CHAPTER 1. INTRODUCTION

1.1

Signaling During Peri-implantation Development

During peri-implantation, the embryo transitions from a free-flowing suspension
environment (i.e. pre-implantation development) in the oviduct (mice) or fallopian
tubes (humans) to an adherent system within the uterus. Pre-implantation
development occurs between fertilization and the blastocyst stage. After
fertilization, the totipotent zygote undergoes a series of cell divisions as well as
morphological changes whereby it reaches the morula and blastocyst stage (Fig.
1.1). In mice, embryos usually become blastocysts by embryonic day 3.5 (E3.5),
where E0.5 is 12 hours post coitus. A blastocyst is characterized by the presence
of an inner cell mass (ICM) toward one end and a fluid-filled cavity (blastocoel)
on the other (Doetschman et al., 1985; Gardner and Johnson, 1972). The inner
cell mass and blastocoel are surrounded by the trophectoderm. The ICM
differentiates into two cell layers, called the epiblast and primitive endoderm. The
epiblast is slated to become the embryo property, while the primitive endoderm
forms the yolk sac. The trophectoderm develops into the embryonic portion of the
placenta (Tarkowski et al., 2010). The zona pellucida (ZP) surrounds the entire
blastocyst, and is produced by the oocyte during maturation to prevent
polyspermy and protect the embryo through early development until the
blastocyst stage (Bleil et al., 1981).
During the late blastocyst stage, the blastocoel expands, causing hydrostatic
pressure on the zona pellucida, which nicks this protective shell. Helped by
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enzymatic degradation, the embryo gradually egresses from the zona pellucida in
a process called hatching (Bergstrom, 1972; Seshagiri et al., 2009). The hatched
blastocyst is now ready for implantation. Mouse embryos implant between E4.5
to E5.5. At this time point, the blastocyst attaches itself to the maternal cells and
the trophectoderm invades the luminal endothelium of the uterus (Johnson and
McConnell, 2004; Red-Horse et al., 2004).
After implantation, the embryo undergoes gastrulation, which is the generation of
three germ layers from the epiblast: ectoderm, mesoderm, and endoderm. The
ectoderm becomes the epithelium and nervous system. The mesoderm forms
somites and notochord that eventually produce muscles, as well as the
circulatory and excretory systems. The endoderm develops into all the digestive
and respiratory tracks of the body (Keller, 1981; Sweeton et al., 1991; Williams et
al.,Figure
2012;1Yamanaka
et al., 2007). development
Mouse pre-implantation
Zygote

Polar body

2-Cell stage 4-Cell stage

Zona
pellucida

Morula

Blastocyst

Trophectoderm

ICM

Hatched
blastocyst

Epiblast

Primitive
endoderm
Blastocoel
Embryonic
Day !

E0.5

E1.5

E2

E2.5-3.5

E3.5

E3.5-E4.5

Days post fertilization

Figure 1.1 Mouse pre-implantation development
Early embryonic stages from the zygote (fertilized egg) to a hatched blastocyst
are shown. Embryos are surrounding by the zona pellucida until the late
blastocyst stage. The polar body is the by-product of the second meiotic division
and can be found in the embryo until the 4-cell stage. E0.5 is denoted as 12
hours after fertilization. At E3.5, the embryo shows distinct cell specification of
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the inner cell mass (ICM) and trophectoderm. The ICM differentiates into the
epiblast and primitive endoderm.
Successful transition of the embryo to the uterine environment requires maternal
and fetal signal transduction cascades that establish and/or maintain maternalfetal boundaries. Studies in humans underscore the importance of these events,
as 25% of all pregnancies are predicted to end in miscarriage by this transition
(Rai and Regan, 2006). According to the American Pregnancy Association
(http://americanpregnancy.org/),

miscarriage

is

the

spontaneous

loss

of

pregnancy before the fetus is viable, and includes all pregnancy loss before or at
24 weeks of gestation. The numbers are staggering, as 25% of women
experience at least one miscarriage in their lives (Stephenson and Kutteh, 2007).
Although 15-20% of clinically recognized pregnancies will end in miscarriage,
upwards of 50% of all pregnancies are predicted to end in miscarriage (Rai and
Regan, 2006).
Although most miscarriage is attributed to sporadic chromosomal deficits,
infection, structural abnormalities, and endocrine problems that often cannot be
detected or controlled in a timely manner, a significant number of women suffer
from recurrent miscarriage, which may have a genetic component (Rai and
Regan, 2006). Recurrent miscarriage is defined as three or more consecutive
pregnancy losses and occurs in 1-5% of couples (Jaslow et al., 2010;
Stephenson et al., 2002). Several causes can lead to miscarriage. Some of the
most common cases during the first trimester, and in particular in recurrent
miscarriage, are caused from genetic abnormalities (Nathan, 2007). Periimplantation is one critical window where genetic, epigenetic, and environmental
factors coordinate embryonic and maternal gene regulation. Correct gene
expression and timing are critical for establishing maternal-fetal interactions, and
failures during this stage often lead to lethality.
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The regulation of peri-implantation development involves multiple pathways, such
as NOTCH, WNT and ribosomal biogenesis. Although disruption of NOTCH
signaling in mice indicates that NOTCH signaling is not necessary for
implantation, all NOTCH receptors and their ligands are detected during preimplantation development. And recent studies that knocked down γ-secretase,
which cleaves the intracellular domain of NOTCH so that it can translocate to the
nucleus to initiate downstream target genes, indicate that γ-secretase levels are
important for blastocyst competency (Chu et al., 2011). This study contradicts
gene-targeting reports (Shi et al., 2005), and suggests that γ-secretase levels
could be imperative during pre-implantation development. Although genetargeting studies indicate that the canonical Wnt pathway is not necessary during
pre-implantation development (de Vries et al., 2004), non-canonical Wnt
signaling is critical for cross-talk between the blastocyst and the uterine
environment (de Vries et al., 2004; Mohamed et al., 2004; Xie et al., 2008), and
successful implantation requires an activated blastocyst and a receptive uterine
niche. While uterine receptivity depends primarily on estrogen and progesterone
(Dey et al., 2004), a variety of factors are crucial for blastocyst activation,
including the cannabinoid, MAPK and Erb1/2 receptors (Wang and Dey, 2006).
Ribosome biogenesis is the process by which a 47S pre-rRNA is systematically
cleaved into mature rRNAs that will be incorporated into ribosomal subunits.
Mutations in genes involved in ribosome biogenesis have deleterious effects
during pre-implantation development (Lerch-Gaggl et al., 2002; Yamamura et al.,
2008; Romanova et al., 2006; Zhang et al., 2008; Ding et al., 2010; Gallenberger
et al., 2011; Vogt et al., 2012). These studies all show disruption in the nucleolus
and increased cell apoptosis, which suggests that nucleolar proteins are
important for embryo development.
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1.2

NOTCH Signaling

The NOTCH signaling pathway, first identified in Drosophila and conserved
across species (Weinmaster et al., 1991), is involved in a wide range of biological
processes from cell fate specification to tissue homeostasis (Artavanis-Tsakonas
et al., 1999; Bolos et al., 2007). The name NOTCH comes from the appearance
of notched wings in mutant fruit flies.
The epidermal growth factor-like (EGF) repeats of the ligand’s extracellular
domain interact with the EGF repeats 11 and 12 of the NOTCH receptors’
extracellular domain to initiate the signaling. This interaction causes the
activation of A Disintegrin And Metalloproteinase (ADAM) 10 or 17 (Figure 1.2).
The ADAMs cleave the extracellular domain of NOTCH, which is then cleaved by
the S3 cleavage to release the NOTCH intracellular domain (NICD). NICD is the
substrate of proteolytic gamma-secretase complex. The C-terminal of NOTCH
translocates to the nucleus. The NOTCH intracellular domain does not contact
DNA directly, that is, it needs to associate with a transcriptional factor. The wellknown NOTCH associated transcriptional factor is RBP-Jk (CSL), which contains
the CGTGGGA recognition motif (Reichrath and Reichrath, 2012). The
interaction between NICD and RBP-Jk recruits the coactivator Mastermind-Like
(MAML) and the histone acetyltransferease p300. Kinase CDK8 later on
phosphorylates NICD to become a substrate for ubitiquination degradation (Fryer
et al., 2004). The NICD translocates to the nucleus, where it disrupts the
repressor complex, leading to the activation of downstream target genes
(Schroeter et al., 1998). NOTCH ligands are transmembrane proteins of the DSL
(Delta/Serrate/LAG-2 like family). NOTCH 1, 2, 3, and 4 are the four
transmembrane receptors on the surface of signal receiving cell that can be
activated by one of the five canonical NOTCH ligands (Jagged 1, 2; Delta-like 1,
Dll 3, and 4 in mammals).
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Signal sending cell
ligand
Cell membrane

EGF repeats

receptor

cleavage by
ADAMs

cleavage by
Υ-Secretase

Signal receiving cell

NICD

MAML HAc

CoR HDAc

RBPJ

RBPJ

Repressed

Activated

CoR HDAc

nucleus

Cell membrane

Figure 1.2 NOTCH signaling pathway
The red protein located on the signal sending cell is the ligand of NOTCH
signaling, JAG1, 2 and DLL 1, 3, 5. The NOTCH receptor contains an
extracellular domain that interacts with the ligand, a transmembrane domain, and
an intracellular domain (NICD). After the binding of the NOTCH ligand on the
receptor, NOTCH receptor is cleaved by ADAMs to release the extracellular
domain and then follows by the cleavage by Υ-secreatase complex to release
NICD. NICD is then translocated to the nucleus, displaces the co-repressors of
NOTCH downstream target genes and histone deacetylase, and then recruits coactivator of NOTCH and histone acetyltransferease to activate downstream gene
expression.
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Despite the simple ligand/receptor activation transduction, NOTCH also elicits
another complex regulation that involves a posttranslational modification.
Common posttranslational modifications are ubiquitination of the ligand,
glycosylation and proteolytic cleavages of receptor, and the inhibiting
ubiquitination of the receptor by the E3 ubiquitin ligase Numb (Lai, 2004). The
most well known NOTCH target genes are members of the Hairy/Enhancer of
Split family (Hes1, Hes5, Hes7) and the Hairy/Enhancer of Split related with
YRPW motif family (Hey1, Hey2, Hey7). Hes genes are important for
somitogenesis (i.e. mesoderm specification) and generation of the nervous
system. The Hey family is critical for the development of the cardiovascular
system (Fischer and Gessler, 2007). Gene regulation by NOTCH can be
mediated by interactions between NICD and other partners. The most wellcharacterized regulator is a DNA-binding protein called CSL (CBF1 in human,
Su(H) in fruit fly, and LAG1 in C. elegans). CSL is also called RBPJ. CSL can
both activate and suppress NOTCH target genes by associating with different
binding partners (Persson and Wilson, 2010).
The NOTCH signaling components are detected from the zygote stage
throughout gestation (Ahnfelt-Ronne et al., 2012; Cormier et al., 2004b; Del
Monte et al., 2007; Yoshikawa et al., 2006). Cormier et al. (Cormier et al., 2004b)
examined the expression of genes that were directly or indirectly involved in the
NOTCH pathway in the pre-implantation embryo development. Notch1-2, Jag1-2,
Dll-3, Rbpj, and Dtx2 are expressed from unfertilized oocytes to late blastocyst
stages; Notch 4 and Dll-4 transcripts are detected from two-cell stage to the
hatched blastocyst stages. Notch 3, Dll1, and Dtx1 mRNA are found in two-cell
embryos and in hatched blastocysts, but are not detectable at the morula stage.
These results suggest that the NOTCH signaling pathway may be active during
pre-implantation development. Using microarray, Wang et al. also uncovered that
other genes of the NOTCH pathway, such as Fringe, Srrt, Psen1 and Dtx1 are
expressed in mouse pre-implantation embryos (Wang et al., 2004).
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NOTCH signaling is essential in regulating mid-gestation processes that include
somitogenesis, lymphopoiesis, and vascular development in a CSL-dependant
process (Conlon et al., 1995; Irvine, 1999; Lai, 2004; Palmeirim et al., 1997).
However, NOTCH might act in a CSL-independent manner before gastrulation.
Several lines of evidence demonstrate that NOTCH signaling is dispensable for
gastrulation in mice. (Table 1.1) Single gene and compound knockout studies of
the Notch receptors and ligands result in either viable animals or embryonic
lethality at mid-gestation (Conlon et al., 1995; Dunwoodie et al., 2002; Hamada
et al., 1999; Hrabe de Angelis et al., 1997; Jiang et al., 1998a; Jiang et al., 1998b;
Jiang et al., 1998c; Krebs et al., 2004; Krebs et al., 2000; Krebs et al., 2003;
McCright et al., 2001; Swiatek et al., 1994). Similarly, deletion of genes that block
NOTCH signaling, such as Pofut1 and members of the Υ-secretase complex,
leads to embryonic failure after gastrulation and midline formation (Shi et al.,
2005b). This suggests that another regulator may play a similar role as CSL to
direct the NOTCH regulation during pre- and peri-implantation stage.
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Table 1.1 Mutant lethality / phenotypes of the NOTCH signaling in mice
Gene

Mutation

Phenotype

Interaction

References

Notch 1

KO

Lethal
~E11.5

Notch 4 (fail to turn
at E9.5)

Swiatek et al., 1994

Notch 2

KO

Lethal
~E11.5

Notch 3

KO

Normal

None with Notch 1

Krebs et al., 2003

Notch 4

KO

Normal

Notch 4 (fail to turn
at E9.5)

Krebs et al., 2003

Delta
Like-1

KO

Lethal ~E12

Hrabe de Angelis et
al., 1997

Delta
Like-3

KO

Skeletal
Malformatio
ns

Dunwoodie et al.,
2002

Delta
Like-4

KO

Lethal ~E12

Krebs et al., 2004

Jagged 1

KO

Lethal
~E11.5

Xue et al., 1999

Nle1

Missense

Lethal<E7.5

Lossie et al., 2012

Hamada et al., 1999
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1.3

Wnt Signaling

Wnt signaling is conserved from Drosophila to human, and it regulates a myriad
of processes, including embryogenesis, cell fate specification, cell proliferation,
and homeostasis in adult tissues (Logan and Nusse, 2004). Canonical Wnt
signaling in mammals, which is mediated by β-catenin, includes 19 Wingless
(WNT) ligands, 10 G-protein coupled frizzled receptors (FZD) and two lowdensity lipoprotein receptor-related protein co-receptors (LRP-5 and 6) (Wodarz
and Nusse, 1998). When a WNT ligand binds to the cysteine-rich domain of its
cognizant FZD receptor, signaling induces heterodimerization of FZD-LRP and
recruits Dishevelled (DSH) to the FZD-LRP dimmer, forming a complex called a
signalosome (Bilic et al., 2007). β-catenin accumulates in the cytoplasm. βcatenin translocates into the nucleus where it co-regulates transcription. The
non-canonical pathway is poorly characterized and involves diverse receptors
and downstream targets. Wnt/planar cell polarity (PCP) and Wnt/Ca2+ pathway
are the two well-characterized non-canonical pathways. Binding of the noncanonical WNT ligands to FZD results in DSH activation without the incorporation
of LRP as a co-receptor (Sheldahl et al., 2003). Signaling then passes down to
different downstream targets depending upon the interacting pathways.
WNT signaling plays important roles in both embryo and the uterus to during
implantation. In situ studies of the Frizzled (Fzd) genes indicate that Fzd5, Fzd7,
and Fzd10 are detected in pre-gastrulation embryos (Kemp et al., 2005; Kemp et
al., 2007), as well as in the uterus during peri-implantation (Hayashi et al., 2007;
Hayashi et al., 2009a; Hayashi et al., 2009b; Miller and Sassoon, 1998). At the
blastocyst stage, several Wnt genes, such as Wnt5a, Wnt7a, and Wnt11 are
expressed at higher levels than in the morula stage (Mohamed et al. 2004). In
addition, expression levels of Wnt7a, Wnt7b, Wnt11, and Wnt16 are much higher
in the implantations sites of maternal uterus compared to non-implantation sites
(Hayashi et al., 2009b). Moreover, in embryos where Wnt3 has been deleted,
embryos do not form a primitive streak, and fail prior to gastrulation (Barrow et al.,
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2007). However, depletion of both maternal and zygotic β-catenin does not
disrupt blastocyst development (de Vries et al., 2004), indicating that canonical
Wnt pathway is dispensable during pre-implantation development.
Therefore, the non-canonical signaling may play a role in pre-implantation
development. For example, overexpression of Dishevelled proteins, which
transduce divergent Wnt pathways, disrupts cell-cell adhesion during preimplantation (Na et al., 2007). Dishevelled proteins regulate cell polarity and cell
adhesion through non-canonical Wnt signaling (Fanto and McNeill, 2004; Moon
et al., 1993). These data suggest that non-canonical Wnt pathway(s) may be
active during pre-implantation development. Nevertheless, the canonical Wnt
pathway becomes critical at implantation. Xie et al. (2008) showed that
inactivation of zygotic nuclear Wnt-β-catenin signaling through activating Dkk1, a
potent inhibitor of β-catenin, limits the competency of blastocysts to implant (Xie
et al., 2008). This cascade initiates in the trophectoderm, which expands during
implantation to invade the maternal decidua and form a protective environment
for the developing embryo. As a whole, these studies suggest that Wnt signaling
undergoes a switch from the non-canonical pathway in the early pre-implantation
blastocyst to canonical signaling as the hatched blastocyst creates its protective
niche within the uterine wall where it interacts with new signaling molecules in the
maternal tissue (Xie et al., 2008).

1.4

Ribosomal Biogenesis

During early development, there is an increased demand in protein synthesis
(Schultz et al., 1990). To meet the high protein requirements, the embryo must
improve its translational capacity by up-regulating ribosomal biogenesis.
Ribosomal biogenesis is a key process that governs protein synthesis and
requires factors for processing rRNA, assembly, and transporting of ribosomal
subunits from nucleolus to cytoplasm (Tschochner and Hurt, 2003). Alterations in
this process can cause defects in protein translation and therefore disrupt
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embryogenesis or lead to detectable disease (Baserga et al., 2010; Fukuda et al.,
2008; Gallenberger et al., 2011; Zhang et al., 2008)
Ribosomal biogenesis is a well-coordinated and evolutionarily conserved process
that takes place in the nucleolus (Fromont-Racine et al., 2003). During mouse
early embryo development, the nucleolus is exclusively maternally inherited. The
maternal nucleolus disassembles after pronuclear fusion, and later on, the
zygotic nucleolus is assembled when the embryonic genome becomes activated.
The oocyte-originated nucleolar components are crucial for serving as the
precursor materials that are required to reassemble the functional zygotic
nucleoli (Ogushi et al., 2008). When the nucleolus is removed from the oocytes,
about 80% of enucleolated oocytes can reach second metaphase (MII) and are
fertilized, which suggests that the nucleolus is not required for fertilization.
However, the embryos that originate from enucleolated oocytes never progress
to the 4-cell stages and show an abnormality of higher chromatin organization in
both female and male pronuclei. After the reinjecting the nucleolus in the oocytes,
these oocytes are fertilized and develop to full term. While reinjection of the
nucleolus at the pronucleus stage can rescue the embryos, it highly reduces the
rate of blastocyst formation (Ogushi and Saitou, 2010). This data indicates that
the nucleolus of oocytes is critical for the early step of pronuclear organization.
Ribosome biogenesis in eukaryotic cells starts with the transcription of the
ribosomal DNA (rDNA) into a 47S (45S in yeast) polycistronic precursor by RNA
polymerase I in the nucleolus (Fig.1.3). The precursor contains the mature 18S,
5.8S and 28S rRNA interspersed with non-coding internal transcribed sequences
ITS1 and ITS2, and is flanked 5’ and 3’ by external transcribed spacers (ETS).
Hundreds of r-proteins, non-ribosomal proteins, and small nucleolar RNAs
(snoRNAs)

associate

with

the

47S

pre-rRNA,

forming

the

90S

pre-

ribonucleoprotein particle (90S pre-RNP) (Cisterna and Biggiogera, 2010;
Fromont-Racine et al., 2003; Tschochner and Hurt, 2003). After cleaving by the
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exo- and endonulceolytic ribonucleases within the ITS1, the 90S precursor splits
into the pre-40S small subunit and the pre-60S large subunit, which further
become mature 40S and 60S subunits, respectively. The 40S subunit consists of
the 18S rRNA, while the 60S subunit contains the 5.8S and 28S rRNAs as well
as the 5S rRNA that is transcribed independently by RNA polymerase III (Eichler
and Craig, 1994; Venema and Tollervey, 1999). The 40S and 60S subunits are
then exported from the nucleolus to the cytoplasm, where final maturation takes
place.
5’ETS 18S
47S pre-rRNA

Nucleus

5.8S
ITS1

28S

3’ETS

ITS2

47S

pre-90S subunit

45S

Nucleolus
5’ETS

18S

5.8S ITS2

ITS1

12S

21S

28S
32S

5.8S
ITS2
5S

Cleavage site

18S

pre-40S
subunit

5.8S
pre-60S
subunit

28S

Ribosomal
biogenesis proteins
Small nucleolar
Ribonucleoproteins
Ribosomal proteins

40S
subunit

Nuclear
pore

60S
subunit

Cytoplasm

Figure 1.3 Ribosomal biogenesis
Ribosomal biogenesis occurs in the nucleolus, where the 47S pre-rRNA is
transcribed by RNA polymerase I. The 47S pre-rRNA is then being processed by
ribosomal proteins, ribonucleoproteins, and ribosomal proteins to generate the
mature 28S, 18S, and 5.8S rRNA. The 18S rRNA will be incorporated into the
pre-40S ribosomal subunit, while 28S, 5.8S and 5S rRNA, and ribosomal
proteins form the pre-60S subunits. The pre-40S and pre-60S subunits transport
from nucleolus to cytoplasm and then initiate the final maturation.
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Several studies have used gene-targeting techniques to identify the role of
nucleolar proteins during early embryogenesis. Most cases have shown defects
in embryo development when the protein function was disrupted. For instance, in
mouse mutants for proteins involved in ribosomal rRNA synthesis and processing,
such as pescadillo-1 (PES-1) (Lerch-Gaggl et al., 2002), RNA polymerase 1
(Yamamura et al., 2008), SURF6 (Romanova et al., 2006), RBM19 (Zhang et al.,
2008), EMG1 (Ding et al., 2010), WDR36 (Gallenberger et al., 2011), LIN28
(Vogt et al., 2012) and so on, mutant embryos are arrested at the morula stage.
For the Tif1a (a gene mediating the processing of rRNA transcription) mutant
(Yuan et al., 2005), and the S6 (Ribosomal protein S6) mutant (Volarevic et al.,
2006), phenotypes appear after implantation. In addition, knocking out of
nulceophosmin, a nucleolar protein that processes rRNA and segregates
chromosome, mutants fail between embryonic day E11.5 and E16.5 (Grisendi et
al., 2005). Although these mutants die at different developmental time points,
they all show disruption in the nucleolus and increased cell apoptosis, which
suggests that nucleolar proteins are important for embryo development.
1.5

Generation and Phenotype of l11Jus1 and l11Jus4

Mouse chromosome (Mmu Chr) 11 shares significant synteny conservation with
regions of six different human (Hsa) chromosomes: 22, 7, 2, 5, 1, and 17 (Boles
et al., 2009). The largest domain of synteny conservation between mouse and
human occurs on distal Mmu Chr11, which is entirely syntenic with Hsa chr 17
(Hentges et al., 2007). The gene-rich domain flanked by Trp53 and Wnt3 in this
region of synteny conservation contains 2545 gene structures, including 1597
predicted protein-coding genes, 450 processed RNAs, and 498 pseudogenes
(Boles et al., 2009).
A large-scale, phenotype-driven ENU (N-ethyl-N-nitrosourea) mutagenesis
screen targeted to this 34 Mb region of Mmu 11 demonstrated the wide functional
diversity of this linkage group (Hentges et al., 2006b; Hentges et al., 2007; Kile et
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al., 2003). Functional analysis of 785 total pedigrees from this ENU mutagenesis
screen resulted in the discovery of a variety of mutant phenotypes, including
infertility, craniofacial abnormalities, neurological defects, and lethality (Kile et al.,
2003). Subsequent studies detailed the embryonic lethal phenotypes of 45
mutant lines that fell into 40 complementation groups (Hentges et al., 2006b; Kile
et al., 2003). Resequencing efforts led to the identification of causative or
putatively causative lesions in 31 genes in 17 lethal lines (Boles et al., 2009).
Although many mutations were identified in the sequencing study, the lesions in
the l11Jus1 and l11Jus4 complementation group have yet to be identified. These
two mutants survive through implantation but arrest prior to embryonic day (E)
6.5 (Fig. 1.4) (Hentges et al., 2006b; Kile et al., 2003). Since these two mutants
fail during this critical window, we undertook a positional cloning strategy to
identify the causative mutations in this complementation group. We identified that
both mutant alleles have non-conservative missense mutations in the Notchless
homolog 1 (Drosophila) gene, Nle1 (Lossie et al., 2012). Moreover, targeted
disruption of Nle1 in mice (Cormier et al., 2006a) results in an embryonic lethal
phenotype that is remarkably similar to l11Jus1 and l11Jus4, providing further
supporting evidence that Nle1 is disrupted in both mutant alleles.
Previous studies have determined that Nle1 is a key regulator in the NOTCH
pathway (Royet et al., 1998b). NLE1 was first discovered in Drosophila and
belongs to the WD40 repeat family of proteins. It can either reduce or enhance
NOTCH activities in a complex manner, depending upon the developmental
stage and the species. Studies in Drosophila and Xenopus demonstrate that
NLE1 signals via the canonical NOTCH pathway (Cormier et al., 2006a; Royet et
al., 1998b). In invertebrates and lower vertebrates, the NOTCH pathway is critical
for directing cell fate prior to gastrulation, and also plays important but varied
roles in germ layer boundary formation. At the 4-cell stage in C. elegans, NOTCH
signaling dictates an ectodermal cell fate in ABp daughter cells by repressing
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expression of TBX-37 and TBX-38 (Good et al., 2004). In sea urchins, the
NOTCH pathway impacts the development and differentiation of the secondary
mesenchymal cells, which are fated to produce mesodermal cells (Sherwood and
McClay, 1999, 2001). In contrast, in X. laevis, induction of NOTCH signaling
leads to an increase in endoderm-specific and a decrease in mesoderm-specific
markers, while suppression of NOTCH signaling has the opposite consequence
(Contakos et al., 2005).

Figure 1.4 Nle1 mutant phenotype
H&E stained sections of implantation sites from the WT and mutant embryos

1.6

NOTCHLESS in the ribosomal biogenesis pathway

For the species that lack NOTCH signaling, such as yeast and plants, NLE1 is
integral to ribosomal biogenesis (Chantha et al., 2007b; de la Cruz et al., 2005a;
Matton and Chantha, 2007). NLE1 is structurally similar to a protein called
WDR12, in that they both contain an Nle domain and WD40 repeats (Nal et al.,
2002). In yeast, the WDR12 homolog Ytm1 and the NLE1 homolog Rsa4 both
interact with the AAA+-ATPase Rea1 in directing rRNA processing (Bassler et al.,
2010; Bottcher et al., 2009). Rea1 is a conserved pre-ribosomal factor that was
identified as a component of the pre-60S particle located in the nucleoplasm
(Galani et al., 2004; Nissan et al., 2004). Rea1 is required for the formation of
60S and processing of ITS2, being specifically involved in a late step generating
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the mature 5.8S rRNA from the 7S pre-rRNA (Galani et al., 2004). Electron
microscopy showed that Rea1 contains two major domains, an AAA motor
domain that binds to the pre-60S particles, and a long flexible tail harboring a
metal ion-dependent adhesion site (MIDAS) (Bottcher et al., 2009). The MIDAS
of Rea1 directly but sequentially contacts the N-terminal NLE domain of Ytm1
and Rsa4 during 60S subunit biogenesis; therefore, the NLE is also called
MIDAS interacting domain (MIDO) (Bassler et al., 2010; Bottcher et al., 2009). A
conserved glutamate in the MIDO has been found to be essential for interacting
with MIDAS. Disruptions of both yeast NLE1 and WDR12 lead to the blocking of
the processing from 35/27S precursor rRNA to the mature 25S rRNA and 5.8S
rRNA (in mammal, corresponding to 36/32S pre-rRNA to 28S rRNA and 5.8S
rRNA) (Bassler et al., 2010). In addition, mutating the conserved glutamate in this
domain in yeast WDR12 causes an early block at the transition of 60S from the
nucleolus to the nucleoplasm (Bassler et al., 2010). The glutamate mutation in
yeast NLE1 leads to inhibition of exporting the pre-60S particles from the
nucleoplasm to the cytoplasm (Bottcher et al., 2009). Because all these proteins
are conserved across species, it is possible that in mouse, the Rea1 homolog
(MDN1) drives a similar interaction between WDR12 and NLE1 during 60S
ribosomal biogenesis.
1.7

P53 Regulation

The tumor suppressor gene p53, which governs the regulation of cell proliferation
and apoptosis (Levine and Oren, 2009), also plays an important role in the
normal development. The function of p53 and the p53 family members (p63 and
p73) is mostly determined by cell context, i.e., the cell’s physiological background
(Vousden and Lane, 2007). For example, when cells are under stress caused by
radiation, hypoxia, metabolite shortages, oncogene dysregulation or viral
infections, the p53 clan members, and in particular p53 itself, can be activated to
restrain damaged cells from transformating by inducing cell cycle arrest,
senescence, apoptosis, and terminal differentiation (Hu et al., 2008; Levine and
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Oren, 2009; Vousden and Lane, 2007). In contrast, lack of proper function of p53
leads to cancer progression (Molchadsky et al., 2010).
P63 and p73 belong to the p53 clan family. They play similar but slightly different
roles than p53. P63 is usually overproduced in tumor cells, while most of these
over-produced p63 are the isoforms that are able to bind DNA, but incapable of
transactivation because they do not contain the transactivation domain (Candi et
al., 2007). Therefore, p63 is thought to act in a dominant negative way toward
transactivation. Like p53, p63 can direct cells to apoptosis in response to DNA
damaging (Gressner et al., 2005). Similarly, p73 is a transcriptional factor
activated by damaging stress and can induce many of the classical p53 target
genes (e.g., p21, Puma, Bax) as well as p53 itself (Wang and El-Deiry, 2006).
Since the p53 response can lead to cell death, it is crucial to maintain appropriate
p53 activity levels. One of the major ways in which p53 is regulated is through a
rapid protein turnover. In normal cells, p53 is expressed at very low levels with a
short half life (Shadfan et al., 2012). The p53 protein is constantly produced and
rapidly degraded by ubiquitylation mediated by MDM2, allowing the quick
removal

or

modifications,

buildup

of

including

p53.

P53

undergoes

phosphorylation,

various

acetylation,

post-translational
methylation,

and

ubiquitination (Appella and Anderson, 2001; Carr et al., 2012; Dai and Gu, 2010).
After cellular stress, p53 is activated and stabilized through acetylation and
phosphorylation, thereby inducing cell cycle arrest or apoptosis. The reversible
acetylation of lysine residues is widely accepted for activating p53 function (Tang
et al., 2008b). Many studies have described how DNA damage can induce p53
acetylation either through activating of acetyltransferases or by recruitment of
those acetyltransferases by phosphorylating p53 (Jenkins et al., 2012; Meek and
Anderson, 2009; Sykes et al., 2006). P300 and CBP are the two highly related
histone acetyltransferases that acetylate the core domain as well as six lysines
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on the C-terminal of p53. These six lysines are K367, K369, K370, K378, K379,
and K383 in mouse, equivalent to the human K370, K372, K373, K381, K382,
and K386, respectively (Feng et al., 2005; Krummel et al., 2005). The same
lysine residues are targeted by MDM2 for ubiquitylation. Since acetylation and
ubiquitylation of the same lysine are mutually exclusive, acetylation on p53 leads
to blocking of ubiquitylation and thereby suppressing the degradation of p53 by
MDM2 (Li et al., 2002). Acetylation of these residues prevents p53 translocation
from the nucleus and inhibits subsequent degradation (Tang et al., 2008b).
Acetylation also increases the DNA-binding ability of p53, and consequently
activates the transcription of its target genes, leading to the induction of cell cycle
arrest or apoptosis, depending on the cell types and the nature of cellular stress
(Gu and Roeder, 1997; Luo et al., 2004; Wang et al., 2003).
An active p53 can be induced by cellular stress. One of the major types of stress
responses that initiates a p53 response is DNA damage (Shadfan et al., 2012).
After DNA damage, proteins are recruited to the damage site and activate the
p53 pathway that leads to cell cycle arrest in order to repair the damage. If the
damage cannot be reversed, the cell will undergo permanent cell cycle arrest or
programmed cell death (apoptosis) (Molchadsky et al., 2010). One of the key
activators in this p53 activation is Ataxia Telangiectasia Mutated (ATM), which
acts on the p53 inhibitor MDM2 (Chun and Gatti, 2004; Maya et al., 2001). ATM
kinase directly phosphorylates MDM2 at S395, which changes the activity of
MDM2 ligase to prevent p53 degradation and export (Mayo and Donner, 2001).
Another kinase, DNA-PK (DNA-activated Protein Kinase), also phosphorylates
MDM2 at its p53-binding domain that leads to reduced affinity of p53 and MDM2
(Mayo et al., 1997). Therefore, the amount of stabilized p53 is increased.
Another type of cellular stress that activates p53 is ribosomal stress (Deisenroth
and Zhang, 2011). Several studies link p53 activation to the interaction between
MDM2 and ribosomal proteins such as L5, L11, L23, L37, S7, S15, and S20
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(Daftuar et al., 2013; Dai and Lu, 2004; Jin et al., 2004; Lohrum et al., 2003;
Zhang et al., 2003; Zhu et al., 2009). These studies determined that during misregulation of ribosomal biogenesis, ribosomal proteins can activate p53 by
binding to and inhibiting MDM2. Moreover, studies have shown that ribosomal
stress induces degradation of MDMX (also known as MDM4) (Gilkes et al., 2006).
MDM2 and MDMX are binding partners and have been shown to regulate p53
activity as a complex (Joseph et al., 2010). When cells are under ribosomal
stress, ribosomal protein L11 promotes MDMX degradation by binding to MDM2
and causes p53 activation (Gilkes and Chen, 2007; Gilkes et al., 2006). 5S rRNA
has been found to stabilize MDMX, which may be important to control the activity
of MDMX under normal cell conditions (Li and Gu, 2011).
1.8

Objective

According to the American Pregnancy Association, miscarriage is the most
common type of pregnancy loss, and 15-20% of clinically recognized
pregnancies terminate in miscarriage (Rai and Regan, 2006). Given the high
number of miscarriage occur in human population, further research in embryonic
development is necessary. The long-term goal of my research is to understand
how genetic and epigenetic events work together to regulate early mammalian
development. This information can be used to develop therapeutic strategies to
reduce the incidence of miscarriage in the U.S. The phenotype of the Nle1
mutant mimics early miscarriage. Mutant animals survive through implantation
but fail prior to gastrulation. NLE1 is a member of the WD40-repeat protein family,
and is thought to signal via the canonical Notch pathway. In invertebrates and
lower vertebrates, the Notch pathway directs cell fate prior to gastrulation.
However, gene-targeting studies demonstrate that Notch signaling is dispensable
for gastrulation in mice. Interestingly, reports in yeast and plants (which lack
NOTCH signaling) demonstrate a role for NLE1 in ribosomal biogenesis. In
addition, previous studies in our laboratory have demonstrated that Nle1-/animals do not exhibit a general disruption in the downstream target gene
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expression, but do show mis-expression of Cdkn1a and several members of the
Wnt pathway, suggesting that NLE1 interacts with other signaling pathways prior
to gastrulation in mammals. Therefore, the objective of my project is to elucidate
the role(s) of Nle1 during early embryonic development. I hypothesize that prior
to gastrulation, Nle1 functions in multiple signaling pathways. The rationale is
that the investigation of the genetic regulatory network of Nle1 would provide
opportunities for developing enhanced diagnostic strategies and potential
treatments to detect and prevent miscarriage.
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CHAPTER 2. IDENTIFICATION OF 129S6/SVEVTAC-SPECIFIC
POLYMORPHISMS ON MOUSE CHROMOSOME 11

The contents in this chapter have been published in DNA Cell Biol. 2012 Mar; 31
(3):402-14

2.1

Introduction

The laboratory mouse is the major animal model used for human disease
research because of its high relevance to human biology and striking genetic
similarities. Understanding the polymorphisms in the laboratory mouse will
provide insights into the evolutionary history of the species and increase
knowledge of the relationship between genotypic and phenotypic differences
(Guenet, 2005). Polymorphisms are genetic variants arise from spontaneous
mutations, and by random genetic drift that occur with a population frequency
greater than 1%, eventual reach steady-state in a population (Schork et al.,
2000). Several types of polymorphisms are found within mammalian genomes,
including single nucleotide variants (SNVs), insertions and deletions (Indels),
variable number tandem repeats (VNTRs), copy number variants (CNVs) and
microsatellite repeats.
Different types of polymorphisms are generally created by different kinds of
alteration events. For example, SNVs, the most common types of polymorphisms,
result from a single base substitution. The most common SNV in the mammalian
genome is a C to T transition, whereby a methylated cytosine is spontaneously
deaminated to form a thymine base (Miller et al., 2001). Since this change is not
recognized by DNA repair enzymes, the SNV segregates within the population
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unless it is under selection, is lost or by chance randomly fixates. SNV variation
in protein-coding genes and in other functionally constrained regions of the
genome, such as promoters, enhancers, miRNAs and other non-coding
sequences contributes significantly to phenotypic variation (Bartel, 2009; Morin
PA, 2004; Sethupathy et al., 2007). Indels are often, but not always, present in
highly repetitive sequences (Chen et al., 2009).They are abundantly distributed
across the genome, but not as common as SNVs (Vali et al., 2008). Both of
these types of genetic variations can be used as tools in genotyping, as well as
discovery of disease- or trait-related genes by directly sequencing SNVs or
identifying Indels based on size separation or sequence.
Many mouse polymorphism databases are available, such as the MGI (Mouse
Genome

Informatics)

Strains,

SNPs

&

Polymorphisms

database

(http://www.informatics.jax.org/strains_SNPs.shtml) (Blake et al., 2011a) and the
MPD (Mouse Phenome Database) SNP collection (http://phenome.jax.org/SNP/)
(Smith JA, 2010). The MGI database provides reference SNV and Indel
information, as well as the corresponding genotyping assays. SNV queries can
be based on strain, map position, marker range or associated genes. Currently,
there are data from 86 mouse strains, but many holes exist in these databases
and more assays are needed to fill in the blanks.
While conducting a positional cloning project to identify induced variants from an
N-ethyl-N-nitrosourea

(ENU)

mutagenesis

screen,

we

detected

several

129S6/SvEvTac polymorphisms in potential candidate genes. This ENU
mutagenesis screen was performed on C57BL/6J males, which were bred to
129S6/SvEvTac animals carrying an inversion chromosome for the targeted
region (Hentges et al., 2006a; Kile et al., 2003). The mouse reference sequence
is based on C57BL/6J, which is one of the most widely used inbred mouse
strains for the generation and analysis of transgenic mice and disease models
(Al-Hasani et al., 2004; Tang et al., 2008a). 129S6/SvEvTac and 129S1/SvImJ
have been used frequently for gene knock out studies (Hibma et al., 2007; Kuo et
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al., 2010). 129S1/ImJ is one of the 17 additional mouse strains being sequenced
by the Sanger Center (Turner et al., 2009). However, there is very little
polymorphism data for 129S6/SvEvTac. As a result, it is important to develop
SNV and other polymorphism detection assays to help identify 129S6/SvEvTac
alleles to facilitate genotyping. Here we provide SNV and insertion/deletion (Indel)
information for 7 genes located on chromosome 11 between these three
commonly used laboratory mouse strains.
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2.2

Methods

We isolated genomic DNA from mouse tail biopsies from 129S6/SvEvTac and
C57BL/6J animals; 129S1/SvImJ DNA was purchased from the Jackson
Laboratory. Exons from each gene were sequenced individually. Each 600-800
bp PCR amplicon contained one or more exons plus upstream and downstream
flanking sequence. Exons larger than 800 bp were sequenced by multiple
overlapping sequencing reactions. All amplicons were sequenced in both
directions using Big Dye v3.1 chemistry (Applied Biosystems, Foster City, CA).
Primers are listed in Table 2.1.
We analyzed the data using Sequencher 4.9 (Gene Codes, Ann Arbor, MI) to
identify polymorphisms among the various strains used in this study. The
sequences from different samples were assembled automatically and then
entered

into

a

BLAT

search

against

the

UCSC

genome

database

(http://genome.ucsc.edu/cgi-bin/hgBlat?command=start) (Kent, 2002)(NCBI Build
37 (Mm11_95772_37)) to obtain the cDNA and genomic DNA sequences. All
sequences (including cDNA and genomic regions) were assembled with our
sequencing data into a contig that spanned one individual exon. The contig was
scanned for any polymorphisms using features of the Sequencher program.
Once a variation was identified, we checked the chromatogram manually to
distinguish true polymorphisms from sequencing errors. All SNVs and other
polymorphisms were compared with SNV information from the MGI database
(dbSNV Build 128) to pinpoint SNVs within the contig and identify unique
polymorphisms. Exon or intron positions were determined using the UCSC
genome database (http://genome.ucsc.edu/) (Fujita et al., 2011). We compiled all
polymorphisms into tables containing gene location, nucleotide number, local
sequence, existing SNV ID using the C57BL/6J as the reference strain.
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Table 2.1 Primers used for this study
Mettl16-E1F
Mettl16-E2F
Mettl16-E3F
Mettl16-E4F
Mettl16E5/6F
Mettl16-E7F
Mettl16E8/9F
Mettl16-E10F
Mettl16-E11F
Mettl16-E12F
Mettl16-E13F

TTCTCCATCCGCTAACCTAAGAAG
GGCACTAAATATGCTGGTTTCCTC
GAACGCTGTACCATGGAGCTATAC
GTGTATCTGCTGTTGTGCTGAATG
CTCTGAGTTATGTGTGAAATGGGC

TCAACAGATGTCTCCCACCTAGAC
AATCACACAAAGCACAGTCCTAGC
ACTTCTCAATGATACCTGCAGCC
TTCTTCCTTCCACGCTTCTCTAAC
CCCAAATCTCAGGGCAATCTATAC

T
m
60
60
60
60
60

TCCAACTCTCCTTCATGGTTTATG
GATAAACTTGATGCGTCTCCATTG

CTGAACAACTTGTGCTAACACTGC
CTCCGGAAGCCTTAATAACTGAAC

60
60

616
504

ACCATGGGCTAATCCAAGTTAATG
CTCCCACTGGCTGTGTGTTC
GGAAATTTGAAGAGCTGGGTATTG
CCTATACTGCAGTTGGAAATACGC

60
60
60
60

490
599
577
425

Mettl16-E14F
Mettl16-E15F
Mettl16-E16F
Evi2aE1F

CTCTACATGCCTTCAGGGTCTATG
AAAGAGCAACAGGAGTTAGCAGC
TCAATAAAGGCCTGAGATTCCTTC
CACTAAAGATGCCATCATGTAATTT
CC
CCCTGACTGTCTCAGCCTTCTAAT
CCATGTTCTCCTTTCCTTCAAGAT
GCCTCAGGTTCCAGTAATCAGAAT
AGAGAAAGCACGAAGAAGGAACTG
ACGGGGCAGAGAGACTACAACT
TTCATTTTCTTTTCTTAGTGAAACGT
G
CCATATGCTTGTGTGGAGCTTAAA
CTATGGACTGTGTGAACAACATGG
TCAGTTGTTGTGTTGAACTTGATGT
GGGCTGGGTATGACAGCTCA
TAGGAACTGGCTTGTGACTTGTG
TTTTGTTTTGCAGCCCAGAAG
TGATGGTGAGGACAGGCTGTTTAT
AGCTTGGTCATGAGAGAGTTTCCT
AGGCAGAGCAGAGGACAGTAAGAT

CAGAACTAGGTGGAGGTCTTCGAG
CTGAGATGGCTGGTAGTCTGTTTC
TTCTAACCTATTTGGGAGGTGGC
ACATGGTATACACACATATACACAGG
C
AAGCTGCTATACCCAAATTTCGAC
GGTCTACCGAAGCTTATCACACAA
CAACAGCAGTGGGCTTAGTGTTAG
TCAAGACCTTCCTCATCCTGATTT

60
60
60
62

928
353
552
626

TTAACAGGCTGCACTTGAGATAGC
GGTGTTCTCCTCACAGACTTCCTT
ATTCAGACAGAGGTCATTCACTGC
GTGTATGCCTAGTTCCCAAGGAAG
ACAGTGAGTCAGCAGCACCATAG
AAAACAGGACTTTCCCTCACCTAT

62
62
62
62
62
62

866
825
845
887
342
320

CATCCTTCCACACACTACCACAGT
ACACTCCCATAACTGGAAGCACTA
AGCAGGACTTTACCGTGACAAAT
GAGGTGAGCAGTAAGAAAGCATGTC
CTCTGACCACCACACTCTGTATCA
ATTAAGGGAGGAAAACAGGGATG
CCTCGAGCTCAGGGATCTGC
GGCCTCTTACCAGACAGACATACC
CATCTCTCTCCACTCCCTTACACA

62
62
62
62
62
62
62
62
62

401
314
375
400
450
200
311
430
574

TAAATAGAAAGGCGTGCTGTGAAA
AGAAGCTGACATAGGTGAGTGCTG

CCAACTCTGCAAGAGAAGACAGAG
CAATTCTGAAGAGGAGGAGAGGTG

62
62

376
500

TCAGTTCTTCCTGATTCACCACTC
TAAGGTCATCCGGGAGAACTAATC
GAAGCAAAGACTTTCATACAATGTT
CA
ACACATTTATGTTAGTGCCGTTGC
TATATTGGTGTTCCTCAGCTCTGC
TTTGAGCCGTGTAACTTAGAGAATA
A
TTACAAATACGAGCCATCATGTCC
GACTTTAGACCTCCCTTGCTTCAG
ATAACCAAAGTGAGCATGGCATAA
TTGAACTGCCTTTGTAACTCAACC
GAAGAGGGCATTACATCCCATTAC
TAGGTTGGGAATGGGATTCTTCTA
GGAGAAAGGAGCCAATAGAGAAAG

CGCACAAGGCTAACAGTTTCTATT
GCACTGCATCTAATACCTGAATCC
ACGGGAGCTTTCTCTTTAACCTTT

62
62
62

545
415
552

TGAATTGTAAATGCTTGCCTTGTT
AGGGAGATCTTCAAGTCAGCATTT
ACTCATGCACATACACACTCACAA

62
62
62

689
587
440

CTTACAAATGTCCACACAGTGCAA
CCCTGACTGTCCTAGAACTCACAA
AAACTGTTCTTCATGGAAACACTCAC
GGCAGCCTACCTTATCTCTCCTCT
CAAGTCCTTCATTTCCCACAAGTA
CTTGATGGTAATGGACTGAACCTG
TACACAGAGGCTGCTGTTACTCCT

62
62
62
60
62
62
60

549
552
158
621
658
469
574

Gene-exon

Evi2aE2aF
Evi2aE2bF
Evi2aE2cF
Evi2aE2dF
Pmsd11E1F
Pmsd11E2F
Pmsd11E3F
Pmsd11E4F
Pmsd11E5F
Pmsd11E6F
Pmsd11E7F
Pmsd11E8F
Pmsd11E9F
Pmsd11E10F
Pmsd11E11/
12F
Pmsd11E13F
Pmsd11E14F
Cct6bE1F
Cct6bE2F
Cct6bE3F
Cct6bE4F
Cct6bE5F
Cct6bE6F
Cct6bE7F
Cct6bE8F
Cct6bE9F
Cct6bE10F
Cct6bE11F
Cct6bE12F
Cct6bE13F

Forward sequence

Reverse sequence

Size
624
468
1081
553
731

27
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Cct6bE14F
RfflE1F
RfflE2F
RfflE3F
RfflE4F
RfflE5F
RfflE6F
RfflE7pcrF
RfflE8aF
RfflE8bpcrF
RfflE8cpcrF
RfflE8dpcrF
Ap2b1-E1/2
Ap2b1-E3
Ap2b1-E4
Ap2b1-E5
Ap2b1-E6
Ap2b1-E7
Ap2b1-E8F
Ap2b1E9/10F
Ap2b1-E11F
Ap2b1-E12F
Ap2b1E13AF
Ap2b1E13BF
Ap2b1E13CF
Ap2b1E13DF
Ap2b1E13D2F
Ap2b1-E14R
Ap2b1-E15R
Ap2b1-E16R
Ap2b1-E17R
Ap2b1-E18R
Ap2b1-E19R
Ap2b1-E20R
Ap2b1-E21R
Ap2b1-E22R
Ap2b1E22AR
Ap2b1E23AR
Ap2b1E23BR
Ap2b1E23CR
Ap2b1E23DR
Ap2b1E23ER

GGTGAGGGTGCTTCCTTGATAATA
CCACACCTGTCCCATGAAAGT
TGGTACTAACAGATTATCACTAACT
TGC
CGATATTTGGAACACTCACTCTGG
CTGTGTGTATCATCTCTGGCTGTG
CTGTGTGTATCATCTCTGGCTGTG
GTGTGTGGCTGTCTGCATAAAGTA
CTCCACATGACTTCTCTGAACACA
TGATCTGAGAGTACCAGACTCAAA
CC
ACGCATGAACGAATGTCCTATCT
CCAGTCTCTCCTGTCCTAAGATCC
GGCCAATAGTATTCCTCAGGTCAG
GGGCTTCTTAACCTTACAAGCAAA
CCTTGAAGCAAGTTGCAGTTCTTA
TAAAGTAGGGTCTGTGTGGCCTTT
GGAAGCCAACACTGTCATCTGTAT
AAAGAATGCCATGAGAGATTGGAT
CTTGGAAGCTGTCTATGCTGTCAT
CAAGAAGGAAACTGGTGTGAGTGT
CAGGCAGAAAGACTGACTTGATTT

AAGCTGGAATTGACTGGGATACTC
GGCCCTACTTCCCTCTGAGTCT
AGGTGTGTGCTTTAGCTACTCG

62
62
62

535
362
393

GGGTCTATGCTGCTGTCTGAGTT
ACTGGACTCAAGGACTTCAGGACT
ACTGGACTCAAGGACTTCAGGACT
AACTGTGTATTCAATGCCTGTTCC
GCAAGGGCAATACCTGACTCTACT
GGATCTTAGGACAGGAGAGACTGG

62
62
62
62
62
62

529
412
412
484
332
663

GATCCAAACTCTGACCTGAGGAAT
AGGACCAGAAGACAAAGACAAAGC
TTCTCAGCTGTGTCAGTGGTGTAA
ATTTACAGCCTTGCCCAAACTAGA
CCTTAGTTTGTAAGCCCACACTCA
TCTCAAGACATTGGTGCTATGTTG
ACAGCATGTCCACTCTCTATCAGC
TACCCTGTAGTCGTGTCTCCAAGA
AATACGCTAGGGATAGCAATGTCC
AGGGCACCAGTCTATAAAGCAATC
CTTCTGGCCTACACAGGTAGTTGA

62
62
62
62
62
60
62
62
62
62
62

586
488
569
1144
570
500
527
479
513
590
810

TAGCAGAGTCAGTGCCTGTCTGA
CTTGGAATCCCTTGTGTATGGTTT
GCATGGTCAATGATTGCTTTGTA

TTCAAAGTGCCTTACTTATACGTTTCC
TAAGCGCTGCAGCTTTGTTATCTA
CTGCAACAGATCAAGAAGAGGTGT

62
62
62

292
429
950

TTCTCAAGAAGCCATCAGAAACAC

AGTCACCCACAGATACCAGATTCA

62

992

GCCTCAAAGCAGATTCTGTTCAAT

TTGAGATTTCAGGCCTGTGCTA

62

1000

ATACTCTGACAAGCGACTTCAGGA

TGAGAGCTCAGAACTGGCAAA

62

945

CCTTTCATAACAGGTCACAACCAG

TGAGAGCTCAGAACTGGCAAA

62

558

CCCTGCCCATATCAATCTATGTTT
TCTCCTTCCATGTGTAGATTCTGG
TTCACTCCCACTGCTCAGTTC
GACAAAGCCTCTAAAGCACGTGTA
AAAGAAGCCAATTGCTCATAGACTT
T
TAGATTGTGTTGGAGCAGGTCAA
ACCTACAGACTGAGGATCATTGG
CTCTTAACTGCATGCTTTCTTCCA
CTGCCTGTATCAGAAGAAGCTCTG
AGTCCTGTGTTGCAATCATGAAAT

AAAGAAGCTCTTCAGAGCAGCAAG
CGGCCAACATGATAAACCTATACA
AGTCAAGACTGGAGGTTCCATTTC
ACGAGGCCCAAACTCAAATAGTTA
TTTGTCCTGTTCTCCAGAGTCAAG

62
62
62
62
62

596
564
507
540
541

CTACCACAATTCTCCGCATGATAC
TGAGATTTGAGGTGGCAGAGTAAG
TAGGGCTGTGCCTTAGAGAGATTT
GGGAAACCTATAGGGTGGAGACTT
GAGGCAGGGTCTCAACTATGAAGT

62
62
62
58
62

504
527
427
1187
287

GCCACACAAGCTGTAGGTAGACAT

AAGACTGTGTTTGATGAGGGTCAG

60

756

TCTTGTGCTGACATTAGCATTCAC

ACCAGTCTCAGCTCTGCTACTCAA

62

853

GAACACTGAGTAGAAAGGGCGACT

CAGTGAGCTGACAGACAGTGAGAA

62

833

TGAGTAGCAGAGCTGAGACTGGTT

GAACTTGGTCAACTTGTCTTTCCA

62

804

TGTGAACACATTGGTGTGAGTCAT

CCAGCTATGTATTGTCCTGGGAAC

62

1100
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Results

We analyzed Nle1, Mettl16, Evi2a, Psmd11, Cct6d, Rffl and Ap2b1 on mouse
chromosome 11. Chromatographs for representative SNVs within each locus are
shown (Figure 2.1). We only detected differences between C57BL/6J and
129S6/SvEvTac in Mettl16 and Ap2b1. However, we summarized SNV
information for sequenced genes.
We identified 21 new polymorphisms and compiled a list of all of the
polymorphisms found to date within the Nle1 locus (MGI dbSNV Build 128)
(Table 2.2) (Blake et al., 2011b). Nle1 is transcribed from the Crick strand, and
variances are ordered in reference to Nle1, not the chromosome. The nucleotide
position is noted in column one (NCBI Build 37) and the location within Nle1 in
column two. Variances detected within exons are designated as synonymous (S)
or non-synonymous (N). Variances reported in the MGI database, but not found
in our sequencing studies are depicted by gray cells, and SNV IDs for previously
identified changes are noted.
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Figure 2.1 Represnetative chromatographs
Mettl16 (A), Evi2a (B), Psmd11 (C), Cct6b (D), Rffl (E) and Ap2b1(F). The SNV
in each sequence is marked in black box. We detected no polymorphisms among
129S6/SvEvTac, 129S1/SvImJ and C57BL/6J in Evi2a, Psmd11, Cct6b or Rffl.
These sites contain known polymorphisms within different inbred mouse strains.
We included known variants in the reference strain (C57BL/6J), as well as those
found in the 129S6/SvImJ, C3H/HeJ, NOD and CzechII strains, and the strains
that we sequenced (l11Jus1, l11Jus4, C57BL/6J, 129S6/SvEvTac, and
C3HeB/FeJ). In total, there are 73 variances across the Nle1 locus, including 5’
and 3’ UTR sequences. We saw no discordance between the C57BL/6J
sequences and the reference sequence. We discovered 9 new indels;
129S6/SvEvTac and C3HeB/FeJ had identical sequences across these regions,
while C57BL/6J, l11Jus1 and l11Jus4 segregated together. cDNA comparison
studies also indicate that the NOD allele (Genbank Accession # AK170853.1)
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has a single nucleotide deletion in the 3’UTR sequence (Carninci and
Hayashizaki, 1999). All polymorphisms identified in the 129S6/SvEvTac and
C3HeB/FeJ strains are new. We identified five new expressed SNVs across the
gene and one expressed indel in the 3’UTR. One previously reported expressed
SNV (rs28209059) is a missense mutation (C 912 G; Table 2.2) in the
129S6/SvImJ and C3J/HeJ strains. This results in a neutral amino acid
substitution (N 291 K) (Livingstone and Barton, 1993) within exon 8, which does
not encode for any type of functional domain.

US
US
US
I1
I1
E2
E3
E3
I3
I3
I3
I3
I4
I4
I4
I4
I4
I4
I4
I4
E5
I5
E6
E6
E6
I6
I6
I6
I7
I7

I7
I7
I7
I7
I7
I7
I7
I7

82721933
82721908
82721877
82721793
82721776
82721648
82721246
82721166
82720449
82720441
82720253
82720130
82719772
82719666
82719658
82719447
82719301
82719207
82719159
82719136
82719059
82718904
82718877
82718839
82718816
82718735
82718697
82718696
82718280
82718241

82718178
82718114
82718099
82718033
82717975
82717963
82717928
Starts 82717908

N

L4 N

S
S

G
G
G
A
C
C
C
T
G
T
A
A
A

AACCGAATCAAC[G/A]GAGAGGTGAGGG
CAGCAGGGTATG[G/A]GGCACTACAAAC
CACCTTTATCTC[G/A]AGCCTGTGCCCA
CTGGGGACCAGG[A/G]TATGCTAAGGAC
CTCATAAAGTAA[C/G]GTTCTGCGACCT
CCCACAGCAGAA[C/T]CTGAAGGACAGA
CATTTGCTGTGG[C/T]CAGTGAGGGTCC
CCTGTGATCCAT[T/A]TGCTGTGGCCAG
GAGCAGGGGAGG[G/C]GCAGCGTTAATC
CCGTTGCTGTCA[T/C]GGGGATGTTTCC
GCCGTTGCTGTC[A/C]TGGGGATGTTTC
CAGACTGGCTTC[A/T]GAATGCCCCTTA
AAGTTTGCAAGC[A/G]GCAAGGCACTGG

AGGTGACATAAG[G/A]CAAGAATCAGGA
CCACCATTGGAC[A/G]GGTGACATAAGG
ACCTAGCATCAA[G/A]GGGAGAGATTAT
GGTCACATATAC[::::::::::/ACAGAAATAT]ACATACATACCT

G
A
G
del10

G

A
A

CCCTGAGGAGAA[A/C]TAGGACACTAAT
ACTCAGTCCAGT[A/G]TCTGCTTCGTTC

CTTCCGCAGAAG[G/C]ACCAGCTGGACT

G
A
G
T
C
T
G
A

G
G
A
in10

G

G
A
A
A
G
T
C
T
C
T
C
T
G

A
A

A
G
A
G
T
G
A
A

G
G
A
in10

G

C
T
G

G
A
A
A
G
T
C
T
C

A
A

A
G
A
G
T
G
A
A

Our study
129S6 C3HeB
C57BL /6J /SvEvTac /FeJ

CGGGCAACCTCC[G/A]GCTACAGCGCCC
ACGGAGCGTTAA[A/G]TCCATGTCGCGC
TCCCCACGTGGA[G/A]GAGAACCGAGGC
TCGGGCCTCGG[T/G]ACCCCACGCGGA
TGTCAGTCCCCCTCCC[C/T]TCCCCTCGGGCC
CGTGATGTCCAC[T/G]GGCACGTCGAAC
AGCATCGTGGAC[G/A]TAGAACGCCAGG
GGCTGGTAGATG[A/T]TATCGACGATTTTCT

Mutation Analysis Performed Using NCBI Build 37 (Mm11_95772_37)
Nucleotide on
AA
Chromosome 11
Location Change
Genomic Sequence
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SNP ID

A
T
T
C
T
G
G
G

rs29476130
rs29465874
rs29420143
rs28209043
rs28209044
rs29436903
rs29423644
rs29482604
rs28209045
rs28209046
rs29395234
rs28209047

rs28209054
rs28209055
rs29411088
rs28209056
rs28209057
rs28209058

G
G
G

C

rs29429431
rs28209050
rs28209051
rs28209052
rs28209053

C
T
C
A
G

C
A
G

C
T
G

G
T

C
T

C
T
G

G
T

A

C

C
A
A

A
G

G

A
G
A

C3H
/HeJ

A
G
C
C

G
A

A
G
A

rs28209048
rs28209049

A
A

G

rs28209042
rs29435903

rs28209039
rs28209040
rs28209041

MGI dbSNP Build 128
129S1
C57BL /6J
/SvImJ

C
T
A

A

T
G
T

T
C
T

A

G
A
A

GenBank mRNA
NOD
CzechII
AK170853.1 BC018399.1
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82717833
82717830
82717824
82717705-82717706
Starts 82717698
82717692
Starts 82717654
82717598
82717566
82717555
82717525
82717192
82717062
82716788
82716727
82716721
82716524
82716448
82716431-82716432
82716426
82716383
Starts 82716354
82716315
82715768
82715672
82715566
82715435
Starts 82715378
82715340
82715048
82714931
82714867
82714745
82714503
Starts 82714383
S

L1 N

S

N
S
S

G
A
T
CC
del12
A
del6
A
A
C
C

G
C
G
A
G
AG
C
C
del3

G
del2
C
C
G

G
del7

AAGTGCCATAGT[G/C]TTCACCCAGTGG
GCTAAGTGCCAT[A/G]GTGTTCACCCAG
GTCTGTGCTAAG[T/C]GCCATAGTGTTC
CTAGGCTCCTTC[CC/::]GTAGGCAGCCTG
CCACCCACTAGG[::::::::::::/CAGGAGAACTGG]
CTCCTTCCCGTA
ACACATCCACCC[A/G]CTAGGCTCCTTC
TGCAGGAATGGG[::::::/GAGAGA]GAGAGAGAGAAAGAA
ACTCACCCGCAC[A/G]AGGTTGTAGCGG
TCCAGAGCTGGG[A/T]CTTCATGTTGGT
GATGAGAAGAGT[C/A]CAGAGCTGGGAC
AGGCCCAAGTGA[C/T]TGGAGTTTCTGT

TGAGGCCTGGCA[G/A]GGACACAAGCTT
CACCGCGTGGGA[C/T]GTGGTCAGATAC
AAAGCACACCGC[G/A]TGGGACGTGGTC
TCCCACAGCTTG[A/G]TAGACTTGTCGA
AAGCAGTGTCGA[G/A]TCCATGCCAAAC
CCAGTGCCACAC[AG/::]AGCAAGCAGTGT
CCCAGCCAGTGC[C/T]ACACAGAGCAAG
GGTGAGGGGTCT[C/G]TGTGTCAGAAGT
ATGCCATTTTAC[:::/CAA]TCCAAATTCAGT

CACAACAGTGGC[G/A]CTCACCTTGGCT
GGTACCTGGGCC[::/GG]GGGGGGGAAAAAAGAGTAT
CTGGTACACGGC[C/T]GCCACGTGGCCA
GCTTCTACCACA[C/:]CCCCACTCACAT
TCTACCTCCCAT[G/T]GAGAATCTGGCT

GGGCAGGTGGGG[:/G]TTGAATCCGGGG
GGCTTCCCCACT[:::::::/GCTGTTA]GCCAGGAAGTGC

G
in7

A
in2
T
del1
T

A
T
A
A
A
del2
T
G
in3

G
G
C
del2
in12
G
in6
G
T
A
T

G
in7

A
in2
T
del1
T

A
T
A
A
A
del2
T
G
in3

G
G
C
del2
in12
G
in6
G
T
A
T
A
A
C
C
G

C
G
A

rs28209069
rs29407135
rs29423161
rs28209070

T
G
C

T

T
C
A

T

rs28209065
rs29474275
rs28209066
rs28209067
rs28209068

C
C
G
G

A

rs28209064

G
T
A
T
T
C
A
T

C

rs28209060

rs3695207
rs3695151
rs3695110
rs3694664
rs3678304
rs28209061
rs28209062
rs28209063

C

rs28209059

C

T

T
C
A

T

A

C
A
T

T

G
T

C

Bold=new SNP or indel
Blue=new info for 129S1/SvImJ

distinction between 129S6 /SvImJ and 129S6 /SvEvTac

E = Exon; I = Intron; US = upstream; DS = downstream; 3'UTR = 3' untranslated region; 5'UTR = 5' untranslated region S = silent variant; M = missense change
no data available in current database
distinction between C57BL /6J and 129S6 /SvEvTac

E8
E8
E8
I8
I8
I8
I8
E9
I9
I9
I9
I9
I9
I9
I9
I9
E10
I10
I10
I10
I10
I10
I10
I10
I10
I10
I10
I10
E11
I12
I12
I12
I12
3'UTR
3'UTR
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del1
del7

C

A

A

G
A
T

G
in7

T

A

G

G
G
C
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The RefSeq annotated transcript for Methyltransferase like 16 (Mettl16), the most
proximal gene in the group, is expressed from the Watson strand and contains
10 exons; 4 additional exons are predicted based on Ensembl annotations. We
sequenced all 14 exons and identified 18 variants (Table 2.3). Although
C57BL/6J is the mouse reference sequence, the dbSNV database lacks
significant C57BL/6J information. Red lettering denotes the variant, grey boxes
indicate new dbSNV information and bold lettering indicates novel sequence
variants between C57BL/6J and 129S6/SvEvTac; all new variants have been
deposited into the dbSNV database.
We identified two new SNVs (10 and 18) and indels (11 and 14) within Mettl16.
SNV 10 is a T to G transversion in intron 5, while SNV 18 is a G to C
transversion located in intron 8. Indel 11 is a 3 bp insertion located within a string
of Ts, and it is therefore impossible to determine the exact insertion site. Indel 14
is a 12 bp deletion in 129S6/SvEvTac. We confirmed the C57BL/6J genotype for
polymorphisms 13, 16 and 17, and updated the dbSNV database for 13
additional C57BL/6J and all 16 129S6/SvEvTac alleles. Within the Mettl16 locus,
129S6/SvEvTac and 129S6/SvImJ are concordant for all variants tested with
both strains. Notably, 6 SNVs (10, 13, and 15-18) and 2 indels (11 and 14) differ
between 129S6/SvEvTac and C57BL/6J.

12
13
14
15
16
17
18

11

1
2
3
4
5
6
7
8
9
10

Poly#

A

A
T

rs26904514
rs26904513
rs29406771
rs29415056
rs26904512

rs26904580
rs26904579
rs26904578
rs26904560
rs26904559
rs26904553
rs26904552
rs26904551
rs26904530

SNP ID

T
G
ins12
C
G
C
C

ins3

MGI dbSNP Build 128
129S6
C57BL/6J
129S1/SvImJ
/SvEvTac
A
T
A
A
G
G
G
C
A
G

Bold=new SNP or indel

no data available in current database

Blue=new info for 129S1/SvImJ

distinction between C57BL /6J and 129S6 /SvEvTac

E = Exon; I = Intron; US = upstream; DS = downstream; 3'UTR = 3' untranslated region; 5'UTR = 5' untranslated region S = silent variant; M = missense change

This study
Nucleotide on
Genome
Chromosome
Genomic Sequence
129S6
Location
C57BL /6J
11
/SvEvTac
74584265
5'UTR
GGGTGAAAACTC[A/G]CCGCCGTCTCCA
A
A
74584508
I1
TCAAAAATCTCT[T/C]ATCCGGTTGCGC
T
T
74584686
I1
CTCGCCTAGGCC[A/G]ATGCTTAGAGAG
A
A
74595996
I2
TGGCATAGTGCT[A/G]TATCAGAGCATG
A
A
74596009
I2
TATCAGAGCATG[G/C]TCCCTTACTGGC
G
G
74597473
I2
TGGGTCCTTGGT[G/T]TAACTGCTTGAT
G
G
74597505
I2
AAGTGCTAGCTA[G/A]TGTACCTAGTGG
G
G
74597800
I3
GCATTCTCAACT[C/T]TCCCTAAGCTCT
C
C
74605879
I5
ATTGCAGAGATA[A/G]GAACAAAAGGCA
A
A
74605904
I5
GGGTTTTTGTTT[T/G]TTTTTTTTTTAG
T
G
Anywhere
within
I5
[…/TTT]
Ref
ins3
74605905 ~
74605915
74616406
I6
GAGTTTCGTCAC[T/G]TTCAACAAAAGA
T
T
74616488
I6
TGTATTTCCCAG[A/G]CTATTTAGAATA
A
G
Start 74616809
I6
CTGAGCTGCTTA[…../TTTATTTATTTA]TTTATTTATTTA
Ref
ins12
74616975
I6
TTAAGGGCAAAC[A/C]TTGACCCAAAAA
A
C
74617278
I6
CAATATTTGTTT[A/G]CTTCTGTTCTCA
A
G
74617316
I6
GTCTCCATTTGT[T/C]TTGCTGCTTTTT
T
C
74621916
I8
CTCATGATCAAC[G/C]ATGGCCTTTCCC
G
C

Table 2.3 Mettl16 Polymorphisms
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Ecotropic viral integration site 2A (Evi2a) is expressed from the Crick strand and
contains two exons (Table 2.4). Table 2.3 is organized the same as Table 2.2,
with the following exceptions: amino acid changes are found in column 3 and the
remaining column numbers are shifted. We designed 5 amplicons for sequencing
Evi2a, as exon 2 spans 2,058 bp. We confirmed the 16 SNVs in the region and
did not identify any additional alleles. However, we added genotyping information
for C57BL/6J for all SNVs. Three SNVs (4 – 6) are located in exon 2; SNVs 4
and 5 cause missense changes (M), while SNV 6 is a silent variant (S).
Proteasome 26non-ATPase subunit 11 (Psmd11) codes from the Watson strand
and contains 14 exons (Table 2.5). Table 2.4 has the same organization as Table
2.3. We designed 13 amplicons for sequencing. Exons 11 and 12 were amplified
from one PCR product. We confirmed the 4 SNVs in the region and did not
identify any additional alleles. However, we added genotyping information for
C57BL/6J for all SNVs. SNV 2 causes a silent variant in exon 3.
Chaperonin containing Tcp1, subunit 6b (zeta) (Cct6b) is expressed from the
Crick strand and contains 14 exons (Table 2.6). Table 5 has the same
organization as Table 2. We sequenced each exon and confirmed 9 SNVs within
this locus. SNV 1 is located downstream to Cct6b, while SNVs 2 and 3 are within
the 3’UTR and should be identified from mRNA. Although we did not identify any
additional alleles, we added genotyping information for C57BL/6J for 9 SNVs.

M: L194F
M: N171S
S

1
2
3
4

Poly#

3'UTR
3'UTR
3'UTR
E2
E2
E2
E2 5'UTR
E2 5'UTR
E2 5'UTR
E2 5'UTR
E2 5'UTR
I1
I1
E1 5'UTR
E1 5'UTR
E1 5'UTR

AATAGAAAAGCA[G/A]TCTTGTCTTACG
ACATAGTTGAAT[T/C]CTACACATTGGG
TATTTCTAACTC[T/C]GCCTTCCTCATT
TGGAGCCTGTGA[G/A]CTCCTTTGCTCT
AGAAAGTCACCG[T/C]TGCTCCGCGGCT
TCCAGAAGACGA[C/T]GAGGCCCACACT
GTTTGTGGAAGA[A/G]CAGTGTCTGGCA
AACAGTGTCTGG[C/T]ACGTGGAGTAAT
TTTAAAAGATAT[A/C]ACAAGTGGCTTT
GCAAGTGTGCAT[C/T]AAATGAGAATGT
TCTGTTGCTGTA[G/A]CTGGCTATGGCT
GCCCTTCCTCTC[T/C]ACTAACCTGAAC
GGAGGAGTAAGA[G/A]AGCCGCATGTGC
CCTTCAGAGCTC[G/A]CCCAGCCGTCAC
AATCTGCAGGGT[T/C]TTTTAAAGAGGA
GCTGCAACTCAA[C/A]TACATGTCACGG

G
T
T
G
T
C
A
C
A
C
G
T
G
G
T
C

C57BL /6J
G
T
T
G
T
C
A
C
A
C
G
T
G
G
T
C

129S6
/SvEvTac
rs28228857
rs28228856
rs28228855
rs28228854
rs28228853
rs28228852
rs28228851
rs28228850
rs28228849
rs28228848
rs28228847
rs28228839
rs28228838
rs28228837
rs28228836
rs28228835

SNP ID

C57BL/6J

S

I2
E3
I3
I4

CAGCTCCCCGAG[A/G]CCCGGCTCTTTA
TAAAGCAGCTCG[T/C]CTGGTCCGGTCT
AACAGATGGTGT[A/G]GAAAGAAGTGTG
GGGCTGAGTTCA[G/A]TTGTTGTGTTGA

This study
129S6
C57BL /6J
/SvEvTac
A
A
T
T
A
A
G
G

rs28212768
rs28197167
rs28197166
rs28197159

SNP ID

MGI dbSNP Build 128
129S6
C57BL/6J
/SvEvTac

Blue=new info for 129S1/SvImJ

129S1
/SvImJ
A
T
A
G

no data available in current database

E = Exon; I = Intron; US = upstream; DS = downstream; 3'UTR = 3' untranslated region; 5'UTR = 5' untranslated region S = silent variant; M = missense change

80251677
80251820
80251912
80259283

Nucleotide on
AA Change Location
Chromosome 11

Genomic Sequence

no data available in current database

G
T
T
G
T
C
A
C
A
C
G
T
G
G
T
C

129S6 129S1
/SvEvTac /SvImJ

MGI dbSNP Build 128

E = Exon; I = Intron; US = upstream; DS = downstream; 3'UTR = 3' untranslated region; 5'UTR = 5' untranslated region S = silent variant; M = missense change

79340133
79340257
79340568
79340705
79340773
79341225
79341344
79341355
79341781
79341847
79341961
79343815
79343851
79343882
79343973
79344056

Genomic Sequence

This study

Table 2.4 Evi2a polymorphisms

Table 2.5 Psmd11 Polymorphisms

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16

Nucleotide on
Location based on
Poly#
AA Change
Chromosome 11
RefSeq: NM_001033711.1
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Table 2.5 Psmd11 polymorphisms

1
2
3
4
5
6
7
8
9

Poly#
DS
3'UTR
3'UTR
I12
I10
I9
I5
I1
US

Genome
Location
TGGGATACTCT[C/T]AAGCTTGTGCCC
AAGGCCATGTGA[C/T]GCTGCTGGGTAT
ACGTATAAAATC[T/C]TGTCTTCCAGAT
TTGTTGACTGAA[T/C]TCTAACAATATT
CACACGCACCAC[G/A]GGAGGAGCTTGC
TCTTCATGGAAA[C/T]ACTCACCAATGC
GGATCAGCCAGG[T/C]CACACATTGTTT
GATCAGCATCAG[A/C]ATCAGAGTGAGC
TCGGACTCCGGC[T/C]GGGAAGCGAGTG

Genomic Sequence

This study
129S6
C57BL /6J
/SvEvTac
C
C
C
C
T
T
T
T
G
G
C
C
T
T
A
A
T
T
rs28225664
rs28225663
rs28225662
rs28225659
rs28225630
rs28225629
rs28225627
rs28225614
rs28225613

SNP ID

MGI dbSNP Build 128
129S6
C57BL /6J
129S1/SvImJ
/SvEvTac
C
C
T
T
G
G
C
T
A
T

no data available in current database

E = Exon; I = Intron; US = upstream; DS = downstream; 3'UTR = 3' untranslated region; 5'UTR = 5' untranslated region S = silent variant; M = missense change

Nucleotide on
Chromosome
11
82532579
82532804
82532833
82533574
82549799
82550586
82555698
82577547
82577906
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Table 2.6 Cct6b polymorphisms

38
Ring finger and FYVE like domain containing (Rffl) is expressed from the Crick
strand, contains 11 exons and produces 5 alternatively spliced products (Table
2.7). Table 2.7 is organized exactly the same as Table 2.3. We designed 13
amplicons for sequence analysis of Rffl; three span exon 11. To reduce
complexity, we incorporated all splice variants into a single transcript. RefSeq
NM_026097.3 contains exons 5-7 and 9-11. RefSeq NM_001164570.1 contains
exons 2, 4, and 6 – 11. RefSeq NM_001007465.3 contains exons 1 and 6 – 11.
RefSeq NM_001164569.1 contains exons 1, 2 and 6 – 11. RefSeq
NM_001164571.1 contains exons 1, 6, 7 and 9 – 11. We confirmed 10 SNVs for
this locus and found no variants between C56BL/6J and 129S6/SvEvTac. SNVs
9 and 10 are within the 5’UTR of exons 4 and 2, respectively. SNV 8 is a
missense variant in exon 6, while SNVs 6 and 4 are silent changes in exons 11
and 8, respectively. SNVs 1-3 are located in the 3’UTR of Rffl. SNV 8 causes an
Ala to Thr missense change at amino acid positions 90 (NM_001164569.1), 69
(NM_001164570.1)

and

55

(NM_026097.3,

NM_001007465.3

and

NM_001164571.1) depending upon the RefSeq.
Adaptor-related protein complex 2, beta 1 (Ap2b1) is expressed from the Watson
strand and contains 22 exons (RefSeq NM_001035854.2) (Table 2.8). Table 2.8
is organized exactly the same as Table 2.3. We designed 30 amplicons; 6 are
necessary to span exon 22, 5 are necessary to span exon 12, while exons 8 and
9 are amplified from a single PCR reaction. We identified 80 SNVs and 4 Indels;
19 of the SNVs (28 – 32, 36, 37, 41 – 48, 50, 65, 66 and 84) and all Indels (4, 12,
27 and 80) are novel. SNVs 1-3 are located upstream of the transcriptional start
site of the two RefSeq genes (NM_001035854.2 and NM_027915.3), but within
the 5’UTR of the predicted Ensembl transcripts (ENSMUST00000018875).
Variant 4 (a 6 bp insertion) is located within the 5’UTR of exon 1. The remaining
3 indels (12, 27 and 80) are located in introns 3, 10 and the 3’UTR, respectively.
SNV 32 causes a silent change in exon 11. The remaining novel SNVs are
located within intron and the 3’UTR. Previously identified SNVs (33 and 56) lead

Poly#
1
2
3
4
5
6
7
8
9
10
M: A90T

S

S

3'UTR
3'UTR
3'UTR
E11
I8
E8
I7
E6
E4 5'UTR
E2 5'UTR

Location
GTGTAAAGCCCC[T/C]GGGAGGGCTGCA
CTTTTCAGCAGC[C/T]GTAGTCATAGTC
CAATACTAAACA[G/C]AAGTGACTCAAC
CCGGCAGATAGG[A/G]CATTCGTTCATG
TCCCAAGAAGAC[C/A]AGGCAAAGAAAC
CTCATCCTCAGT[A/G]GGTACTCTGGCT
CCATGGGCCGCT[C/T]TCAGTTCACACG
GGGTTGTGCTTG[C/T]GAAATGGACCCC
GGTGCTTCTCCA[C/A]CAGGTTGCGGTA
TGCCTCTGTAGA[C/T]GGTTTTCTGTCC

Genomic Sequence
T
C
G
A
C
A
C
C
C
C

C57BL /6J
T
C
G
A
C
A
C
C
C
C

129S6
/SvEvTac

Our study

rs6284732
rs28225526
rs28225525
rs28225524
rs28225509
rs28225508
rs28225507
rs28225470
rs28225441
rs28209144

SNP ID
T

C57BL/6J

T
C
G
A
C
A
C
C
C
C

129S6 129S1/
/SvEvTac SvImJ

MGI dbSNP Build 128

no data available in current database

Blue=new info for 129S1/SvImJ

E = Exon; I = Intron; US = upstream; DS = downstream; 3'UTR = 3' untranslated region; 5'UTR = 5' untranslated region S = silent variant; M = missense change

82618486
82618575
82618921
82619561
82624485
82624548
82624681
82631935
82647709
82684226

Nucleotide on
AA Change
Chromosome 11
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Table 2.7 Rffl polymorphisms

40
to missense variants (F490L and A602T) in exons 11 and 14, respectively.
Additional expressed polymorphisms include exons 4, 7, 12, 13, 14, 17 and 20.
We identified 5 variants between 129S6/SvEvTac and 129S1/SvImJ (blue boxes,
16, 33, 53, 60 and 82) and 46 differences between 129S6/SvEvTac and
C57BL/6J (yellow boxes). Notably, SNV 33 leads to a missense variant between
129S6/SvEvTac and 129S1/SvImJ that could account for differences between
these two distinct 129 strains.
The polymorphisms located in these 7 genes between 129S6/SvEvTac and
C57BL/6J strain are summarized in Table 2.9. In total, we identified 15 Indels
and 181 SNVs in all 7 genes; we are the first to report 44 of these SNVs and all
Indels. Regarding our analyses, it becomes clear that the major distinctions
between the 129S6/SvEvTac and C57BL/6J strains lie within Ap2b1, Nle1 and
Mettl16, while the variations between 129S6/SvEvTac and 129S1/SvImJ lie in
Ap2b1 and Nle1. This suggests that the remaining four genes might be more
highly conserved among the 129S6/SvEvTac, 129S1/SvImJ and C57BL/6J
strains.
We converted the current dbSNV information within this region into a heatmap
that represents the polymorphism density across the region (Figure 2.2). Red
areas contain more variants than yellow segments. It is clear that the 7 target
genes all map to regions that contain high or intermediate numbers of SNVs.
Interestingly, there are two blocks with a low SNV density. The first lies between
Mettl16 and Evi2a while the second falls between Evi2a and Psmd11. Based on
the SNV density, we predict that these two regions contain elements under
selective pressure in the two mouse strains or harbor important functional
domains.

83154991

83155035

83155044

36

37

83154908

32

35

83154758

31

83154911

83154754

30

83154957

83154720

29

34

83115978
83116045
83116118
start 83116316
83116563
83121650
83121867
83122050
83129752
83130051
83130082
83130094
83135573
83135730
83135731
83135857
83135884
83137966
83138305
83148637
83148754
83149060
83149173
83149174
83149996
83150389
83154700
83154714

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28

33

Nucleotide on
Chromosome 11

Poly#

F469L

S

S

S

AA
Change

Table 2.8. Ap2b1 Polymorphisms

I11

I11

I11

I11

E11

E11

I10

I10

I10

US
US
US
E1 UTR
I1
I2
I2
I2
I2
I3
I3
I3
E4
I4
I4
I4
I4
I4
I5
I6
I6
E7
I7
I7
I8
I9
I10
I10

Location based on
RefSeq:
NM_001035854.2

TCATGGTTTCTT[C/T]GTCTCAAAAGGG

GTTTGTTTGTCA[T/C]GGTTTCTTCGTC

AACAAGAGCTGA[G/A]AAGGTGAAATGT

GTCTCTTCCAT[C/G]CCGTGCTCTAGA

ACTAGAGAGTTT[C/G]CTGGAAGGTTTT

ATTACTAGAGAG[T/C]TTCCTGGAAGGT

CCTTAGTAACTA[G/A]TCCATTTGTTAC

TTGGCCTTAGTA[A/G]CTAGTCCATTTG

CTTTAGCTTCTA[C/T]TGTTAAATACAG

TTTCACAAAAAT[C/A]TTGTTCACGGGA
AAAGCAACTGCG[G/A]GTCTCCTGAGTG
AGGCGACAGACA[C/A]GACCTGGCCGTT
GCCGCCGCCGCC[GCCGCC/::::::]ACCCCGCCCTTG
TGCGCTCCGGTG[T/G]AGCAGCGGGAGT
TAAATAGAGATG[G/T]TCTCAAAATTTG
ACGTCTTTACAC[T/A]TGCGTTTGCAGT
TCGATTTATCCC[A/C]TTTGTGGTCAGT
GTTGATGGGGTC[T/G]TTGTCGGTGGGT
TCTTGCCCCCCT[A/G]TGGACAGTCAGC
AGCTTTCCTAGA[C/T]GCTGCAGACCCC
CGCTGCAGACCC[C/:]TGAGGTAGCCGC
CAACAGCTTTGT[G/A]AAGGTAGTTTCC
TGTAAGCATTCT[G/A]TACACTAGGGAT
GTAAGCATTCTG[T/C]ACACTAGGGATA
TTCAGCATATTA[T/A]TCGTTGCTTGCT
TAGAGAGTGGAC[A/G]TGCTGTCATATT
GGCTTGTAATCA[C/T]CTTGTATTCATA
TGAAAGTGAGCC[C/T]GTTCCAAGGCAT
GGTGTTGGGGAT[C/T]GCTAGGATCTCC
TCAGCATGGAGC[T/C]TTGACTTTTCTA
GGAGCCAGAAGT[A/G]CAGTACGTCGCC
CAGATGATTGCT[T/C]TATAGACTGGTG
AGATGATTGCTT[T/C]ATAGACTGGTGC
TAAGTTTGTGCC[G/A]GCTGAGAGCTTA
GGAGATGAGATC[G/A]CACATATGGGAT
CCTTGTGTATGG[:/T]TTTTTTTACTTT
TTTTTACTTTAG[C/T]TTCTACTGTTAA

Genomic Sequence

C

T

G

C

C

T

G

A

C

C
G
C
Ref
T
G
T
A
T
A
C
Ref
G
G
T
T
A
C
C
C
T
A
T
T
G
G
Ref
C

T

C

G

C

C

C

A

G

T

C
G
C
del6
G
T
A
C
T
A
T
del1
G
G
C
A
A
T
T
C
T
A
T
T
G
G
ins1
T

Our study
129S6
C57BL /6J
/SvEvTac

rs28210242

rs28210243

rs28210244

rs28210288
rs28210287
rs28210286
rs28210285
rs28210284
rs28210279
rs29392050
rs28210260
rs28210259
rs28210258
rs29406029
rs29406086
rs28210254
rs28210253

rs6243183
rs29400459
rs28210329
rs28210328
rs28210304
rs28210303
rs28210303

rs28210348
rs28210347
rs28210346

SNP ID

T
T

C
C
C

T

T
G
T

MGI dbSNP Build 128
129S6
C57BL /6J
/SvEvTac

T

C

G

C

G

C

A

G

T

C
G
C
del6
G
T
A
C
T
A
T
del1
G
G
C
T
A
T
T
C
T
A
T
T
G
G
ins1
T

129S1
/SvImJ
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Table 2.8 Ap2b1 polymorphisms

83156122

83156168

83156221

83156391
83156465
83156506
83156567
83156628
83156662
83156694
83156695
83156739
83156788
83160098
83160173
83160451
83160512
83164338
83164488
83164532
83164640
83178192
83178405
83178577
83178974
83178981
83179047
83179406
83181262
83181627
83183224
83183468
83202971
83203016
83203129
83211375
83211619
83212053
83216679
83217239

38

39

40

41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
S

S

A602T
S
S

S

S

S

I12
I12
I12
I12
I12
I12
I12
I12
I12
I12
I12
E13
I13
I13
I13
E14
E14
E14
I14
I15
I15
I15
I15
I15
I16
I16
I17
E18
I18
I18
I18
I18
E21
I21
I21
3'UTR
3'UTR

I12

E12

E12

CACACTGCTCAC[C/T]GCCATAGTGAAG

GCCAACACAGGA [C/A]CTCAACCCAGTA
ACAGGCTTGCTC[C/T]TTGTGGCTTCCT
AGAACCCAGACC[A/C]CTGGTTGGCCTT
ATTTAAGAAAAT[C/T]TGTGCCTAAGTC
TCTCAGACGACT[T/C]GAGCTTGTGTCA
AAAACTAGCCAG[G/A]ACATTTCCCAAG
ATCTGGGGCAGG[G/C]TTTAGTTCTGAA
TCTGGGGCAGGG[T/C]TTAGTTCTGAAA
AAGCAGATTCTG[T/C]TCAATTGTATCT
TGACTGAGGCTG[G/A]AGAGGTGGCTCA
CTGGCATCTTGG[T/C]GTCTCTGGAAAA
CCCTGACCTTCG[A/C]GATCGGGGTTAT
AGTGACTTGCTG[T/G]TTAGGCACTTTG
TGCATTCCACAC[C/T]CTTGCTGCTCTG
AATCTTGGTGTT[A/G]AATCTTGGTGTT
TGCAGCACTGAT[G/A]CAGGTGATAGCC
AACCAACCTGGA[G/A]CAGCCTCAGGTC
GCAGATGGGAGC[G/A]GTGGATCTTTTA
TCAAATGGCATG[T/C]GTTTCCAATGAC
CCTTCACACGCG[T/A]TGTCAGAGCCAC
TGTTTCTGACAT[C/T]AAAGAGCTGAAG
GCCTCTAAAGCA[C/T]GTGTACGTTTAT
AAGCACGTGTAC[G/A]TTTATCAGTGGT
AAATCCTGTAAC[T/G]GCAGTGTTTTCT
AAAGGGTAGCAT[A/C]GAACTTAGCCAT
CTTCTCACATGG[A/G]CTTAGTATTTGT
AAGCTGGCAAGT[C/T]CTGAGTGTAGAG
GAGCATTGACGT[C/G]TCTCTGCCGCTC
ACTCTGATGAGG[G/A]TGCTTTGGCTTC
GACTGAGGATCA[T/C]TGGCCTGGAGGG
AAAGACTTCTTA[T/C]AAGTGGTCACAG
AGTAGATTTCTA[T/G]ATACACACCTGT
TTGGATTTTGGC[A/T]GAGCTGCGGATC
ACAAGGCATGGT[A/G]CTGGGGACAGAC
TCTCAGGGGGAC[G/A]GGACGTGATAGA
AGCCCTGCTCCT[T/G]GCCTTTTGCATT
TTTGGTGCTCCA[C/A]CCATTCACTGGG

GCCAGGCTGATT[C/T]CACATATGGGAT

GAAACACAGGAG[C/T]TGGTCCAACAGG
C
C
A
C
T
G
G
T
T
G
T
A
T
C
A
G
G
G
T
T
C
C
G
T
A
A
C
C
G
T
T
T
A
A
G
T
C

C

C

C

T

A
T
C
T
C
A
C
C
C
A
T
C
G
G
A
G
G
G
T
T
C
C
G
T
C
G
T
C
G
T
C
T
T
G
G
G
A

T

T

rs28210181
rs28210179
rs28210178
rs6256784
rs6256883
rs6257414
rs28210093
rs29395887
rs6157128
rs13462751
rs13462753

rs28210233
rs3700640
rs6338647
rs4139523
rs28210226
rs29405321
rs28210225
rs28210224
rs28210193
rs28210192
rs28210191
rs28210189
rs28210188
rs28210187

rs28210238

rs3707795

rs3693644

rs3693555

T
T
T
A
A
G
T
C

G

A
T
C

C

C

C

A
T
C
T
C
A
C
C
C
A
T
C
T
G
A
G
G
G
T
A
C
C
G
T
C
G
T
C
G
T
C
T
T
G
G
G

T

T

T
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78
79
80
81
82
83
84

3'UTR
3'UTR
3'UTR
3'UTR
3'UTR
3'UTR
3'UTR

GGAGGGAGATTC[T/G]CTCAGCAGGCCC
TGGCACTTGTCG[A/C]ACAGCCTGGCAC
AGGCTGAAAAAA[:/A]TCAGAGTAGAAA
TAATCCTGTTTC[C/T]TCCCAGCTGCAA
GGTGGTATGTTG[A/G]GTGGAAAGACAA
CTTGTCGATGCT[G/A]ATTCCTGGAGTC
TGGGAGAACTGG[A/G]CTCAGTTTAACC

T
A
Ref
C
A
G
A

T
A
ins1
C
G
G
G
rs28210089
rs13462752
rs28210088

rs28210091
rs28210090

T
A
ins1
C
A
G
G

Bold=new SNP or indel
Blue=new info for 129S1/SvImJ

distinction between 129S6 /SvImJ and 129S6 /SvEvTac

E = Exon; I = Intron; US = upstream; DS = downstream; 3'UTR = 3' untranslated region; 5'UTR = 5' untranslated region S = silent variant; M = missense change
no data available in current database
distinction between C57BL /6J and 129S6 /SvEvTac

83217452
83217576
83217663
83217716
83217876
83217915
83218254
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Name

Mettl16

80242117-80285635
82532752-82577808
82617324-82684246
82900768-82908395
83116199-83218535 102337

11
11
11
11
11

7628

66923

45057

43519

4049

79340063-79344111

11

47830

22

13

8

14

14

2

10

Forward

Reversed

Reversed

Reversed

Forward

Reversed

Forward

80
181

46

10

9

4

16

16

19
44

23

0

0

0

0

2

12
51

13

8

3

1

14

0

57
138

55

2

4

3

2

15

11
19

5

0

2

0

0

1

2.

4
15

9

0

0

0

0

2

46
91

40

0

0

0

0

5

5
9

4

0

0

0

0

0

44
72

23

0

0

0

0

5

Distinction between Distinction between Distinction between
Genomic Number of Express Identified Novel SNP in SNP in UTR
Indel 129S6/SvEvTac and
129S6/SvEvTac
C57BL/6J and
size
exons
direction
SNP
SNP exon intron SNP 1
C57BL/6J. 2
and 129S1 /SvImJ 3 129S1 /SvImJ 4

74584365-74632194

Location

11

Chromosome

UTR SNP indicates the number of SNPs within the untranslated regions
The Distinction indicates the number of differences in SNPs or indel between 129S6/SvEvTac and C57BL/6J.
3.
The Distinction indicates the number of differences in SNPs or indel between 129S6/SvEvTac and 129S1/SvImJ.
4.
The Distinction indicates the number of differences in SNPs or indel between C57BL/6J and 129S1/SvImJ.

1.

methyltransferase
like 16
ecotropic viral
Evi2a
integration site 2A
proteasome 26S
non-ATPase
Psmd11
subunit 11
chaperonin subunit
Cct6b
6b (zeta)
ring finger and
FYVE like domain
Rffl
containing
Notchless homolog
Nle1
1 (Drosophila)
adaptor-related
protein complex 2,
Ap2b1
beta 1
Total

Gene
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73

16

31

Nle1

7

7
4

Mettl16

Evi2a

Chr11:74,584,365
low

Psmd11

4

Cct6b Rffl

Ap2b1

Chr11:83,218,535
high

1Mb

Polymorphism concentration

Figure 2.2 Density map of polymorphisms located in the domain of study
The heatmap represent current dbSNV information across this region. Red
indicates highest amount of SNVs and yellow stands for lowest amount. The 7
genes in this study are marked on the heatmap based on their chromosome
locations and gene sizes. Genetic variations including SNVs and Indel identified
in this study are shown by black lines. Each black line correlates with the number
of polymorphisms within a 10kb domain; longer lines signify increased
polymorphism densities.
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2.4

Discussion

In order to identify the mutations generated from an N-ethyl-N-nitrosourea (ENU)
mutagenesis screen, we detected several 129S6/SvEvTac polymorphisms in the
7 genes discussed in the results. We found no non-synonymous mutations
Ap2b1, Cct6b, Suz12, Rffl, Evi2a, and Psmd11. However, we identified a T 1184
G transversion (I 395 S missense mutation) in l11Jus1 heterozygotes in exon 10
of Nle1 (Table 2.2). This non-conservative substitution replaces an aliphatic,
hydrophobic amino acid with a polar residue, which likely disrupts functionality
(Livingstone and Barton, 1993). Subsequent mutation detection efforts resulted in
the identification of a second missense mutation (T 484 C transition; S 162 P
missense mutation) in exon 5 of Nle1 for the l11Jus4 allele (Table 2.2). This nonconservative amino acid substitution has a high probability to alter protein
function, as serines easily form hydrogen bonds with polar substrates, while
prolines are rarely found in active sites (Livingstone and Barton, 1993). In
addition, we detected an endogenous C57BL/6J non-synonymous SNP (A 535 G
transition; I 179 V) in exon 6 (Table 2.2). This well-documented SNP (rs2820949)
leads to a very conservative amino acid substitution (Livingstone and Barton,
1993). Both mutants share the endogenous mutation, indicating that l11Jus1 and
l11Jus4 homozygotes harbor two coding changes in Nle1–an ENU-induced allele
and an endogenous C57BL/6J missense mutation.
The 7 genes in this study span a 6.8 Mb domain that contains a total of 154
genes, 9 miRNAs and 5 snoRNAs. We concentrated our efforts on genes that
are expressed during pre-implantation development or in gametes. The Evi2a
locus, which is adjacent to Evi2b, resides within intron 33 of the Nf1 gene.
Although the function of Evi2a is unknown, the locus demarcates the boundary
between the two conserved regions, as it contains a high number of
polymorphisms in a relatively small genomic region. We identified 16 genetic
variants within the 4kb Evi2a locus, while the average number of variants
identified in this study is 6 within 10kb. Although C57BL/6J, 129S6/SvEvTac and
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129S1/SvImJ are concordant for all variants of Evi2a, this gene could be crucial
for the divergence of other mouse strains. Alternatively, polymorphisms within
this intron could be important for Nf1 gene regulation. Consistent with this
hypothesis, EVI2A is upregulated in malignant peripheral nerve sheath tumors in
Neurofibramatosis patients harboring microdeletions within the NF1 locus
(Pasmant et al., 2011). The dbSNV database indicates that high levels of allelic
variants are present in the distal end of the 6.8Mb domain that overlaps with
Cct6b, Rffl and Ap2b1. This is consistent with our results, as we sequenced 84
variants within this locus.
The 129 strain is commonly used for knockout and other genetic manipulation
studies because of the efficiency of obtaining ES cells that colonize to the
germline. (te Riele et al., 1992). This strain originated in 1928 and has diverged
into more than 15 substrains. Different breeding strategies used in the past
resulted in phenotypic and genetic diversity among these substrains (Simpson et
al., 1997). In this report, we sequenced the 129S6/SvEvTac strain that has been
maintained since 1992 at Taconic. According to Simpson et al., (1997), the origin
of 129S6/SvEvTac can be traced back to the breeding of the “Steel” substrains,
which resulted from the outcross of the 129/Sv strain to C3HeB/FeJ followed by
12-14 generations of backcrossing to the parental 129/Sv line. The resulting mice,
termed 129/SvEv, were distributed to Martin Evans and were maintained by
selection for the SteelJ allele. The 129/SvEv strains underwent further genetic
manipulations to produce 129/SvEvBrd and 129/SvEv-Gpilc. Taconic crossed
129/SvEvBrd and 129/SvEv-Gpilc to generate 129S6/SvEvTac. This line has
been bred as a separate inbred line at Taconic since 1992.
129S1/SvImJ was developed as a control-inbred strain for many of the Steelderived strains. (Petkov et al., 2004) Therefore, we included this strain as
reference to compare the genetic variation between 129S1/SvImJ and
129S6/SvEvTac. Ap2b1, which has 84 polymorphisms across the locus, is the
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only gene in this study to contain variants between the 129S1/SvImJ and
129S6/SvEvTac inbred strains. There are 46 variants between C57BL/6J and
129S6/SvEvTac, 44 alterations between C57BL/6J and 129S1/SvImJ and 5
SNVs

between

129S6/SvEvTac

and

129S1/SvImJ

across

the

gene.

Polymorphism #33 (rs28210244) is a C1571G transversion in exon 11 that
causes an F469L amino acid substitution. The remaining variants between the
two 129 strains lie within introns or in the 3’UTR.
Ap2b1 encodes one of the two large chain components of the clathrin assembly
protein complex 2. Ap2b1 protein is found on the intracellular domain of
transmembrane coated vesicles and is important for protein transport (Schmid et
al., 2006). It is unclear why Nle1 and Ap2b1 contains so many polymorphisms
and why there are differences between 129S6/SvEvTac and 129S1/SvImJ. It is
possible that the genetic variations lead to alterations in gene regulation and/or
protein structure changes that respond to strain-specific factors. However, it is
equally likely that the high number of polymorphisms between 129S6/SvEvTac
and 129S1/SvImJ is simply due to random silent mutations.

Most of the

variances within the Ap2b1 locus (82/84) lead to silent changes or are located
within non-protein coding regions of the gene (i.e. introns or UTR), which is
consistent with the latter explanation.
Although there are many variants between C57BL/6J and the 129-derived lines
in this region of MMU 11, all of the polymorphisms between 129S6/SvEvTac and
129S1/SvImJ are located within a single gene. The domain proximal to Ap2b1
contains no variants between the two 129 strains. Regions of conservation
suggest sequences critical for function, i.e. gene variation is not functionally
tolerated. Phylogenetic studies of 9 different 129 strains indicates that the
129S6/SvEvTac and 129S1/SvImJ strains are highly related (Threadgill et al.,
1997), Both were derived from a common ancestor bearing the Steel allele of the
Kit ligand, although 129S1/SvImJ has been maintained at The Jackson
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Laboratories and 129S6/SvEvTac is maintained by Taconic. Since 6 of the
commonly used mouse embryonic stem (ES) cell lines have been derived from
these two 129 strains, it is important to document the variants between these two
129 strains for future gene targeting and genotyping studies.
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CHAPTER 3. ENU MUTAGENESIS REVEALS THAT NOTCHLESS HOMOLOG
1 (DROSOPHILA) AFFECTS CDKN1A AND SEVERAL MEMBERS OF THE
WNT PATHWAY DURING MURINE PRE-IMPLANTATION DEVELOPMENT

The contents in this chapter have been published in BMC Genetics 2012, 13:106.
3.1

Introduction

Mouse chromosome (Mmu Chr) 11 shares significant synteny conservation with
regions of six different human (Hsa) chromosomes: 22, 7, 2, 5, 1 and 17 (Boles
et al., 2009). The largest domain of synteny conservation between mouse and
human occurs on distal Mmu 11, which is entirely syntenic with Hsa chr 17
(Hentges et al., 2007). The gene-rich domain flanked by Trp53 and Wnt3 in this
region of synteny conservation contains 2545 gene structures, including 1597
predicted protein-coding genes, 450 processed RNAs and 498 pseudogenes
(Boles et al., 2009).
A large-scale, phenotype-driven ENU (N-ethyl-N-nitrosourea) mutagenesis
screen targeted to this 34 Mb region of Mmu 11 demonstrated the wide functional
diversity of this linkage group (Hentges et al., 2006b; Hentges et al., 2007; Kile et
al., 2003). Functional analysis of 785 total pedigrees from this ENU mutagenesis
screen resulted in the discovery of a variety of mutant phenotypes, including
infertility, craniofacial abnormalities, neurological defects and lethality (Kile et al.,
2003). Subsequent studies detailed the embryonic lethal phenotypes of 45
mutant lines that fell into 40 complementation groups (Hentges et al., 2006b; Kile
et al., 2003). Resequencing efforts led to the identification of causative or
putatively causative lesions in 31 genes in 17 lethal lines (Boles et al., 2009).
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Although many mutations were identified in the sequencing study, the lesions in
the l11Jus1 and l11Jus4 complementation group have yet to be identified. These
two alleles survive through implantation but arrest prior to embryonic day (E) 6.5
(Hentges et al., 2006b; Kile et al., 2003). Our interests lie in determining the
genes and genetic pathways that are important for establishing and maintaining
maternal-fetal interactions during pregnancy. Since these two mutants fail during
this critical window, we undertook a positional cloning strategy to identify the
causative mutations in this complementation group. Here, we present evidence
that both mutant alleles have non-conservative missense mutations in the
Notchless homolog 1 (Drosophila) gene, Nle1. Moreover, targeted disruption of
Nle1 in mice (Cormier et al., 2006b) results in an embryonic lethal phenotype that
is remarkably similar to l11Jus1 and l11Jus4, providing further supporting
evidence that Nle1 is disrupted in both mutant alleles.
NLE1, which is a member of the WD40 repeat protein family, was first identified
as a suppressor of the notchoid phenotype in Drosophila (Royet et al., 1998a),
and has been implicated in both positive and negative regulation of NOTCH
signaling, depending upon developmental stage and species (Cormier et al.,
2006b; Royet et al., 1998a). Studies in Drosophila and Xenopus demonstrate
that NLE1 signals via the canonical NOTCH pathway (Cormier et al., 2006b;
Royet et al., 1998a). In invertebrates and lower vertebrates, the NOTCH pathway
is critical for directing cell fate prior to gastrulation, and also plays important, but
varied roles in germ layer boundary formation. At the 4-cell stage in C. elegans,
NOTCH signaling dictates an ectodermal cell fate in ABp daughter cells by
repressing expression of TBX-37 and TBX-38 (Good et al., 2004). In sea urchins,
the NOTCH pathway impacts the development and differentiation of the
secondary mesenchymal cells, which are fated to produce mesodermal cells
(Sherwood and McClay, 1999, 2001). In contrast, in X. laevis, induction of
NOTCH signaling leads to an increase in endoderm-specific and a decrease in
mesoderm-specific markers, while suppression of NOTCH signaling has the
opposite consequence (Contakos et al., 2005).
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The role of NOTCH signaling during the earliest stages of mammalian
development is much less clear. Several lines of evidence demonstrate that
NOTCH signaling is dispensable for gastrulation in mice. Single gene and
compound knockout studies of the Notch receptors and ligands results in either
viable animals or embryonic lethality at mid-gestation (Conlon et al., 1995;
Dunwoodie et al., 2002; Hamada et al., 1999; Hrabe de Angelis et al., 1997;
Jiang et al., 1998a; Jiang et al., 1998c; Krebs et al., 2004; Krebs et al., 2000;
Krebs et al., 2003; McCright et al., 2001; Swiatek et al., 1994). Similarly, deletion
of genes that block NOTCH signaling, such as Pofut1 and members of the γsecretase complex, leads to embryonic failure after gastrulation and midline
formation. POFUT1 adds O-fucose molecules to NOTCH receptors prior to their
translocation to the cell surface, while Presenilin 1 and 2 are members of the γsecretase complex (Kopan and Ilagan, 2009; Schwanbeck et al., 2011). This
complex cleaves NOTCH at the cell membrane, releasing the NOTCH
intracellular domain (NICD) into the cytoplasm. The NICD translocates to the
nucleus and binds to RBPJ, thereby modulating transcription of downstream
target genes.
Deletion of Pofut1, which effectively blocks NOTCH signaling through inhibition of
post-translational modifications to NOTCH receptors (Shi and Stanley, 2006),
leads to embryonic lethality at E9.5 (Shi et al., 2005a; Shi and Stanley, 2003).
Targeted disruption of Presenilin 2 in a Presenilin 1 null background leads to
embryonic lethality at E9.5. Compound mutants exhibit cardiac, somite and
neurological phenotypes (Donoviel et al., 1999). Finally, deletion of the corepressor, Rbpj, causes somitogenesis defects, placental abnormalities and
marked growth delay (Oka et al., 1995; Souilhol et al., 2006). These studies
demonstrate that unlike lower vertebrates and invertebrates, and despite the fact
that Notch receptors and ligands are expressed prior to and during gastrulation
(Cormier et al., 2004a), NOTCH signaling is dispensable prior to gastrulation in
mice.
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Since Nle1l11Jus1 and Nle1l11Jus4 mutants have more severe phenotypes than
mutations that disrupt NOTCH signaling in mice, we hypothesized that NLE1
interacts with NOTCH and other signaling pathways during pre-implantation
development. To address this hypothesis, we conducted targeted gene
expression studies in homozygous mutant embryos. Surprisingly, and in contrast
to studies in Xenopus and Drosophila, our data indicate that canonical NOTCH
signaling is not disrupted in Nle1 mutant embryos; instead, we discovered that
Cdkn1a was upregulated, while several members of the Wnt cascade were
downregulated in homozygous mutant embryos. These results highlight the
differences in NOTCH signaling between mammals (where canonical NOTCH
signaling is dispensable for gastrulation) and other species (where NOTCH
signaling is required for gastrulation) and indicate that NLE1 could play divergent
roles in development that depend upon other signal transduction cascades.
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3.2

Methods

3.2.1 Mouse Strains, Meiotic Mapping and Generation of Mutants
The l11Jus1 and l11Jus4 mutants were induced by ENU mutagenesis on a
C57BL/6J background (Hentges et al., 2006b; Kile et al., 2003), and maintained
in trans using a balancer chromosome (In(11Trp53;11Wnt3)8Brd) harboring a 35
Mb inversion between Trp53 and Wnt3 that expresses the agouti protein under
the Keratin 14 promoter (Zheng et al., 1999). Thee inversion animals were on a
129S6/SvEvTac background. Animals carrying one copy of the balancer
chromosome have light ears and tails due to ectopic agouti expression that
reduces pigment (Hentges and Justice, 2004; Hentges et al., 2006b; Kile et al.,
2003; Zheng et al., 1999). The l11Jus1 line has been continually maintained in
our colony. The l11Jus4 line was resuscitated from cryopreserved spermatozoa
of

an

l11Jus4/In(11Trp53;11Wnt3)8Brd

male

with

a

C3H/HeJ

female

(www.MMRRC.org, MMRRC:000074-UCD). Pups were genotyped at weaning
and l11Jus4/C3H/HeJ males were backcrossed to In(11Trp53;11Wnt3)8Brd/Rex
females on a 129S6/SvEvTAC genetic background. We genotyped the progeny
of both lines at least every 10 generations by microsatellite analysis or direct
sequencing of the mutations to ensure that we maintained the mutations.
To generate recombinant animals for meiotic mapping it is necessary to remove
the balancer chromosome. Animals heterozygous for the l11Jus1 mutation
(l11Jus1/In(11Trp53;11Wnt3)8Brd) were mated to animals carrying one copy of
the

inversion

and

the

dominant

curly

coat

marker,

Rex

(In(11Trp53;11Wnt3)8Brd/Rex). We selected animals with a curly coat (i.e.
inherited the Rex allele) and dark ears and tail (i.e. inherited the l11Jus1 mutation)
for meiotic mapping. We intercrossed F1 animals to generate recombinant F2
animals, which were genotyped at several microsatellite markers (D11Mit4, 219,
245, 120, 39, 327, and 32) and single nucleotide polymorphisms (SNPs; Slc6a,
Wsb1, Rad51l3 and Rasl10) along the 35Mb interval. Primers and PCR
conditions are available upon request.
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For the Notch PCR array studies, qRT-PCR analysis and Caspase 3 detection,
we outcrossed heterozygous males to 129S6/SvEvTac females (Taconic,
Hudson, New York) to eliminate genetic interactions with Wnt3. Heterozygotes,
which had light ears and tails (Zheng et al., 1999) were mated, generating F2
blastocysts for analysis. Notch PCR array studies were conducted on N5F2
embryos (Nle1l11Jus1). qRT-PCR studies were performed on N14F2 and N15F2
(Nle1l11Jus1) and N4F2 (Nle1l11Jus4) embryos dissected at E3.5. Caspase detection
assays were carried out on N15F2 (Nle1l11Jus1), as well as N14F2 or N15F2
(Nle1l11Jus4) embryos. All mouse studies were conducted in facilities approved by
the American Association for the Accreditation of Laboratory Animals with the
approval of the Baylor College of Medicine Animal Care and Use Committee or
the Purdue University Animal Care and Use Committee.
3.2.2 Embryo Analysis
To determine time of death and perform phenotypic studies, we examined
embryos after timed matings, with the day of the vaginal plug designated E0.5.
We genotyped each one as described (Hentges et al., 2006b; Kile et al., 2003).
DNA was isolated by incubating whole embryos (E6.5 to E9.5) in 1 X PCR buffer
(Invitrogen, Carlsbad, CA) and 0.08 mg/ml Proteinase K (Invitrogen, Carlsbad,
CA) at 55ºC for 2-3 hours. Proteinase K was inactivated by either heating to 95ºC
for 10 min or by phenol:chloroform:Isoamyl alcohol extraction followed by ethanol
precipitation. Alternatively, embryos were incubated in 25 to 50 µl of 25 mM
NaOH, 0.2 mM EDTA for 60 min. at 95ºC. Genomic DNA was neutralized by the
addition of an equal amount of 40 mM Tris-HCl, pH 8.0 and stored at -20ºC.
D11Mit327 was used to genotype the embryos in a 25 µl PCR reaction under the
following conditions:

1 X PCR buffer, 1.5 mM MgCl2, 0.2 mM dNTPs, 250

pmoles of each primer and 0.625 U of Taq Polymerase (Invitrogen, Carlsbad,
CA). After an initial denaturing step at 95°C for 5 min, D11Mit327 was amplified
with the following cycling parameters: 30 cycles of 94°C for 30 s, 60°C for 30 s
min followed by 72°C for 30 s, with a final 5 min incubation at 72°C. Products
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were size fractionated on 5% Metaphor (Cambrex, Bio Science, Rockland, ME),
0.5 X TBE gels.
3.2.3 Histology
Deciduas were dissected at E6.5–E8.5. Implantation sites were fixed for 3 hours
in Bouin’s fixative, embedded in paraffin, sectioned in 5–7 µm slices and stained
in hematoxylin and eosin as described (Noveroske et al., 2002). Stained sections
were analyzed under light microscopy.
3.2.4 Candidate Gene interrogation
Exons of candidate genes were bidirectionally sequenced directly from PCR
amplicons using the Big Dye® Teminator v3.1 (Applied Biosystems, Foster City,
CA) sequencing mix. Each amplicon contained at least one exon, plus ≥ 200 bp
of flanking sequence. For the l11Jus1 mutation, genomic DNAs from
129S6/SvEvTAC, C57BL/6J and l11Jus1/In(11Trp53;11Wnt3)8Brd mice were
sequenced as controls. For the l11Jus4 mutation, genomic DNAs from
129S6/SvEvTAC, C57BL/6J, In(11Trp53;11Wnt3)8Brd/C3H, and l11Jus4/C3H,
and l11Jus4/In(11Trp53;11Wnt3)8Brd mice were sequenced as controls.
Sequence data was analyzed (Sequencher; Gene Codes, Ann Arbor, MI) to
identify mutations on the l11Jus1 and l11Jus4 alleles, as well as any additional
sequence variants.
3.2.5 Notch Pathway Expression of l11Jus1 mutants at E3.5
We analyzed Notch pathway gene expression in homozygous mutant and
homozygous

wild-type

blastocysts

using

the

SAB

PCR

Arrays

(SABiosciences/Qiagen, Frederick, MD). Embryos were washed in EmbryoMax©
M2 media (M2; EMD Milllipore, Billerica, MA) and transferred into 100 µl of
RNAqueous lysis buffer (RNAqueous-Micro Kit, Applied Biosystems/Ambion,
Austin, TX). After vortexing, we snap-froze each tube in liquid nitrogen and
stored each sample at –80°. Total RNA was isolated following manufacturer’s
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instructions, eluting with 20 µl of nuclease-free water. We used 5 µl of RNA to
generate cDNA for genotyping in a half reaction of SuperScript One-Step RTPCR with Platinum Taq (Invitrogen, Carlsbad, CA) with gene specific primers,
oligo dT, and PCR primers (Table 3.1). We used nested PCR for sequencing
(Figure 1E). We collected 45 mutant and 45 wild-type E3.5 embryos, and split
embryos with the same genotype into 3 pools (i.e. biological replicates); each
pool consisted of morulae, half-blastocysts, full blastocysts and hatched
blastocysts. We then performed a linear amplification step on each pool using the
RT2 Nano PreAMP cDNA synthesis kit (SABioscience, Frederick, MD). Each
biological replicate was subdivided into 3 technical replicates. Data from each
PCR plate were analyzed using an iCycler Real Time PCR detection system
(Bio-Rad, Hercules, CA).
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Figure 3.1 Postional cloning of l11Jus1 and l11Jus4
A. Exclusion Mapping Breeding Scheme. Blue line: ENU-mutated allele (l11Jus1;
C57BL/6J); Green line with the double arrow: 35 Mb inversion
(In(11Trp53;11Wnt3)8Brd; 129S6/SvEvTac); yellow line: dominant Rex allele
(129S6/SvEvTac), which confers a curly coat. Plus sign: wild type locus. All
animals carrying two copies of the l11Jus1 allele will die in utero. Representative
phenotypes and crossover events are depicted in the F2 generation. B. Mapping
the Nle1 mutation by haplotype analysis in the F2 generation. Each box
represents a locus within Mmu Chr 11 with color indicating the genotype of the
animals produced through heterozygous matings. Yellow boxes are noninformative, homozygous 129S6/SvEvTac genotypes; green boxes are
heterozygous for 129S6/SvEvTac and C57BL/6J genotypes; while blue boxes
indicate informative, homozygous C57BL/6J genotypes. Wsb1 & D11Mit120
define the boundaries of the critical region. C. Physical map of the nonrecombinant interval. Nle1 lies ~700 kb centromeric to D11Mit120. D. Mutation
analysis. Arrows indicate the location of each mutation. Stacked chromatographs
show the sequence for each strain. E. The Nle1 cDNA and genotyping primers.
The full-length, spliced mRNA product is shown with exons represented by empty
boxes. Primer locations are depicted by arrows. The 5’ and 3’UTRs are
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represented by a thin line on the mRNA transcript. F. NLE1 protein structure.
Green oval :NLE specific domain; yellow boxes: WD40 Repeat-like domains;
green diamonds: mutation sites.

Table 3.1 Primers used for this study

Forward Sequence
E1/2
E3
E4
E5/6
E7
E8/9
E10
E11/12
E13

GSP
cDNA
cDNA
2nd
gDNA
geno

Reverse Sequence

T Size
m (bp)

Nle1 sequencing primers
CTTGACTCCTCCGAACACGAG
AAACACAGCCTGTCTGTAGGTGAG
GATTAAATTTGTCGCATGGTGGTA
GTCTGTTACTTGCAACGTGAGTCC
TATTTCTCCTCAGGGAATGGAGAG
CCACACTCAGTCCAGTATCTGCTT
CTGTGTTCTCCCTCACCTCTCC
ATAGTAGGCCAAGCCGTTGCT
ACAGCCTTGCTCTGCTGTTAGAA
GGACCAGCTGGACTCTTGGTATAA
TTCCTGATTCTTGCCTTATGTCAC
AACCCTAACTAAGACAACCAAGAACAA
TGGAGTTGCATGTAAGCTTGTGT
GTCACTAGCCCTAAAGATGCCATT
CCGGCCCAGGTACCTAGCTT
ACCTACAGGTTCTCCCAGAGTCTCC
ACTTGATACTTGGCAGTAGGCACA
CTCCTGCTATCCAGTGCAAGG

62
62
62
62
62
62
62
62
62

500
475
377
557
440
544
488
498
570

Nle1 genotyping primers
GCTGTAATGTCCTGACTGT
CTGTGTCGTACTCTTCAAGGTCAT
CTGTGGAGTCATCTTCTCCATATC

60

637

TCAGACGACTTCACCTTATTCCTG

CAGTCAACAGCATATACCTCATCG

62

351

TCTCCTTCAGCTCCTTCACTGT

TCCAATGGTGGAGTATAGGGTATAA

60

341

cDNA amplification primers
1st
round

ATATGGATCCGGCGCGCCGTCGACTT
TTTTTTTTTTTTTTTTTTTTTT

ATATCTCGAGGGCGCGCCGGATCCTT
TTTTTTTTTTTTTTTTTTTTTT

67

2nd
round
Eed
cDNA

(NH2)ATATGGATCCGGCGCGCCGTCG
ACTTTTTTTTTTTTTTTTTTTTTTTT

(NH2)ATATCTCGAGGGCGCGCCGGAT
CCTTTTTTTTTTTTTTTTTTTTTTTT

67

GTGTGACATTTGGTACATGAGGTT

ACATTTATGATGGGTCAGTGTTGT

60

Trp53
Cdkn1a
Gapdh

Assay ID
Mm01731290_g1
Mm04205640_g1
Mm99999915_g1

ABI TaqMan gene expression assay
Amplicon Size (bp)
119
80
107

148
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3.2.6 PCR Array Data Analysis for Gene Expression
Cycle threshold (Ct) values were calculated for all data obtained from 18 PCR
plates. We calculated the optimal threshold values based on the value for each
plate by selecting the auto calculate threshold position and the PCR base-line
subtracted analysis mode from the iCycler Data Analysis Software (Bio-Rad,
Hercules, CA). The highest threshold position was 1415 PCR base-line
subtracted relative fluorescence units (RFU). We re-analyzed each plate by
entering 1415 as the user defined threshold position. Therefore, we were able to
compare replicates across multiple plates using Ct values generated from the
common threshold position.
We used the SABiosciences RT2 Profiler Data Analysis Software to determine
gene expression profiles (http://www.sabiosciences.com/pcr/arrayanalysis.php).
This software calculated fold regulation values for each gene using the relative
quantification 2-∆∆Ct method (Livak and Schmittgen, 2001). Each plate met the
quality assurance criteria listed by the manufacturer for genomic DNA
contamination, reverse transcription inhibition, and PCR cycling conditions. ∆Ct
values were normalized using the mean values of three housekeeping genes:
Gusb, Hsp90ab1, and Actb. All wells with a Ct value above 29.5 cycles were
excluded from the analysis. This left 65 transcripts for analysis.
3.2.7 Caspase 3 Detection
Active Caspases were detected based on a fluorescent inhibitor of Caspases
(FLICA) approach (Bedner et al., 2000; Slee et al., 1999). Zona-free embryos
were placed on slides and incubated with FLICA caspase3 reagent (Image-iT™
LIVE Red Caspase-3 and -7 Detection Kit, Invitrogen, Grand Island, NY) in M2
medium at 37°C for one hour. FLICA was removed and the embryos were
washed with M2 media, counterstained with Hoechst dye for 3 minutes and
washed with buffer provided by the manufacturer. Embryos were fixed in 1% PFA
for 10 min and mounted on cover slides. Each embryo was imaged with Zeiss
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LSM510 microscope (20X objective) and the images were pseudo-colored using
Adobe Photoshop (Adobe Systems, Inc., San Jose, CA). To genotype, we
collected each embryo in 10 µl of 100 µg/ml proteinase K solution, incubated the
embryos at 55°C for 10 minutes, and then heat inactivated at 95°C for 5 minutes.
We used these lysates to genotype each embryo by two rounds of PCR using
primers that flanked an insertion/deletion in exon 8.

3.2.8 Quantitative RT-PCR by Taqman
RNA isolated from embryos separated by genotype (mutant vs. wild-type) and
stage (morula, full blastocyst and hatched blastocyst) was reverse transcribed
individually following the protocol by Tang and Colleagues (Tang et al., 2010).
Following a 1:1 addition of 100% ethanol, RNA was concentrated with a
SpeedVac for 15 mins, resuspended in 4.5 µl lysis buffer and reverse transcribed.
We performed a two-step linear amplification process using barcoded primers as
described (Tang et al., 2010). Products from the first and second rounds were
purified using Zymo DNA concentration kits (Zymo Research, Irvine, CA) and
eluted in 30 µl of 1 X T10E0.1. Eed expression was used to check the cDNA
quality following the first linear amplification step (primers listed in Table 1).
cDNA was quantified using a Bio-Rad SmartSpec™ Plus Spectrophotometer.
Ten ng of cDNA was used as a template for qRT-PCR in combination with
TaqMan® Gene Expression Master Mix (PN#4369514; ABI, Carlsbad, CA) and
Taqman Gene-specific probes (ABI, Carlsbad, CA) on a Prism 7000HT
Sequence Detection System (ABI, Carlsbad, CA). We assayed a minimum of
three biological replicates for each group. Cycling reactions were performed in
duplicate or triplicate. The relative expression of each gene was calculated based
on the ΔΔCt value, where the results were normalized to the average Ct value of
Gapdh. Samples that failed to generate a signal above threshold at the end of
the reaction were given a Ct value of 40.
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3.2.9 Statistical Methods
SAB PCR Array Study. These data can be thought of as a complex nested block
design: Plate is nested within Pool and Pool is nested within Genotype (Plate and
Pool are both blocks). Transcript is nested within biological Role (each transcript
was assigned one biological Role), and transcript and role are crossed with each
level of nesting (i.e. each transcript is measured on each plate). The data were
analyzed in a GLM, blocked by Plate nested within Pool, and Pool nested within
Genotype. Transcript was nested within Role; and Role and Transcript crossed
with the blocking factors Plate and Pool, and with the experimental factor
Genotype. Each Plate and Pool acted as its own control. The relationship of
Plates as technical replicates from the same Pools is recognized. Transcript
describes the overall expression profile, while Role describes the overall
Functional Profile, and their interactions with Genotype test (respectively)
whether particular Transcripts differ from the average for the Role between
Genotypes, and whether particular Roles differ as a whole between Genotypes.
We partitioned out between-plate error and used this as the error term for
analyses for two reasons: 1) the plate reader software controls within plate error
and 2) the use of between-plate error is conceptually equivalent to (the source of
error in a traditional ANOVA approach testing each gene independently. By using
∆Ct values, the analysis directly calculates ∆∆Ct.
qRT-PCR study by TaqMan analysis. We adopted a similar GLM approach to
individually test and calculate the ∆∆Ct values from Cdkn1a and Trp53 gene
expression studies. Since we used the –∆Ct for each individual as raw data,
genotype interactions figures and tests a ∆∆Ct value. We also tested for common
changes in gene expression in different stages of pre-implantation development
and used the full pairwise comparisons table to generate the individual ∆∆Ct
values and standard errors.
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3.3

Results

3.3.1 Phenotypic Analysis of l11Jus1 and l11Jus4
We screened a cohort of 59 lethal mutants (45 of which were embryonic lethal)
that were generated by ENU mutagenesis (Hentges et al., 2006b), and identified
an allelic series of two mutants (l11Jus1 and l11Jus4) mapping to mouse
chromosome 11 that failed to gastrulate. Histological sections performed at
embryonic day (E) 7.5 show completely resorbing implantation sites compared to
control littermates (Figure 3.2). In contrast, animals inheriting two copies of the
35 Mb inversion, In(11Trp53;11Wnt3)8Brd, are homozygous mutant for Wnt3 and
display a distinct, much less severe phenotype during the gastrulation stage
(Table 3) (Hentges et al., 2006b; Kile et al., 2003). Complementation studies
revealed that the phenotype of the l11Jus1/l11Jus4 double heterozygotes is
identical to either single homozygous mutant (data not shown), thereby placing
l11Jus1 and l11Jus4 in the same complementation group.

A

B

C

D"

D"

Ex"

Em"
D"

Figure 3.2 Mutant phenotypes
H&E stained sections at E7.5 A. Wild type implantation site B. l11Jus1
implantation site. C. l11Jus4 implantation site. embryo (Em), extra-embryonic
region (Ex), and maternal decidua (D).
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Penetrance of l11Jus1 (L1) (Table 3.2A): We genotyped a total of 34 l11Jus1
(L1/L1)

homozygotes

(32

normal

and

2

abnormal

blastocysts),

117

heterozygotes (L1/Inv) and 49 animals homozygous for the inversion (Inv/Inv).
We failed to genotype 98 embryos due to lack of DNA from normal (n=40) and
abnormal (n=2) embryos; resorption sites (n=38) and lost embryos (n=18)
accounted for the remainder of non-genotyped embryos. At E6.5, we detected 0
homozygous mutant embryos out of 62 total embryos. X2 analysis indicates that
these numbers are statistically significant, with p<0.0001 (Table 3). At the
blastocyst stage (E3.5), we detected normal Mendelian ratios, indicating that the
time of death occurs between E3.5 and E6.5.
Penetrance of l11Jus4 (L4) (Table 3.2B). We genotyped a total of 28 l11Jus4
(L4/L4) homozygotes (all normal), 153 heterozygotes (L4/Inv) and 49 animals
homozygous for the inversion (Inv/Inv). We failed to genotype 58 embryos due to
lack of DNA from normal (n=9) and abnormal (n=2) embryos; resorption sites
(n=46) and lost embryos (n=1) accounted for the remainder of non-genotyped
embryos. At E6.5, we detected 0 homozygous mutant embryos out of 32 total
embryos. X2 analysis indicates that these numbers are statistically significant,
with a p-value of 0.004 (Table 3.2). At the blastocyst stage (E3.5), we detected
all genotypes, but saw an unexpectedly high number of heterozygotes (p=0.014).
Together, these data indicate that l11Jus1 homozygotes and l11Jus4
homozygotes both die in utero prior to E6.5.
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Table 3.2 Time of death for Nle1 mutants
A. Time of Death for l11Jus1 Mutants
Abnormal
No
DNA L1/L1

Normal
L1/Inv

Inv/
Inv

No
DNA

L1/L1

L1/Inv

Inv/
Inv

Lost

Total

Day

Resorb

3.5

0

2

2

4

3

40

32

58

23

1

165

6.5

28

0

0

0

18

0

0

42

0

10

98

7.5

3

0

0

0

1

0

0

5

0

3

12

8.5

3

0

0

2

3

0

0

1

0

4

13

9.5

4

0

0

1

1

0

0

4

0

0

10

Total

38

2

2

7

26

40

32

110

23

18
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B. Time of Death for l11Jus4 Mutants
Abnormal
No
DNA L4/L4

Normal
L4/Inv

Inv/
Inv

No
DNA

L4/L4

L4/Inv

Inv/
Inv

Lost

Total

Day

Resorb

3.5

0

2

0

8

3

6

28

86

27

1

161

6.5

16

0

0

4

9

0

0

19

0

0

48

7.5

7

0

0

0

4

0

0

19

0

0

30

8.5

13

0

0

5

5

0

0

11

0

0

34

9.5

10

0

0

0

1

3

0

1

0

0

15

Total

46

2

0

17

22

9

28

136

27

1

288
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Table 3.3 X2 analysis of selected timed matings
Observed

Expected

Stage

Total
Embryos

p value

L1/L1
L1/Inv
Inv/Inv

34
117
49

50
100
50

All

200

0.018

L1/L1
L1/Inv
Inv/Inv

34
62
26

30.5
61
30.5

E3.5

122

0.582

L1/L1
L1/Inv
Inv/Inv

0
42
18

15
30
15

E6.5

60

3.71703E-05

L4/L4
L4/Inv
Inv/Inv

28
153
49

57.5
115
57.5

All

230

5.17678E-07

L4/L4
L4/Inv
Inv/Inv

28
94
30

38
76
38

E3.5

152

0.014

L4/L4
L4/Inv
Inv/Inv

0
23
9

8
16
8

E6.5

32

0.004

Genotype

3.3.2 Positional Cloning of l11Jus1 and l11Jus4
Since L1 and L4 homozygotes failed at the implantation stage, meiotic mapping
would be difficult, at best, using traditional methods that rely on haplotype
analysis in phenotypically mutant animals. To circumvent this obstacle, we
narrowed the critical interval by exclusion mapping (Figure 3.1A). Exclusion
mapping involves haplotype analysis of all progeny at weaning for several
markers across the candidate interval (i.e. from Trp53 to Wnt3 on Mmu 11).
Since homozygous mutants are embryonic lethal, any marker that is
homozygous for the mutant allele (i.e. C57BL/6J) will effectively ‘exclude’ this
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marker from the candidate interval. Parents were heterozygous for the l11Jus1
mutation and for the dominant coat color marker, Rex. Throughout the 35 Mb
critical interval, l11Jus1 is on a C57BL/6J background, while Rex is on a
129S6/SvEvTac background. Since the balancer chromosome is not present in
the F1 generation, it is possible to obtain animals that have recombination events
on one or both parental alleles. These recombination events were visualized by
haplotype analysis in the F2 generation (Figures 1, 4). We genotyped 487
progeny (974 individual meiotic events), and narrowed the critical region to a 4.4
Mb domain flanked by Wsb1 and D11Mit120 (Figure 3.1B, C).
Of the 75 genes in this interval, 16 top candidates were selected based on
microarray expression data and mutant phenotype. We sequenced 8 of these
genes in the process of identifying the l11Jus1 and l11Jus4 mutations: adaptorrelated protein complex 2, beta1 subunit (Ap2b1); chaperonin containing Tcp1,
subunit 6b (zeta) (Cct6b); suppressor of zest 12 homolog (Suz12); fringe isoform
1 (Rffl); ecotropic viral integration site 2a (Evi2a); proteasome (prosome,
macropain) 26S subunit non-ATPase 11 (Psmd11); TAF15 RNA polymerase II,
TATA box binding protein (TBP)-associated factor (Taf15); and Notchless
homolog 1 (Drosophila) (Nle1).
We found no non-synonymous mutations in our first 7 candidates (Ap2b1, Cct6b,
Suz12, Rffl, Evi2a, Psmd11 or Taf15) (Lo et al., 2011). However, we identified a
T 1184 G transversion (I 395 S missense mutation) in l11Jus1 heterozygotes in
exon 10 of Nle1 (Figure 3.1D). This non-conservative substitution replaces an
aliphatic, hydrophobic amino acid with a polar residue, which likely disrupts
functionality (Livingstone and Barton, 1993). Subsequent mutation detection
efforts resulted in the identification of a second missense mutation (T 484 C
transition; S 162 P missense mutation) in exon 5 of Nle1 for the l11Jus4 allele
(Figure 3.1D). This non-conservative amino acid substitution has a high
probability to alter protein function, as serines easily form hydrogen bonds with
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polar substrates, while prolines are rarely found in active sites (Livingstone and
Barton, 1993). In addition, we detected an endogenous C57BL/6J nonsynonymous SNP (A 535 G transition; I 179 V) in exon 6 (Figure 3.1D). This welldocumented SNP (rs2820949) leads to a very conservative amino acid
substitution (Livingstone and Barton, 1993). Both mutants share the endogenous
mutation (Figures 2D, 7), indicating that l11Jus1 and l11Jus4 homozygotes
harbor two coding changes in Nle1–an ENU-induced allele and an endogenous
C57BL/6J missense mutation.
3.3.3 The Nle1 locus
BLAT analysis of the mouse RefSeq cDNA (Accession # NM_15431) at the
UCSC genome browser (Kent, 2002), reveals that the Nle1 locus contains 13
exons and spans 7628 bp of genomic DNA. cDNA and EST sequences indicate
the potential for generating several alternatively-spliced transcripts. The RefSeq
cDNA is predicted to encode a 485 amino acid protein that has an NLE1 domain
at the N-terminus and 8 WD40-like repeats (Figure 1F). NLE1 is highly
conserved, with orthologs in multiple species, even yeast and plants; it is over 91%
identical among mouse, rat, human and cow (Figure 3.3). In addition, it is highly
conserved in yeast (42%), drosophila (55%) and potato (58%) (data not shown).
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L1
L4
C57BL/6
Mouse
CZECHII
Rat
Human
Cow

--MAAAVVEEAAAGDVQRLLVQFQDEGGQLLGSPFDVPVDITPDKLQLVCNALLAQEEPL
--MAAAVVEEAAAGDVQRLLVQFQDEGGQLLGSPFDVPVDITPDKLQLVCNALLAQEEPL
--MAAAVVEEAAAGDVQRLLVQFQDEGGQLLGSPFDVPVDITPDKLQLVCNALLAQEEPL
--MAAAVVEEAAAGDVQRLLVQFQDEGGQLLGSPFDVPVDITPDKLQLVCNALLAQEEPL
--MAAAVVEEAAAGDVQRLLVQFQDEGGQLLGSPFDVPVDITPDKLQLVCNALLAQEEPL
MAAAVEVSDEAAASDVQRLLVQFQDEGGQLLGSPFDVPVDITPDQLQLVCNALLAQDEPL
--MAAAVPDEAVARDVQRLLVQFQDEGGQLLGSPFDVPVDITPDRLQLVCNALLAQEDPL
-MAAAAAADEAATRDVQRLLVQFQDEGGQLLGSPFDVPVDITPDKLQLVCNALLAQEDPL
*. . :**.: ******************************:***********::**

58
58
58
58
58
60
58
59

L1
L4
C57BL/6
Mouse
CZECHII
Rat
Human
Cow

PLAFYVHDAEIVSSLGKTLESQSVETEKIVDIIYQPQAVFRVRAVTRCTSSLEGHSEAVI
PLAFYVHDAEIVSSLGKTLESQSVETEKIVDIIYQPQAVFRVRAVTRCTSSLEGHSEAVI
PLAFYVHDAEIVSSLGKTLESQSVETEKIVDIIYQPQAVFRVRAVTRCTSSLEGHSEAVI
PLAFYVHDAEIVSSLGKTLESQSVETEKIVDIIYQPQAVFRVRAVTRCTSSLEGHSEAVI
PLAFYVHDAEIVSSLGKTLESQSVETEKIVDIIYQPQAVFRVRAVTRCTSSLEGHSEAVI
PLAFYVHDAEIVSSLGKTLESQSVETEKIVDIIYQPQAVFRVRAVTRCTSSLEGHSEAVI
PLAFFVHDAEIVSSLGKTLESQAVETEKVLDIIYQPQAIFRVRAVTRCTSSLEGHSEAVI
PLAFYVHDAEIVSSLGRTLESQAVETEKVLDIIYQPQAIFRVRAVTRCTSSLEGHSEAVI
****:***********:*****:*****::********:*********************

118
118
118
118
118
120
118
119

L1
L4
C57BL/6
Mouse
CZECHII
Rat
Human
Cow

SVAFSPTGKYLASGSGDTTVRFWDLSTETPHFTCKGHRHWVLSISWSPDGKKLASGCKNG
SVAFSPTGKYLASGSGDTTVRFWDLSTETPHFTCKGHRHWVLSIPWSPDGKKLASGCKNG
SVAFSPTGKYLASGSGDTTVRFWDLSTETPHFTCKGHRHWVLSISWSPDGKKLASGCKNG
SVAFSPTGKYLASGSGDTTVRFWDLSTETPHFTCKGHRHWVLSISWSPDGKKLASGCKNG
SVAFSPTGKYLASGSGDTTVRFWDLSTETPHFTCKGHRHWVLSISWSPDGKKLASGCKNG
SVAFSPTGKYLASGSGDTTVRFWDLSTETPHFTCKGHRHWVLSISWSPDGKKLASGCKNG
SVAFSPTGKYLASGSGDTTVRFWDLSTETPHFTCKGHRHWVLSISWSPDGRKLASGCKNG
SVAFSPTGKYLASGSGDTTVRFWDLSTETPHFTCQGHRHWVLSISWSPDGKKLASGCKNG
**********************************:*********.*****:*********

178
178
178
178
178
180
178
179

L1
L4
C57BL/6
Mouse
CZECHII
Rat
Human
Cow

QVLLWDPSTGLQVGRTLTGHSKWITGLSWEPLHMNPECRYVASSSKDGSVRVWDTTAGRC
QVLLWDPSTGLQVGRTLTGHSKWITGLSWEPLHMNPECRYVASSSKDGSVRVWDTTAGRC
QVLLWDPSTGLQVGRTLTGHSKWITGLSWEPLHMNPECRYVASSSKDGSVRVWDTTAGRC
QILLWDPSTGLQVGRTLTGHSKWITGLSWEPLHMNPECRYVASSSKDGSVRVWDTTAGRC
QILLWDPSTGLQVGRTLTGHSKWITGLSWEPLHMNPECRYVASSSKDGSVRVWDTTAGRC
QILLWDPSTGTQVGRTLTGHSKWITGLSWEPLHMNPECRYVASSSKDGSVRVWDTTAGRC
QILLWDPSTGKQVGRTLAGHSKWITGLSWEPLHANPECRYVASSSKDGSVRIWDTTAGRC
QILLWDPSTGKQVGRALTGHSKWITALSWEPLHANPECRYVASSSKDGSVRVWDTTAGRC
*:******** ****:*:*******.******* *****************:********

238
238
238
238
238
240
238
239

L1
L4
C57BL/6
Mouse
CZECHII
Rat
Human
Cow

ERILTGHTQSVTCLRWGGDGLLYSASQDRTIKVWRAHDGVLCRTLQGHGHWVNTMALSTD
ERILTGHTQSVTCLRWGGDGLLYSASQDRTIKVWRAHDGVLCRTLQGHGHWVNTMALSTD
ERILTGHTQSVTCLRWGGDGLLYSASQDRTIKVWRAHDGVLCRTLQGHGHWVNTMALSTD
ERILTGHTQSVTCLRWGGDGLLYSASQDRTIKVWRAHDGVLCRTLQGHGHWVNTMALSTD
ERILTGHTQSVTCLRWGGDGLLYSASQDRTIKVWRAHDGVLCRTLQGHGHWVNTMALSTD
ERILTGHTQSVTCLRWGGDGLLYSASQDRTIKVWRAHDGVLCRTLQGHGHWVNTMALSTD
ERILTGHTQSVTCLRWGGDGLLYSASQDRTIKVWRAHDGVLCRTLQGHGHWVNTMALSTD
ERTLTGHAQSVTCLRWGGDGLLYSASQDRTIKVWRAHDGVLCRTLQGHGHWVNTMALSTD
** ****:****************************************************

298
298
298
298
298
300
298
299

L1
L4
C57BL/6
Mouse
CZECHII
Rat
Human
Cow

YALRTGAFEPAEATVNAQDLQGSLKELKERASSRYNLVRGQGPERLVSGSDDFTLFLWSP
YALRTGAFEPAEATVNAQDLQGSLKELKERASSRYNLVRGQGPERLVSGSDDFTLFLWSP
YALRTGAFEPAEATVNAQDLQGSLKELKERASSRYNLVRGQGPERLVSGSDDFTLFLWSP
YALRTGAFEPAEATVNAQDLQGSLKELKERASSRYNLVRGQGPERLVSGSDDFTLFLWSP
YALRTGAFEPAEATVNAQDLQGSLKELKERASSRYNLVRGQGPERLVSGSDDFTLFLWSP
YALRTGAFEPAEATVNAQDLQGSLKELKERASSRYNLVRGQGPERLVSGSDDFTLFLWSP
YALRTGAFEPAEASVNPQDLQGSLQELKERALSRYNLVRGQGPERLVSGSDDFTLFLWSP
YALRTGAFEPAEASVNAQDLRGSLQELKERALSRYNLVRGQGPERLVSGSDDFTLFLWSP
*************:**.***:***:****** ****************************

358
358
358
358
358
360
358
359

L1
L4
C57BL/6
Mouse
CZECHII
Rat
Human
Cow

AEDKKPLARMTGHQALINQVLFSPDSRIVASASFDKSVKLWDGRTGKYLASLRGHVAAVY
AEDKKPLARMTGHQALINQVLFSPDSRIVASASFDKSIKLWDGRTGKYLASLRGHVAAVY
AEDKKPLARMTGHQALINQVLFSPDSRIVASASFDKSIKLWDGRTGKYLASLRGHVAAVY
AEDKKPLARMTGHQALINQVLFSPDSRIVASASFDKSIKLWDGRTGKYLASLRGHVAAVY
AEDKKPLARMTGHQALINQVLFSPDSRIVASASFDKSIKLWDGRTGKYLASLRGHVAAVY
AEDKKPLARMTGHQALINQVLFSPDSRIVASASFDKSIKLWDGRTGKYLASLRGHVAAVY
AEDKKPLTRMTGHQALINQVLFSPDSRIVASASFDKSIKLWDGRTGKYLASLRGHVAAVY
AEDKKPLARMTGHQALINQVVFSPDSRVIASASFDKSIKLWDGRTGKYLASLRGHVAAVY
*******:************:******::********:**********************

418
418
418
418
418
420
418
419

L1
L4
C57BL/6
Mouse
CZECHII
Rat
Human
Cow

QIAWSADSRLLVSGSSDSTLKVWDVKAQKLATDLPGHADEVYAVDWSPDGQRVASGGKDK
QIAWSADSRLLVSGSSDSTLKVWDVKAQKLATDLPGHADEVYAVDWSPDGQRVASGGKDK
QIAWSADSRLLVSGSSDSTLKVWDVKAQKLATDLPGHADEVYAVDWSPDGQRVASGGKDK
QIAWSADSRLLVSGSSDSTLKVWDVKAQKLATDLPGHADEVYAVDWSPDGQRVASGGKDK
QIAWSADSRLLVSGSSDSTLKVWDVKAQKLATDLPGHADEVYAVDWSPDGQRVASGGKDK
QIAWSADSRLLVSGSSDSTLKVWDVKAQKLTTDLPGHADEVYAVDWSPDGQRVASGGKDK
QIAWSADSRLLVSGSSDSTLKVWDVKAQKLAMDLPGHADEVYAVDWSPDGQRVASGGKDK
QIAWSADSRLLVSGSSDSTLKVWDVKAQKLSTDLPGHADEVYAVDWSPDGQRVASGGKDK
******************************: ****************************

478
478
478
478
478
480
478
479

L1
L4
C57BL/6
Mouse
CZECHII
Rat
Human
Cow

CLRIWRR
CLRIWRR
CLRIWRR
CLRIWRR
CLRIWRR
CLRIWRR
CLRIWRR
CLRIWRR
*******

485
485
485
485
485
487
485
486

Figure 3.3 NLE1 protein sequence alignment
NLE1 is highly conserved among mouse, rat, cow and human.
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3.3.4 Expression Analysis of the Notch Pathway in Mutant Embryos
Since Nle1l11Jus1/l11Jus1 embryos die shortly after implantation, while disruption of
NOTCH signaling by multiple methods (i.e. targeted deletion of Notch receptors
and ligands, (Conlon et al., 1995; Dunwoodie et al., 2002; Hamada et al., 1999;
Hrabe de Angelis et al., 1997; Jiang et al., 1998a; Jiang et al., 1998c; Krebs et al.,
2004; Krebs et al., 2000; Krebs et al., 2003; McCright et al., 2001; Swiatek et al.,
1994), γ-secretase (Donoviel et al., 1999) or Pofut1 (Shi et al., 2005a; Shi and
Stanley, 2003)) in mice leads to embryonic lethality after mid-gestation, we
hypothesized that Nle1l11Jus1/l11Jus1 and Nle1l11Ju41/l11Jus4 mutants had defects in
multiple signaling pathways. To test for defects in NOTCH signaling, we analyzed
Notch pathway gene expression in homozygous mutant (i.e. Nle1l11Jus1/l11Jus1)
blastocysts

using

the

PAMM-059

Notch

Pathway

SAB

PCR

Array

(SABiosciences/Qiagen, Frederick, MD). We compared expression levels of 84
Notch pathway genes in Nle1l11Jus1/l11Jus1 pre-implantation embryos to Nle+/+
control littermates.
We eliminated 19 genes, including 8 Notch downstream targets (Cflar, Ifng, Il2ra,
Pparγ, Cd44, Dtx1, Krt1 and Ptcra) and the Notch ligand, Dll1, due to lack of
expression (i.e. had a Ct value ≥ 29.5). This left 65 genes for statistical analysis,
including the Notch receptors (Notch1-4), Jagged ligands (Jag1-2) and receptor
processing and modifying enzymes (i.e. the γ-secretase complex and protein Ofucosyltransferase genes: Adam10, Adam17, Psen1, Psen2, Psenen and Pofut1).
Notch target genes include Cdkn1a (a marker of cell cycle arrest), Hes1, Hey1,
Stat6, Nr4ar, Nfkb1 and Pparg (transcriptional regulators), Ccnd1 (cell cycle), as
well as Chuk, Il17b and Krt1 (downstream targets with unspecified functions in
the NOTCH pathway). In addition, the PCR array contains several members of
the Wnt (Aes, Axin1, Lrp5, Fzd1-7 and Wnt11) and Hedgehog signaling
pathways (Gli1, Gsk3, Shh, Smo and Sufu). To ensure biological significance,
genes with less than a 1.5 fold change were included in the statistical analyses,
but not considered differentially expressed.
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We analyzed the data using a GLM blocked by plate (technical replicate) nested
within pool (biological replicate) and pool nested within genotype. Transcript
levels were nested within biological function/pathway (role). Role and transcript
were crossed with the blocking factors plate and pool, and with the experimental
factor genotype. Therefore, testing for genotype X transcript interactions will
identify single genes that are statistically upregulated or downregulated in mutant
embryos, while testing for genotype X role interactions identifies groups of genes
with similar biological functions (i.e. Wnt pathway, transcriptional regulation, etc.)
that are as a whole misregulated in mutant embryos compared to wild-type
controls. The Role (GLM: F7,84=248.3; P<0.0001) and Transcript (F7,84=224.0;
P<0.0001) effects were significant, indicating the presence of consistent
functional and expression profiles in both genotypes.
The Genotype*Transcript interaction was significant (F57,684=1.5490; P=0.0073),
indicating that at least one transcript differed from the overall mean of transcripts
within the same Role. Of the 16 Notch target genes detected in this study, 6 were
overexpressed by at least 1.5 fold (Cdkn1a, Nfkb1, Hes1, Erb2, Il17b, Mapk27).
However only Cdkn1a, which was upregulated by 4.7 fold in mutant samples
(Figure 3.4) (p=1.94X10-8), was statistically significant using post hoc tests
corrected for multiple comparisons (accepting p<0.000769); none of the other
genes approached significance, even at an uncorrected threshold of p<0.05.
Seven genes demonstrated a more than 1.5 fold reduction in expression in
Nle1l11Jus1/l11Jus1 embryos: Lrp5, Fzd7, Fzd4 and Wnt11, which are members of
the Wnt signaling pathway, and Chuk, Nr4a2 and Stat6. However, none of these
met the rigorous criteria (p<0.000769) that accounts for the multiple comparison
analysis. Setting aside Bonferroni corrections for false positive detection rate,
and accepting a false discovery rate (FDR) of 5% leads to the inclusion of Fzd7
(p=0.00168), Nr4a2 (p=0.00422), Fzd4 (p=0.00461) and Chuk (p=0.02492);
using an FDR of 10% leads to the inclusion of Wnt11 (p=0.02679) (Figure 3.4).
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Fold change in expression Mutant / Wildtype
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Figure 3.4 Expression of Nle1l11Jus1 embryos using a Notch-specific PCR array
Each transcript is listed (left), with fold change indicated (top). The mean
expression level for each transcript is indicated. The least-squares mean ΔΔCT
±SE is shown for each transcript, with equivalent fold-change. The dashed line
indicates that Cdkn1a is the only gene with significant differences in expression
following a Bonferonni correction for multiple comparisons. The dotted line
represents transcripts where p < 0.05. Biological roles were taken directly from
the SAB website.
This analysis indicates that multiple members of the Wnt pathway are
downregulated in Nle1 mutant embryos.
3.3.5 Confirmation of Cdkn1a in Different Stages in Pre-Implantation
The SAB PCR array study was performed on three pools (n=15) of E3.5 embryos
at different stages (i.e. a mix of morula, blastocysts and hatched blastocysts).
This could have introduced biased expression or masked subtle alterations in
stage-specific gene expression due to pooling of embryos from different stages.
To control for these possibilities and confirm the PCR array results, we analyzed
expression of Cdkn1a between wild type and mutant embryos at multiple
embryonic stages (morula, full blastocyst and hatched blastocyst) in single
embryos using TaqMan assays. Expression of each gene was normalized
relative to expression of Gapdh and compared to the stage-matched wild type
controls. Wild type expression was set at a value of one.
We used a multivariate GLM model to calculate ΔΔCt and fold change and to
properly control and test for differences between the mutant alleles and stages of
development. Using a least squares mean, which corrected for all of the
variables in the analysis (line, genotype, stage of development), we did not
detect differences in Cdkn1a expression between mutants compared to control
embryos as a function of stage (morula, blastocyst and hatchet blastocyst;
F2,32=0.2701; P=0.7650), line (Nle1l11Jus1 and Nle1l11Jus4; F1,32=1.293; P=0.2640)
or stage and line (F2,32=0.0574; P=0.9444), indicating that we did not detect
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differences in expression due to developmental stage or mutant line. However,
overall, Cdkn1a was expressed at 4.69 fold (95% CI: 1.02 - 21.5 fold) higher
levels both in Nle1l11Jus1/l11Jus1 and Nle1l11Jus4/l11Jus4 mutant embryos compared to
wild-type controls at all stages (GLM: F1,32=4.2561; P=0.0473). These data are
consistent with our PCR array findings for l11Jus1 mutant embryos, show that
there are no significant differences in expression of Cdkn1a at the different
stages tested in the PCR array, and demonstrate that the phenotypes associated
with l11Jus1 and l11Jus4 do not differ at the molecular level.
3.3.6 Apoptosis Occurs at E4.5 in Nle1l11Jus1/l11Jus1 and Nle1l11Jus4/l11Jus4 Mutants
These Cdkn1a expression findings are intriguing, as targeted disruption of Nle1
in mice indicated that mutant embryos started to undergo apoptosis at E3.5 plus
1 day in culture, which is approximately equivalent to E4.5 embryos (i.e. hatched
blastocysts) (Cormier et al., 2004a). If our mutant embryos were also undergoing
apoptosis, we would expect that they would not show high levels of Cdkn1a, as
Cdkn1a expression is most often an indication that cells have exited the cell
cycle following a DNA damage response or other type of cellular stress event
(Brugarolas et al., 1995; Deng et al., 1995). However the function of CDKN1A in
cell cycle arrest and apoptosis is still unclear, as other studies have shown that
Cdkn1a expression levels can be upregulated in cells undergoing apoptosis
(Gartel, 2005). Given that Cdkn1a was expressed at much higher levels in Nle1
mutants compared to wild-type embryos, we hypothesized that animals
expressing high levels of Cdkn1a would be protected from apoptosis at E3.5, but
would ultimately become apoptotic by E4.5, which would be consistent with
previous studies (Cormier et al., 2004a).
Therefore, we analyzed Caspase 3 activity at E3.5 and E4.5 (Figure 3.5; Table
3.4). We tested these data in a single logistic multiple regression. We detected
Caspase 3 activity solely in homozygous mutants (Likelihood Ratio χ2 = 21.75;
p<0.0001) at E4.5 (LR χ2 = 15.11; p=0.0001) p<0.0001. Strain had no effect (LR
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χ2 < 0.0001; p>0.9999). We did not find any evidence for an interaction between
genotype and stage (LR χ2 < 0.0001; p>0.9999). Overall, these data indicate
that apoptosis appears at E4.5, but not at E3.5; that apoptosis is only seen in
homozygous mutants, and that these two effects are independent and additive in
both alleles.

Mutant

Wildtype

E3.5

10µm

10µm

E4.5

10µm

10µm

Figure 3.5 Caspase 3 detection in Nle1l11Jus1 mutant embryos
Caspase 3 detection in mutant and wild type embryos at E3.5 (200X) and E4.5
(200X). Positive Caspase 3 staining is only detected in E4.5 mutants. Red
staining indicates the presence of Caspase 3 signal and blue is Hoechst staining.
White arrows point out Caspase staining. Merged images are shown.
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Table 3.4 Logistic multiple regression analysis of caspase 3 detection
Genotype/stage

Homozygous WT

Heterozygous

Homozygous
Mutant

Total

Caspase 3

+

–

+

–

+

–

l11Jus1 E3.5
morula/blastocyst

0

1

0

5

0

2

8

l11Jus1 E4.5
hatched blastocyst

0

2

0

5

2

0

9

l11Jus4 E3.5
morula/blastocyst

0

4

0

5

0

3

12

l11Jus4 E4.5
hatched blastocyst

0

3

0

4

3

0

10

3.3.7 qRT-PCR Analysis of Trp53 in Mutant Embryos
We then asked whether the apoptotic phenotype is Trp53-dependent. Taqman
assays were conducted to compare Trp53 expression between wild-type and
mutant embryos. Identical GLM models were used to calculate fold change and
test significance, with additional planned contrasts performed to test differences
at different embryonic stages. Trp53 expression did not differ between control
and

mutant

embryos

overall

(GLM:

F1,33=0.5316;

P=0.4711),

by

line

(F1,33=0.0057; P=0.9404), by embryonic stage (F2,33=0.0994; P=0.9056), or the
interaction of line and stage (F2,33=0.1782; P=0.8376).
Together, the gene expression and Caspase 3 data indicate that Nle1l11Jus1/l11Jus1
and Nle1l11Jus4/l11Jus4 homozygotes undergo Caspase 3-mediated apoptosis at the
hatched blastocyst stage. This is not mediated by alterations in mRNA levels of
Trp53, and apoptosis does not correlate with upregulation of Cdkn1a expression
in homozygous mutant embryos, as upregulation of Cdnk1a occurs from the
morula through the hatched blastocyst stage, even though apoptosis only is
observed at the latest stages. Furthermore, we demonstrate that several
members of the Wnt pathway are downregulated in mutant embryos, suggesting
that NLE1 interacts with the WNT pathway during pre-implantation development.
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3.4

Discussion

We present evidence that the l11Jus1 and l11Jus4 mutant phenotypes are
caused by non-conservative missense mutations in the Nle1 gene. Gene
targeting studies indicate that l11Jus1 and l11Jus4 phenocopy the null allele
(Cormier et al., 2006b). These ENU mutants were created on a C57BL/6J
background, which also contains a conservative missense mutation in Nle1.
Therefore, l11Jus1 and l11Jus4 homozygotes harbor two mutations within
predicted functional domains of NLE1. Previous studies in Drosophila and
Xenopus indicate that NLE1 is a member of the NOTCH pathway (Cormier et al.,
2006b; Royet et al., 1998a). NOTCH signaling facilitates short-range cell-cell
communication during diverse cellular processes, in multiple tissues and at a
multitude of developmental stages. Loss of function or gain of function mutations
in various factors that are fundamental to canonical NOTCH signaling are often
associated with developmental disorders, adult-onset diseases and a variety of
cancers in humans (Kopan and Ilagan, 2009).
However, the function of NLE1 in NOTCH signaling remains elusive. Initial
studies in Drosophila show that NLE1 function is context and dosage dependent.
NLE1 was identified as a dominant suppressor of the viable mutant allele,
notchoid (Royet et al., 1998a). Notchoid mutants have characteristic wing
notches; in the notchoid mutant background, Nle1 heterozygosity (i.e. Nle1/+)
rescued the notchoid phenotype, while simultaneously causing shortened and
thickened wing veins (Royet et al., 1998a). Interestingly, overexpression of
wingless, the Drosophila Wnt ortholog, in the notchoid background also rescues
the notchoid phenotype (Couso and Martinez Arias, 1994; Hing et al., 1994),
while overexpression of Notch leads to shortened, thickened wing veins
(Matsuno et al., 1995). Since NLE1 can bind the NOTCH intracellular domain
(NICD), these experiments suggest that NLE1 is a negative regulator of NOTCH,
and that NLE1 functions by blocking the ability of the NICD to regulate
expression of downstream targets. Studies in Xenopus come to the opposite
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conclusion, as overexpression of Murine (Cormier et al., 2006b) or a combination
of Xenopus and Drosophila (Royet et al., 1998a) Nle1 mRNAs into single
blastomeres at the 4-cell or 2-cell stage, respectively, lead to decreased numbers
of primary neurons at the early neurula stage. These results indicate that NOTCH
activity was upregulated following injection of Nle1 mRNAs, suggesting that
NLE1 positively regulates NOTCH signaling.
These studies indicate that NLE1 acts as both a positive and negative regulator
of NOTCH signaling. If NLE1 acts as a general positive regulator of NOTCH
signaling during murine pre-implantation development, then elimination of NLE1
could lead to compensatory over-expression of the Notch receptors, ligands and
protease family members, but reduced expression of downstream target genes.
In contrast, if NLE1 functions as a negative regulator of NOTCH signaling, we
would predict that disruption of NLE1 would lead to increased expression of
Notch target genes. To our surprise, we saw no generalized misregulation of
Notch target genes in the PCR array study. In addition, the Notch receptors,
ligands and other family members were not significantly altered. At a false
discovery rate of 5%, the only genes that are misregulated in the PCR array
study were: Cdkn1a, Nr4a2, Fzd7, Fzd4 and Chuk. Cdkn1a, Nr4a2 and Chuk
are downstream targets of NOTCH signaling, while Fzd7 and Fzd4 encode
receptors in the WNT pathway. To tease out the gene expression changes that
occurred during specific pre-implantation stages, we analyzed expression of
Cdkn1a on individual staged embryos (morulae, full blastocysts and hatched
blastocysts). Cdkn1a was significantly upregulated in Nle1l11Jus1/l11Jus1 and
Nle1l11Jus4/l11Jus4 animals at all three stages. These studies indicate that mutations
in Nle1 do not significantly affect the NOTCH pathway during pre-implantation
development.
CDKN1A is a powerful cyclin-dependent kinase inhibitor that functions in several
developmental pathways and negatively regulates the cell cycle at G1 via a
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TRP53-mediated response to DNA damage (Abbas and Dutta, 2009). This can
happen directly by competing with DNA polymerase δ for PCNA binding sites at
the replication fork, leading to decreased DNA synthesis (Moldovan et al., 2007).
Alternatively, CDKN1A can inhibit CDK2, which leads to suppression of E2fdependent transcripts, downregulation of components of the DNA synthesis
machinery and reduced firing at origins of replication (Zhu et al., 2005). In
addition, CDKN1A can act as a negative regulator of Caspase-mediated
apoptosis (Abbas and Dutta, 2009). Gene targeting studies demonstrated that
the inner cell mass of Nle1-/- embryos was undergoing apoptosis via a caspasedependent mechanism in E3.5 blastocysts that were cultured for 24 hours
(Cormier et al., 2006b). We analyzed Caspase 3 activity in blastocysts and
hatched blastocysts at E3.5 and E4.5. Consistent with the results of Cormier and
colleagues (2006), we demonstrate that l11Jus1 and l11Jus4 show evidence of
apoptosis only in hatched blastocysts.
Although we show upregulation of Cdkn1a and downregulation of several
members of the Wnt pathway, how these two networks work together to regulate
pre-implantation development is still unknown. One attractive possibility is via the
TRP53-mediated stress response pathway, which is upstream of CDKN1A. We
predicted that if our Nle1 mutations were causing severe cellular damage, the
cell would not be able to recover during cell cycle arrest (at E3.5), which would
then force the cell to undergo apoptosis (at E4.5). If this were true, we would
expect to see increased expression of Trp53, as the cells proceeded through
apoptosis. However, we did not detect altered expression of Trp53 by qRT-PCR
studies in our mutants at any stage. In retrospect, this result is not that surprising,
as TRP53-mediated apoptosis (via Cdkn1a upregulation) is not necessarily
correlated with mRNA expression of Trp53, but is instead associated with
upregulation of the active, acetylated form of the TRP53 protein (Yamakuchi and
Lowenstein, 2009). Alternately, it is possible that the expression changes in
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Trp53 were too subtle to detect, or apoptosis could be occurring via non-TRP53
mediated pathways (Gurley et al., 2009).
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CHAPTER 4. NLE1 MISSENSE MUTATIONS TIGGER TRP53 ACTIVATION
AND DISRUPTION IN RIBOSOMAL BIOGENESIS DURING MURINE PREIMPLANTATION DEVELOPMENT

4.1

Introduction

Previously, we reported that missense mutations in Notchless (Nle1) result in
embryonic lethality at peri-implantation (Lossie et al., 2012). Mutant embryos
implant and elongate, but fail to establish and/or maintain maternal/fetal contacts,
ultimately failing prior to gastrulation. Nle1 mutant embryos display alter
expression of Cdkn1a and several members of the Wnt pathway (e.g. Fzd4, Fzd7,
and Wnt11). The Wnt pathway is critical for establishing and maintaining
pregnancies (Pey et al., 1998; Wang et al., 2004; Xie et al., 2008). For example,
targeted disruption of Wnt3 results in embryonic lethality prior to primitive streak
formation (Barrow et al., 2007). Wnt pathway genes are highly expressed in
blastocysts (Kemp et al., 2005; Kemp et al., 2007; Lloyd et al., 2003; Mohamed
et al., 2004), as well as in the uterus during peri-implantation (Hayashi et al.,
2007; Hayashi et al., 2009; Miller and Sassoon, 1998).
CDKN1A is thought to play important roles in cell cycle arrest and/or apoptosis
through activation of TRP53-mediated programmed cell death (Abbas and Dutta,
2009). Activation of TRP53 can be induced by cellular stress or DNA damage
(Yuan et al., 2005). In our case, we believe the cellular stress is resulted from the
missense mutation in NLE1. Therefore, it is crucial to tease out the functional role
of NLE1 in mouse early development. Nle1 was first identified as a suppressor of
the notchoid phenotype in Drosophila, and has been determined to interact with
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the intracellular domain of Notch (Royet et al., 1998). NLE1 acts both as a
positive and a negative regulator of NOTCH signaling, depending upon
developmental stage and species (Cormier et al., 2006b; Royet et al., 1998a).
Studies in Drosophila and Xenopus demonstrate that NLE1 signals via the
canonical NOTCH pathway (Cormier et al., 2006b; Royet et al., 1998a). In
invertebrates and lower vertebrates, the NOTCH pathway is critical for directing
cell fate prior to gastrulation, and also plays important, but varied roles in germ
layer boundary formation (Good et al., 2004). However, our findings refute the
possibility of NLE1 in the NOTCH pathway in mouse early development, as
mutation of Nle1 does not lead to altered expression of Notch downstream genes
(Lossie et al., 2012). Furthermore, several lines of evidence demonstrate that
NOTCH signaling is dispensable for gastrulation in mice. Single gene and
compound knockout studies of the Notch receptors and ligands results in either
viable animals or embryonic lethality at mid-gestation (Conlon et al., 1995;
Dunwoodie et al., 2002; Hamada et al., 1999; Hrabe de Angelis et al., 1997;
Jiang et al., 1998a; Jiang et al., 1998c; Krebs et al., 2004; Krebs et al., 2000;
Krebs et al., 2003; McCright et al., 2001; Swiatek et al., 1994). Similarly, deletion
of genes that block NOTCH signaling, such as Pofut1 and members of the gsecretase complex, leads to embryonic failure after gastrulation and midline
formation (Shi et al., 2005a; Shi and Stanley, 2003). These studies demonstrate
that unlike lower vertebrates and invertebrates, and despite the fact that Notch
receptors and ligands are expressed prior to and during gastrulation (Cormier et
al., 2004a), NOTCH signaling is dispensable prior to gastrulation in mice.
Several studies in yeast and plants (which lack NOTCH signaling) demonstrate a
role for NLE1 in ribosomal biogenesis (Chantha et al., 2007a; Chantha et al.,
2006; Chantha and Matton, 2007; de la Cruz et al., 2005b; Strain et al., 2001).
Ribosomal biogenesis is necessary during preimplantation development, as
genetic ablation of proteins involved in rRNA processing usually causes growth
arrest prior to implantation (Gallenberger et al., 2011; Lerch-Gaggl et al., 2002;
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Romanova et al., 2006; Zhang et al., 2008). For instance, in mice with mutations
in the proteins involved in ribosomal rRNA synthesis and processing, such as
pescadillo-1 (PES1) (Lerch-Gaggl et al., 2002), RNA polymerase 1 (Rpol1)
(Yamamura et al., 2008), surfeit gene 6 (SURF6) (Romanova et al., 2006), RNA
binding motif protein 19 (RBM19) (Zhang et al., 2008), EMG1 nucleolar protein
homolog (S. cerevisiae) (EMG1) (Ding et al., 2010), WD repeat domain 36
(WDR36) (Gallenberger et al., 2011), and lin-28 homolog A (C. elegans) LIN28a
(Vogt et al., 2012), mutant embryos are arrested at the morula stage, leading us
to hypothesize that NLE1 is involved in murine ribosomal biogenesis preimplantation development.
The general paradigm for ribosomal biogenesis is the coordinated assembly of
approximately 80 ribosomal proteins and four ribosomal RNAs to generate the
60S and 40S ribosome precursors(Lempiainen and Shore, 2009). This process
requires all of the RNA polymerases. RNA polymerase I transcribes the 47S
precursor rRNA, which is subsequently processed into 28S, 18S and 5.8S rRNAs.
5S rRNA is transcribed by RNA polymerase III, translocated to the cytoplasm and
then imported back into the nucleolus where it incorporates into the large
ribosomal subunit (Venema and Tollervey, 1999). Ribosomal proteins and other
factors that assist rRNA processing and assembly, rRNA export and final
maturation are transcribed by RNA polymerase II (Kressler et al., 1999). Misregulation of ribosomal biogenesis (e.g. defects in rRNA transcription and
disruptions in rRNA processing) triggers ribosomal stress, and in most case,
causes the breakdown of nucleolar structure which leads to activation of the RPMDM2-p53 pathway and p53-dependent cell cycle arrest and/or apoptosis
(Deisenroth and Zhang, 2010) .
Several lines of studies have shown that the appropriate amount of ribosome is
required for allowing G1-S transition and further regulates cell cycle progression
through the regulation of p53. For example, conditional deletion of the 40S
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ribosomal protein S6 in mouse hypatocytes leads to defects in 40S ribosome
production and a block of entry into S phase (Volarevic et al., 2000). Drug
induced inhibition of rRNA synthesis caused a delay in the G1-S transition due to
the reduction of 18S and 28S rRNA produced during the G1 phase (Derenzini et
al., 2005).

These pieces of evidence point out that there appears to be a

threshold level of ribosomes necessary for progression in the cell cycle, and that
disruptions in rRNA processing could seriously disrupt important cellular
checkpoints during pre-implantation development.
P53 is part of a feedback loop that includes the E3 ubiquitin ligase MDM2, as
MDM2 catalyzes ubiquitination of P53, leading to protein degradation (Deisenroth
and Zhang, 2011). Many of the p53 regulators function through binding to and
inhibiting the function of MDM2 or induce posttranslational modifications that
block the MDM2-P53 interaction. Upon induction, the nucleolar protein ARF
(Alternative Reading Frame), a product of the INK4A/ARF locus, binds to MDM2
to inhibit degradation of P53 (Sharpless, 2005). In addition, protein modifications
to MDM2 (e.g. ubiquitination, sumoylation and phosphorylation) inhibit the
MDM2-p53 interaction, thereby stabilizing p53 activity (Meek and Knippschild,
2003). Like ARF, a number of ribosomal protein (RPs) have been reported to
interact with MDM2 to block p53 ubiquitination, and specifically ‘lock in’ the active
form of p53 (Deisenroth and Zhang, 2011). For instance, the ribosomal proteins
RPL5, PRL11, RPL23 and S7 bind MDM2 and therefore stabilize p53 activity.
Furthermore, inhibition of rRNA transcription by drugs (5-fluorouracil, actinomycin)
or by deleting the Pol I complex also causes similar outcomes through RPdependent inactivation of MDM2. The active p53 thereby induces the expression
of Cdkn1a, inhibits cyclin E/Cdk2 complexes and leads to pRB-dependent cell
cycle arrest (Zhao et al., 2003).
In yeast, NLE1 (Rsa4) mutations block processing of the 35S/27S precursor
rRNA to the mature 25S and 5.8S rRNAs (Bassler et al., 2010). The
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corresponding mammalian transcripts are the 36S/32S pre-rRNA, and the mature
28S and 5.8S rRNAs). Given that mutations in Nle1 induce Cdkn1a and
ultimately lead to apoptosis (Lossie et al., 2012), we hypothesize that the primary
cellular insult to the mutant embryos was a disruption in rRNA processing of the
36S/32S pre-rRNA transcript that activates the RP-MDM2-p53 pathway and
leads to cell cycle arrest and/or apoptosis in mutant embryos. To test this
hypothesis, we determined that TRP53 is activated in the mutants and several
TRP53 regulated genes involved cell cycle and apoptosis pathways are misexpressed. Next, we performed RNASeq using the MiSeq platform to sequence
and quantify total cellular rRNA. We also examined nucleologenesis by detecting
the expression pattern of the nucleolar protein, Fibrillarin during pre-implantation
development.
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4.2

Methods

4.2.1 Immunofluorescence
Incubation of the embryos in acid Tyrode’s solution (Sigma-Aldrich, Cat# T1788100ML, St. Louis, MO) denuded the embryos of the zona pellucida. Embryos
were fixed in 1% paraformaldehyde for 10 minutes, wash in 1X PBS, and then
directly stored in 70% Ethanol at 4°C for later use. Fixed embryos were washed
three times in PBST (0.1% Triton X-100 in 1X PBS), permeabilized for 30
minutes in 0.5% Triton in PBS at room temperature, and blocked for two hours in
3% BSA, 0.1% Triton X-100 in PBS at room temperature. Embryos were then
incubated with the primary antibody in blocking buffer at 4°C overnight. The
primary antibodies used in this study are rabbit polyclonal anti-Fibrillarin antibody
(1:100 dilution) (Abcam, Cat# ab5821, Cambridge, MA) and rabbit polyclonal
anti-p53 (acetyl K378) (1:750 dilution) (Abcam, Cat# ab61241, Cambridge, MA).
We incubated the embryos in Chromeo 642 Goat Anti-Rabbit secondary antibody
(Active Motif, Cat# 15044, Carlsbad, CA) using a 1: 1000 dilution in PBST for one
hour at room temperature. Embryos were washed in 1 X PBST in 0.5 ul
eppendorf tubes for 3 X 10 minutes between each step and stirred with pipette
tips. Embryos were counterstained with Hoechst dye for 15 minutes and mounted
on slides for imaging. Each embryo was imaged using a Zeiss LSM510
microscope (20 X objective); images were pseudo-colored using Adobe
Photoshop (Adobe Systems, Inc., San Jose, CA). We genotyped each embryo
following immunofluorescence analysis by collecting them separately in 10 µl of a
100 µg/ml proteinase K solution prepared in PCR water. Embryos were lysed by
incubation at 55°C for 10 minutes, followed by heat inactivated at 95°C for 5
minutes to the eliminate proteinase K. We used these lysates to genotype each
embryo by two rounds of PCR using primers that flanked an insertion/deletion in
exon 8 (Lossie et al., 2012) (primers listed in Table 4.1).
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Table
4.1
Primers
used
for this study
Table 4.1.
Primers
used for
this study
Forward Sequence

Reverse Sequence
Nle1 genotyping primers

Nle1 GSP
GCTGTAATGTCCTGACTGT
cDNA geno
CTGTGTCGTACTCTTCAAGGTCAT
cDNA geno 2nd TCAGACGACTTCACCTTATTCCTG
Nle1 gDNA geno TCTCCTTCAGCTCCTTCACTGT

CTGTGGAGTCATCTTCTCCATATC
CAGTCAACAGCATATACCTCATCG
TCCAATGGTGGAGTATAGGGTATAA

Tm

Amplicon
Size (bp)

60
62
60

637
351
341

1st round

cDNA amplification primers
ATATGGATCCGGCGCGCCGTCGACT ATATCTCGAGGGCGCGCCGGATCCTT
TTTTTTTTTTTTTTTTTTTTTTT
TTTTTTTTTTTTTTTTTTTTTT

67

2nd round
Eed cDNA

(NH2)ATATGGATCCGGCGCGCCGTC (NH2)ATATCTCGAGGGCGCGCCGGAT
GACTTTTTTTTTTTTTTTTTTTTTTTT CCTTTTTTTTTTTTTTTTTTTTTTTT
GTGTGACATTTGGTACATGAGGTT
ACATTTATGATGGGTCAGTGTTGT

67
60

Ccne1
Ccng1
Cdk9
Mad2I
Plk1
Bax
Mdm2
Gapdh

Assay ID
Mm00432367_m1
Mm00438084_m1
Mm01731275_m1
Mm00786984_s1
Mm00440924_g1
Mm00432051_m1
Mm01233136_m1
Mm99999915_g1

148

ABI TaqMan gene expression assay
Amplicon Size (bp)
63
89
150
144
92
84
113
107

4.2.2 Quantitative RT-PCR
Individual total RNA from each embryo was segregated according to genotype
(mutant vs. wild-type) and stage (morula, full blastocyst and hatched blastocyst).
cDNA from individual embryos was produced from reverse transcription following
the protocol by Tang and Colleagues (Tang et al., 2010). RNA was precipitated
by addition of 100% ethanol (1:1; V:V) in a 15 minute SpeedVac run and
resuspended in 4.5 µl of lysis buffer prior to reverse transcription using a twostep linear amplification process with barcoded primers (Tang et al., 2010).
Products from the first and second rounds were purified using Zymo DNA
concentration kits (Zymo Research, Irvine, CA) and eluted in 30 µl of 1 X T10E0.1.
Eed expression was used to check the cDNA quality following the first linear
amplification step. cDNA was quantified using a Bio-Rad SmartSpec™ Plus
Spectrophotometer, and 10 ng of cDNA was used as a template for qRT-PCR in
combination with TaqMan® Gene Expression Master Mix (PN#4369514; ABI,
Carlsbad, CA) and Taqman Gene-specific probes (Life Technologies, Grand
Island, NY) (Table 4.1) on a StepOnePlus™ Real-Time PCR System (Life
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Technologies, Grand Island, NY). We assayed a minimum of three biological
replicates for each group; cycling reactions were performed in duplicate. The
relative expression of each gene was calculated based on the ΔΔCt value, where
the results were normalized to the average Ct value of Gapdh. Samples that
failed to generate a signal above threshold at the end of the reaction were given
a Ct value of 40, as described previously (Lossie et al., 2012) .
4.2.3 Sample Preparation for rRNASeq
We staged E3.5 embryos and collected four mutants and four wild-type morulae
for this study. To examine the repertoire of rRNA in these samples, we extracted
total RNA from single embryos; we genotyped each embryo using 25% of the
total RNA, as described (Lossie et al., 2012). Total RNA was reverse transcribed
using the iScript cDNA synthesis kit (Bio-Rad, Cat#170-8890, Hercules, CA)
according to manufacturer’s instructions. The iScript system contains both
oligo(d)T and random hexamers, to ensure accurate representation of rRNA
transcripts. The entire 20ul solution was concentrated using SpeedVac for 10
minutes to obtain the appropriate sample volume (5 µl) for RNASeq. The entire
cDNA sample was used for the Illumina Nextera XT sample preparation (Illumina,
Cat# FC-131-1024, San Diego, CA) following the manufacturer’s instruction.
Prior to normalization, we analyzed 5 µl from each sample using the High
Sensitivity DNA Assay (Agilent Technologies, Santa Clara, CA) for quality control
purposes. After sample preparation, each sample was given a unique DNA
barcoded index during Tagmentation and library preparation, according to
standard protocols (Illumina, Cat# FC-131-1002, San Diego, CA). Pooled
libraries were loaded into the MiSeqTM platform (Illumina, San Diego, CA) using a
MiSeq™ Reagent Kit v2 (500 Cycles).
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4.2.4 Data analysis
The filtered Fastq files generated from the MiSeq run were trimmed by the
Purdue Genomics Core Facility to remove the index and adapter sequences. The
Fastq files were uploaded into CLC Genomics Workbench (CLC Bio, Cambridge,
MA) for analysis. We downloaded individual rRNA sequences from Mus
musculus [45S rRNA (NR_046233.1); 28S rRNA 5’end (M19226.1); 28S rRNA
3’end (K01366.1); 18S RNA (NR_003278.3); and 5.8S rRNA (J01871.1)] from
NCBI (http://www.ncbi.nlm.nih.gov/nuccore/) (Pruitt et al., 2009) and assembled
them into one contig that represented the entire, unprocessed 45S rRNA using
Sequencher 5.0 (Gene Codes, Ann Arbor, MI). See figure 4.1 for an explanation
of rRNA processing.
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28S
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5’ETS
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ITS1

5.8S

21S

12S
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5.8S

ITS2

28S

28S

Figure 4.1 Mammalian rRNA prcessing
The 45S pre-rRNA is transcribed by RNA Polymerase I. It is processed into
mature 18S, 5.8S, and 28S rRNAs by endonucleases and exonucleases, which
cleave the external (ETS) and internal transcribed spacers (ITS). This figure is
modified from Burger and Eick, 2013
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We delineated the 5’ETS, ITS1 and ITS2 domains to the full-length, in silicoassembled unprocessed rRNA transcript and then mapped the MiSeq reads from
each sample to the 45S rRNA sequence under the following parameters:
similarity fraction 0.9, length fraction 0.5, nonspecific map-ignored. The
remaining parameters were set to default values. We used this data to generate
the coverage table that shows the coverage at each base pair (bp). To quantitate
the levels of 28S, 18S, 5’ETS, and ITS2 transcripts, determined the range of 28S,
18S, 5’ETS, and ITS2 in our reference contig, and then averaged the coverage
within the range of 28S, 18S, 5’ETS, and ITS2. For example, 5’ETS starts from
bp 1 to bp 4008 in the 45S contig, we then averaged the coverage between bp 1
to bp 4008 to denote the average coverage of 5’ETS. To reduce amplification
bias, we normalized the 28S coverage to 18S, and normalized ITS2 to 5’ETS.
Since ITS2 is cleaved when the 32S transcript is processed into the 28S rRNA,
we are able to quantify the levels of 32S rRNA and 28S RNA by comparing the
coverage between ITS2 and 28S sequence. We computed the ratio between
normalized ITS2 and normalized 28S, and then compared this ration between
WT and mutant. (See formula in Table 4.3). A Student’s t test was used to
determine significance.
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4.3

Results

4.3.1 TRP53 Is Activated in Mutant Embryos
Previously, our data indicates that apoptosis occurs at E4.5 in mutant embryos
(Lossie et al., 2012). Although we failed to detect altered Trp53 expression in
mutant embyros (Lossie et al., 2012) , we hypothesized that TRP53 is activated
in our mutants. To test that hypothesis, we performed immunocytochemistry to
detect expression of acetyl-K378 TRP53 (equivalent to K381 in human) in
Nle1l11Jus1/l11Jus1 embryos at E3.5 and E4.5 (Fig. 4.2, Table 4.2). Acetylation of
lysine 378 by p300/CBP has been shown to activate TRP53, which induces
transcription of downstream genes, eventually leading to apoptosis (Kim et al.,
2012; Xu et al., 2011). Using single logistic multiple regression, we determined
that acetyl-K378 TRP53 is found solely in homozygous mutants (Likelihood Ratio
χ2 = 31.69, P<0.0001) at E3.5 (LR χ2 = 16.57, P<0.0001) and E4.5 (LR χ2 =
15.01, P = 0.0001). We did not find any evidence for an interaction between
genotype and stage (LR χ2 < 0.0001; p>0.9999), suggesting no difference was
found between E3.5 and E4.5 with the same genotype. Overall, these data
indicate that TRP53 is activated at both E3.5 and E4.5, suggesting that apoptotic
phenotype could be mediated by acetylation of TRP53.
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Wildtype

Mutant

E3.5
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E4.5

Figure 4.2 Acety-K378 TRP53 expression in Nle1 embryos
Acety-K378 TPR53 detection in wild-type and mutant embryos at E3.5 (200X)
and E4.5 (200X). Active TRP53 is only detected in the mutants. Red staining
indicates the presence of acetyl TRP53 signal and green is the Hoechst staining.
Merged images are shown.
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Table 4.2 Logistic multiple regression analysis of active TRP53 detection
Stage
129/129
L1/129
L1/L1
Total
Acetyl-K378
TRP53
E3.5 morula/
blastocyst
E4.5 hatched
blastocyst

+

–

+

–

+

–

0

7

0

9

3

0

19

0

9

0

3

3

0

15

4.3.2 Altered Gene Expression in the Cell Cycle and Apoptosis Pathways
Acetylation of Lysine 378 by p300/CBP activates TRP53, which activates
transcription of downstream genes, eventually leading to apoptosis (Kim et al.,
2012; Xu et al., 2011). Previously, we showed that Cdkn1a is upregulated in the
mutants at all stages (morula, blastocyst and hatched blastocyst), and several
members of the Wnt pathway are down-regulated (Lossie et al., 2012). Since
Cdkn1a is a transcriptional target of p53 that controls cell cycle regulation, we
wanted to determine if mutant embryos display misregulation of additional p53
target genes and/or genes involved in the cell cycle. Therefore, we analyzed
expression of CyclinE1 (Ccne1), CyclinG1(Ccng1), Cdk9, Mad21, Plk1, Bax and
Mdm2 between wild-type and Nle1l11Jus1/l11Jus1 mutant embryos at both the morula
and E3.5 hatched blastocyst stages using Taqman assays. Expression of each
gene was normalized relative to expression of Gapdh and compared to stagematched wild-type controls. Wild-type expression was set at a value of one.
Ccne1, Ccng1 Mad2l and Plk1 are involved in cell cycle regulation (Derenzini et
al., 2005; Mandal et al., 2010; Ren et al., 2002; van de Weerdt and Medema,
2006; Zhao et al., 2003), while Bax is a regulator of the caspase-mediated
apoptotic pathway (Basu and Haldar, 1998; De Angelis et al., 1998; Salakou et
al., 2007). Mdm2 is a transcription target of p53 that functions in a feedback loop,
as the MDM2 protein inhibits TRP53 (Ard et al., 2002; Deisenroth and Zhang,
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2011). We used a Generalized Linear Model (GLM) to calculate DDCt and fold
change, as well as to properly control and test for differences among the mutant
alleles and stages of development. Our data showed that Ccne1 was expressed
at 5.56 fold lower levels in mutant morulae compared to wild-type controls
(P=0.021) (Fig 4.3A). However, we did not detect differences in Ccne1
expression between control embryos and mutants at the hatched blastocyst
stage (P=0.29). In contrast, Cdk9 expression was 3.22 fold decreased in the
mutant hatched blastocysts (P=0.0066) (Fig 4.3A), but was not significantly
altered at the morula stage (P=0.68). Ccng1, Mad2I and Plk1 expression did not
differ between control and mutant embryos at either stage. Mdm2 and Bax were
highly up-regulated in hatched blastocysts (Mdm2: P=0.047; Bax: P=0.041) (Fig
4.3B), but were not significantly different at the morula stage.
In addition, our NOTCH PCR array data revealed that several genes in the Wnt
pathway were down-regulated in mutant embryos (Lossie et al., 2012). To
determine if the canonical Wnt pathway is altered, we analyzed β-catenin
expression. We confirmed that β-catenin was expressed at 2.63 fold lower levels
in mutant hatched blastocysts (P=0.041), which suggests that the canonical Wnt
pathway could be disrupted in our mutants.
Overall, we found stage-specific downregulation of Ccne1, Cdk9, and β-catenin
in Nle1 mutants, while Mdm2 and Bax were highly up-regulated. CCNE1 (Cyclin
E1) is required for progression through the cell cycle at the G1/S transition
(Mandal et al., 2010), and CDK9 is involved in the replication stress response in
S phase (Zhang et al., 2013). Therefore, down-regulation of Ccne1 and Cdk9
indicates that mutant embryos display a major defect at the G1/S transition,
which is consistent with previous studies showing that the G1/S transition is
blocked under ribosomal stress (Derenzini et al., 2005; Volarevic et al., 2000).
Therefore, increased levels of Mdm2 and Bax are expected, as Mdm2 and Bax
are transcriptional targets of activated TRP53, and BAX can induce activation of
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caspases-dependent apoptosis (Ard et al., 2002; Basu and Haldar, 1998;
Salakou et al., 2007). This result supported our previous finding that showed the
Nle1 mutants were undergoing caspase-dependent apoptosis.
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Figure 4.3 Altered gene expressions in Nle1 mutants
Genes that were mis-regulated in the mutants were displayed in fold changes by
comparing wilt-type (WT) and mutant expression. Fold change of the wild-type is
set to one. (A) Down-regulated genes included Ccne1 in mutant morulae
(P=0.021), Cdk9 in mutant hatched blastocysts (P=0.0066), and β-catenin in
mutant hatched blastocysts (P=0.041). (B) Up-regulated genes are Mdm2
(P=0.047) and Bax (P=0.041) both in mutant hatched blastocysts.
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4.3.3 rRNA Processing Is Disrupted in the Nle1 Mutants
Studies in yeast demonstrated that NLE1 (called Rsa4 in yeast) functions in the
sequential processing of the 32S pre-rRNA to the mature 28S rRNA (Figure 4.1)
(Bassler et al., 2010; de la Cruz et al., 2005). Cleavage of internal transcribed
spacers 2 (ITS2) produces the mature 28S rRNA transcript. If NLE1 participates
in murine rRNA processing, we expect to observe a disruption of 32S to 28S
rRNA processing in our mutants as we predict the function of NLE1 to be
conserved across species. To test this, we quantified all potential rRNA products
using RNASeq. Because it is difficult to get enough amount of RNA from
embryos to perform Northern blot for quantifying rRNA, RNAseq circumvents the
technical limitations (i.e. obtaining nanogram quantities of starting material)
encountered with pre-implantation embryos and allows us to directly sequence
and quantify all of the rRNA products in individual embryos.
We compared the rRNA expression in four wild-type E3.5 morulae and four
mutant morulae. The reason for choosing morulae is that we hypothesize that
disruption in rRNA processing is the primary cellular insult to the mutant embryos.
Since we observed alteration in gene expression as early as the morula stage,
we expect to see disruption in rRNA processing at or before the morula stage. If
mutation in NLE1 leads to a reduction of 28S rRNA and an accumulation of 32S
rRNA, we would expect to see increased levels of internal transcribed spacers 2
(ITS2) in the mutants. Based on the rRNASeq results, we detected a 2.65 fold
higher coverage of ITS2/28S in the mutants (P=0.022, t-test) compared to wild
type embryos (Fig. 4.4, Table 4.3), while the 18S, 5.8S and total 28S coverage
show no differences (p≥0.82), indicating that only the 32S/28S processing is
being disrupted.
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Figure 4.4 RNASeq analysis of rRNA processing
(A) Gene structure of 45S rRNA. Black boxes indicate the mature 18S, 5.8S and
28S region, and black lines are the external or internal transcribed spacers
(5’ETS, ITS1 and ITS2) a, b, c, and d denote the coverage regions that are
corresponding to the formula in Table 4.3 (B) Heat map of rRNASeq coverage in
45S rRNA. The average coverage from 4 biological replicates was used to
generate this heat map. The overall coverage ranges from 0 to 730 counts. (C)
Quantification on the relative amount of ITS2/28S rRNA, which is based on the
average coverage on the ITS2 and 28S regions. Student t-test was performed to
determine significance (P=0.022).
Table
4.3
Average
coverage
of subunits
each rRNA subunits
Table 4.3
Average
coverage
at each rRNA
Genotype
mutant
mutant
mutant
mutant
WT
WT
WT
WT
Formula

Average
ITS2
coverage
7.86
1.778
12.616
3.21

Average Average Average Average
28S
5' ETS
18S
5.8S
ITS2/ETS 28S/18S
coverage coverage coverage coverage
259.128
3.564
197.516
156.482
2.205
1.312
97.609
1.046
80.091
68.154
1.7
1.219
721.356
4.908
730.794
540.121
2.572
0.987
71.953
2.179
104.02
34.454
1.473
0.692

3.034
219.827
3.127
324.31
201.421
0.97
0.501
19.741
1.019
32.006
24.211
0.492
3.076
391.521
3.53
321.034
308.852
0.871
0.002
352.162
0.263
291.704
241.369
0.007
a
b
c
d
=a/c
P value= 0.022 by Student t-test
Mutants have relaitve 2.648 folds higher coverage of ITS2/28s than WT

0.678
0.617
1.22
1.207
=b/d

Relative
ITS/28S
1.681
1.395
2.606
2.13
1.431
0.798
0.715
0.006
=(a/c)/(b/d)

Average
Ratio
ITS2/28S
1.953

2.65

0.737

1
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Abnormal ribosomal biogenesis is usually coupled with disrupted nucleolar
structure (Gallenberger et al., 2011; Zhang et al., 2008). Therefore, we examined
nucleolar structure by detecting the expression pattern of fibrillarin, a nucleolar
protein. In the E3.5 mutants, we observed circular stainings of fibrillarin (Fig. 4.5),
which is similar to the structure of immature nucleolus precursor body in E2.5. In
mice, the inactive nucleolus precursor body is gradually organized into a
functional nucleolus during four- to eight-cell stages and is disappeared in morula
stage. For the E3.5 wild-type embryos, fibrillarin staining shows clear punctate
structure.
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Figure 4.5 Immunofluorescent images of nucleolar structure
(A) Embryos at indicated stages were stained for fibrillarin (red), showing in the
middle panel. Nucleus is labeled using Hoechst fluorescent blue dye (left panel)
(200X). Fibrillarin staining reveals the morphology of nucleolar precursor body in
E2.5 wild-type embryo. At E3.5, the nucleoli are smaller than E2.5 stage. In the
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E3.5 mutant blastocyst and hatched blastocyst, fibrillarin staining show a circular
structure (yellow arrows in (B)) that resembles nucleolar precursor body in E2.5,
while the E3.5 wild-type embryo displays normal punctate structure (blue arrows
in (B)). (B) Enlarged images from (A).
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4.4

Discussion

The I11Jus1 and l11Jus4 alleles harbor missense mutations in the Nle1 gene
(Lossie et al., 2012). Studies in Drosophila and Xenopus indicate that NLE1 is a
member of the NOTCH pathway that functions as a negative regulator of Notch
signaling (Cormier et al., 2006a; Royet et al., 1998b). However, our previous data
refuted the possibility that NLE1 functions as a negative regulator of NOTCH
signaling during mammalian pre-implantation development, as mutation of Nle1
does not lead to increased expression of key Notch downstream target genes.
On the contrary, reports in yeast and plants (which lack NOTCH signaling)
demonstrate a role for NLE1 in ribosomal biogenesis (Chantha et al., 2007a;
Chantha et al., 2006; Chantha and Matton, 2007; de la Cruz et al., 2005b; Strain
et al., 2001).
Here, we present evidence that support a role of NLE1 in ribosomal biogenesis in
mammalian pre-implantation development, as l11Jus1 and l11Jus4 mutants
show disruption in 32S/28S rRNA processing and abnormal nucleolar structures.
Furthermore, Nle1 mutants displayed abnormal activation of TRP53 at both E3.5
and E4.5, disruptions in the cell cycle and eventual apoptosis. The big question is
what is the initial insult that leads to activation of TRP53, and initiation of the
apoptotic mechanism. We provided evidence here that the causative insult is
likely induction of ribosomal stress that occurs due to mutations in Nle1.
Activation of TRP53 induces expression of TRP53 target genes, including
Cdkn1a (Lossie et al., 2012), Bax and Mdm2. Activation of Cdkn1a can cause
cell cycle arrest, which is also supported by our data, since Ccne1 (Cyclin E1)
(which controls GS/S transition) and Cdk9 (which regulates replication) are
down-regulated in the E3.5 mutants, implicating a disruption in G1/S transition.
Previously, we determined that E4.5 mutants were undergoing caspasedependent apoptosis (Lossie et al., 2012), which can be initiated by the
overexpression of Bax, which is consistent with our data.
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It is not surprising that mouse embryos with defects in genes that encode for
proteins

involved

in

ribosomal

biogenesis

fail

during

pre-implantation

development. For example, mutations in multiple proteins involved in ribosomal
rRNA synthesis and processing (e.g. pescadillo-1 (PES-1) (Lerch-Gaggl et al.,
2002), RNA polymerase 1 (Yamamura et al., 2008), SURF6 (Romanova et al.,
2006), RBM19 (Zhang et al., 2008), EMG1 (Ding et al., 2010), WDR36
(Gallenberger et al., 2011), LIN28 (Vogt et al., 2012)) cause embryonic lethality
at the morula stage. However, at a gross level, our mutant phenotype appears
around E4.5-E5.5 as they implant but fail to outgrow. This delayed phenotype is
probably due to compensation by other protein.
Other WD40 proteins play important roles in rRNA biogenesis. WDR12, which
contains an NLE1 domain and several WD40 repeats (Nal et al., 2002), shares
34.8% identity to NLE1 on the protein level, as determined by the SIM program
(http://web.expasy.org/sim/) (Huang and Miller, 1991) and on the cDNA level
(Kolmogorov-Smirnov P-value=0.0467) (Pearson, 1996). The yeast WDR12
homolog, Ytm1, and the NLE1 homolog, Rsa4, both interact with the AAA+ATPase Rea1 in directing rRNA processing, (Bassler et al., 2010; Bottcher et al.,
2009). Disruptions of Ytm1 and Rsa4 block processing of the 35/27S precursor
rRNA to the mature 25S and 5.8S rRNAs (Bassler et al., 2010) (In mammals,
these correspond to 36/32S pre-rRNA, 28S rRNA and 5.8S rRNA). Based on the
findings described above, it is possible that the function of NLE1 and WDR12
overlap, therefore mutation in NLE1 causes a slightly later phenotype. We can
test this hypothesis by disrupting Wdr12 in the Nle1 mutants to see if the
embryos arrest earlier.
The association between ribosomal stress and TRP53 activation still needs to be
determined in our mutants. Several studies reported that ribosomal stress
induces the RP(Ribosomal protein)-MDM2-p53 pathway (Daftuar et al., 2013; Dai
and Lu, 2004; Gilkes et al., 2006). That is, disruption of rRNA biogenesis
releases ribosomal proteins from the nucleoli to nucleoplasm where they bind to
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MDM2 and inhibit p53 degradation, thereby activating p53 the apoptotic pathway.
To test if the RP-MDM2-p53 pathway is activated in our mutants, our next step
will be to investigate the possible interaction between ribosomal proteins and
MDM2 in our system.
Together, our data implicate NLE1 in ribosomal biogenesis that mediates cell
cycle arrest and apoptosis via TRP53 signaling. Intriguingly, ribosomal
biogenesis is critical for pre-implantation development in mice as described
before. These pathways could provide novel targets for the design of therapeutic
interventions for infertility.
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CHAPTER 5. DISCUSSION

5.1

NLE1 and Its Potential Biological Function in Ribosomal Biogenesis

Through conducting positional cloning and sequencing analysis, we determined
that the l11Jus1 (L1) and l11Jus4 (L4) phenotypes are caused by nonconservative missense mutations in the Nle1 gene. l11Jus1 and l11Jus4 were
generated by N-ethyl-N-nitrosourea (ENU) mutagenesis on the C57BL/6J (B6)
background, which also contains a non-conservative missense mutation in Nle1.
Therefore, l11Jus1 and l11Jus4 homozygotes harbor two mutations within the
predicted functional domain of NLE1. Although the endogenous C57BL/6J
mutation is not lethal, it potentially interacts with the L1 and L4 mutations, as
there is significant loss in viability of l11Jus1 and l11Jus4 on the C57BL/6J
background (Lossie et al., personal observation).

NLE1 belongs to the WD40 repeat family of proteins; it contains eight WD40
repeat-like domains and a NLE domain at the N terminus. The L4 mutation and
B6 mutation are located in the second WD40 domain, while L1 is in the sixth
WD40 domain. Despite the differences in L1 and L4 alleles, the phenotype is
indistinguishable and the gene expression data between l11Jus1 and l11Jus4
are not significantly different (Lossie et al., 2012). Gene targeting studies also
indicate that the mutant phenotypes of l11Jus1 and l11Jus4 phenocopy the null
allele (Cormier et al., 2006a). These data suggest that these two single point
mutations in the coding region are each sufficient to disrupt protein function. ENU
mutagenesis has demonstrated that single point mutations can recapitulate the
null phenotype. For example, Favor et al. (2001) identified nine independent
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Pax6 mutations generated by ENU mutagenesis, out of those, seven mutations
expressed phenotypes characteristic of null alleles (Favor et al., 2001). A mouse
model of the Human Fragile X Syndrome that harbors a missense mutation in
Fmr1I304N (created by targeted knock-in approach) also displayed Fmr1 null-like
phenotypes, including increased audiogenic seizure rates, decreased acoustic
startle responses, and greater exploratory behavior (Zang et al., 2009).
The fact that L1 and L4 phenocopy the null allele suggests that the WD40 repeat
domains are critical for the function of NLE1. The eight WD40 repeats in NLE1
are predicted to form a ‘β-propeller’ structure serves as a role for protein-protein
interaction. The L1 and L4 mutations may cause structural change to the βpropeller in NLE1 that disrupts the interaction between NLE1 and its binding
partner, leading to a malfunctioned protein complex. So far, no protein in the
WD40 family has been found to display enzymatic activity (Xu and Min, 2011).
WD40-repeat proteins usually comprise components within higher order
molecular complexes that are responsible for sequential or simultaneous
interactions. In addition to the interaction through the β-propeller motif, WDrepeat proteins may have other functions provided by the N- or C-terminus (Nal
et al., 2002; Steimle et al., 2001).
NLE1 and WDR12 are structurally similar; they both contain an NLE domain and
WD40 repeats. WDR12 is a critical component of the PeBoW complex in
mammalian cell lines. The PeBoW complex contains PES1 (pescadillo), BOP1
(block of proliferation) and WDR12. It is required for maturation of the 60S large
ribosomal subunit and for cell proliferation in rat fibroblasts(Holzel et al., 2005;
Rohrmoser et al., 2007). Knocking down Pes1 and Bop1 by dominant negative
mutations or siRNA technology blocks processing of the 36/32S precursor rRNA
into the mature 28S rRNA and 5.8S rRNA, and subsequently disrupts maturation
of the 60S large ribosomal subunit. Maturation of the 40S small subunit is not
affected. Moreover, p53 activity is induced after knockdown, followed by a block
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of cell cycle in G1 phase and growth arrest (Eick et al., 2006; Holzel et al., 2005;
Pestov et al., 2001b).
The PeBoW complex is conserved throughout evolution (Rohrmoser et al., 2007;
Woolford et al., 2008). The yeast PeBoW ortholog (Nop7, Erb1 and Ytm1 are
orthologs of Pes1, Bop1, and WDR12 respectively) is also involved in ribosome
biogenesis and cell cycle progression (Miles et al., 2005). Similar to the
mammalian systems, ablation of the proteins leads to disruption in large
ribosomal subunit maturation (Miles et al., 2005; Oeffinger et al., 2002). Woolford
et al. (2008) further identified how these three proteins interacting with each and
what are the interacting domains in each of the three proteins. Specifically, Erb1
and Nop7 form a heterodimer, and then Ytm1 is recruited to assemble into a
preribosome (Miles et al., 2005). The recruitment of Ytm1 stabilizes the
association between Erb1 and Nop7. Erb1 serves as a bridge that connects
Ytm1 and Nop7 via its N-terminus (Pestov et al., 2001a; Woolford et al., 2008).
Ytm1 binds to the N-terminus of Erb1 through its C-terminal WD40 domain, while
Nop7 interacts with Erb1 via the central region (Woolford et al., 2008).
Since NLE1 and WDR12 are the closest known family members, I predict that
NLE1 interacts with analogous proteins through the WD40 repeats to form a
protein complex that is similar to PeBow. By searching the Saccharomyces
Genome Database (SGD) (http://www.yeastgenome.org/) (Cherry et al., 2012), I
determined 44 proteins that interact with Rsa4. Out of them, 33 proteins are
involved in ribosomal biogenesis and the rest are involved the other processes
such as DNA replication and ubiquitination. Interestingly, Erb1 and Nop7 are a
subset of these 44 proteins reported by a very recent study (Ohmayer et al.,
2013). It is likely that NLE1 forms a complex with Erb1 and Nop7 to exhibit the
similar function as PeBoW.
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The functional relationship between NLE1 and WDR12 has been identified in
yeast. The orthologs for WDR12 (Ytm1) and NLE1 (Rsa4) both interact with the
ATPase, Rea1 (Bassler et al., 2010; Bottcher et al., 2009). Rea1 is a conserved
pre-ribosomal factor found in the nucleoplasm that is a component of the pre-60S
ribosomal subunit (Galani et al., 2004; Nissan et al., 2004). Rea1 is required for
the formation of 60S. It is necessary for processing of ITS2 from the 32S rRNA to
28S rRNA and is specifically involved in a late step that generates the mature
5.8S rRNA from the 7S pre-rRNA (Fig. 1.4) (Galani et al., 2004). Electron
microscopy demonstrated that Real1 contains two major domains: an ATPases
Associated with cellular Activities (AAA) motor domain that binds to the pre-60S
particles, and a long flexible tail harboring a metal ion-dependent adhesion site
(MIDAS) (Bottcher et al., 2009). The Rea1 MIDAS domain contacts the Nterminal NLE domain of Ytm1 and Rsa4 directly and sequentially during 60S
subunit biogenesis. Therefore, the NLE domain can also be called the MIDAS
interacting domain (MIDO) (Bassler et al., 2010; Bottcher et al., 2009).
A conserved glutamate (E114 in Rsa4 and E80 in Ytm1) in the MIDO is essential
for interacting with MIDAS (Bassler et al., 2010; Bottcher et al., 2009). Both Ytm1
(WDR12) and Rsa4 (NLE1) share this conserved amino acid. This site is
necessary for proper, sequential exportation of the 60S subunit from the
nucleolus to the cytoplasm. Mutations in this glutamate residue in Ytm1 cause an
early block at the transition of 60S from the nucleolus to the nucleoplasm
(Bassler et al., 2010). The analogous glutamate mutation in Rsa4 inhibits
exportation of the pre-60S particles from the nucleoplasm to the cytoplasm
(Bottcher et al., 2009). Since Ytm1 is recruited first to the pre-ribosomal particle
in the nucleolus, it is possible that Ytm1 and Rsa4 share the same binding site on
the pre-60S subunit and the yeast PeBoW complex blocks the association of
Rsa4 to the nucleolar pre-60S transcript until it is ready to be exported to the
cytoplasm. How Rea1 mediates the replacement of Rsa4 from Ytm1 is still
unknown. Since all of these proteins are conserved across species, it is possible
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that in mammalian, Rea1 homolog (MDN1) drives a similar interaction between
NLE1 and WDR12 during 60S ribosomal biogenesis. I speculate that MDN1mediated export of the 60S transcript from the nucleolus to the nucleoplasm, and
from the nucleoplasm to the cytoplasm occurs through interactions with WDR12
and NLE1, respectively (Fig. 5.1). To test that, future studies could be conducted
to determine the interaction of WDR12 and NLE1 with MDN1 by coimmunoprecipitation

and

immune-FLIM-FRET

detection

to

identify

the

intracellular localization of these proteins and protein complexes. This could be
conducted in embryonic stem cells from Wdr12 and Nle1 mutants. Furthermore,
these studies could be designed to examine the distribution of pre-60S subunits
after mutation of the MIDO domain of within NLE1 and WDR12, and
immunostaining of RPL27 to track the 60S ribosomal subunits.
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Cytoplasm
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Figure 5.1 Proposed model for the biological function of NLE1
The ATPase MDN1 acts at distinct, successive 60S biogenesis steps. The MDN1
MIDAS domain interacts directly with the N-terminal MIDO domain of WDR12.
MDN1 then releases WDR12 from pre-60S particles in an ATP-dependent
manner. The released WDR12 is replaced with NLE1 to direct the nuclear exit of
pre-60S particles (modified from Baßler et al, 2010).

5.2

The rRNASeq study

To the best of my knowledge, we are the first to use RNASeq to analyze rRNA
processing. The most common ways to study rRNA processing are by Northern
blot and pulse-chase labeling of rRNA by

32

P-orthophosphate. These methods

require significantly more RNA than can be obtained from a single blastocyst. For
example, northern blot require a minimum of 20 µg of total RNA or 4 µg of mRNA
(Bergeron et al., 2001). However, a 64-cell embryo produces approximately 1 ng
of total RNA. It is prohibitive to collect and genotype enough embryos to conduct
this type of assay. Although quantitative RT-PCR could be used to address this
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question, there are significant potential biases with this technique. First, there are
several repetitive sequences in the rDNA, which means that each set of primers
must be thoroughly validated prior, and although polymorphisms exist in the
repetitive sequences (James et al., 2009), this experiment requires that primers
be designed for specific regions of the transcript, which may or may not span
enough polymorphisms to ensure accurate amplification, which can lead to nonspecific binding. Second, it is difficult to determine the appropriate control for
these experiments. 18S rRNA is often used as a control because it is less variant
in expression level under normal condition. However, in our case we are
uncertain if 18S rRNA proceesing is also disrupted. Third, in order to quantify
different rRNA subunits, one needs to design and validate multiple primer sets.
To overcome these limitations and difficulties, we took an advantage of the Next
Generation Sequencing (NGS) technology. We used the Illumina MiSeq platform
and Nextera Sample Preparation kit to sequence total RNA in individual embryos.
Nextera system only requires 1 nanogram of input material and uses a limited
number of cycles of PCR amplification for library preparation. As we expect 1
nanogram of total from one blastocyst, the Nextera system allows us to perform
rRNASeq in single embryo. RNASeq overcomes many of the limitations of
northern blot and reduces the amplification bias of qRT-PCR. RNASeq also
allows us to quantify all of the rRNA products in one single experiment.
We are able to assemble the raw reads from MiSeq to the 45S pre-rRNA. By
comparing the coverage of different rRNA subunits between the mutants and the
wildtype, we detected a 2.65 fold higher coverage of ITS2 in the mutants. This
indicates a block of processing from the 32S rRNA to the 28S rRNA because
ITS2 is being cleaved during this process under normal condition. This result is
consistent with the study in yeast (Bassler et al., 2010; de la Cruz et al., 2005).
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5.3

Mutations in NLE1 Affect Wnt Signaling

NLE1 was first identified in Drosophila by a suppressor screen of the notchoid
phenotype (Royet et al., 1998b). The same research group also determined that
NLE1 is a regulator in the Notch pathway. Based on this evidence, we
hypothesized initially that NLE1 is also involved in Notch signaling during mouse
pre-implantation development. However, our Notch PCR array data refuted this
possibility as none of the Notch receptor, ligands, or downstream targets were
misregulated in the l11Jus1 mutants. To our surprise, several genes in the Wnt
pathway were downregulated. Using Taqman qRT-PCR assays, we determined
that β-catenin is expressed at lower levels in the mutants in comparison to wildtype embryso, indicating that the canonical Wnt pathway is potentially
downregulated, at least at the transcriptional level.
The mechanisms underlying disruption of Wnt signaling in the Nle1 mutant needs
to be elucidated. As we demonstrated that TPR53 is activated in the mutant
embryos, it is possible that Wnt is regulated by TRP53. Since TRP53 inhibits
self-renewal and promotes differentiation of human ES cells (Jain et al., 2012),
the mutants could be inducing Trp53 in an attempt to differentiate cells stuck in a
pluripotent state that was brought on by abnormal Wnt signaling. Interestingly,
this study links upregulation of Trp53 with induction of microRNA-34 (miR-34).
This miRNA cluster is a link between the TRP53 and Wnt pathways (Kim et al.,
2011); miR-34a, miR-34b and miR-34c are direct transcriptional targets of TRP53,
as activation of TRP53 mediated by DNA damage or oncogenic stress induces
miR-34 expression. Chromatin-immunoprecipitation and luciferase assays further
showed that TRP53 binds to and activates transcription of the miR-34 genes (He
et al., 2007). MiR-34a also regulates TRP53 through post-transcriptional binding
to SIRT1, which inhibits translation. SIRT1 deacetylates and reduces activity of
TRP53, thereby increasing the active form of TRP53 and inducing expression of
TRP53 targets such as Cdkn1a and Puma (Yamakuchi et al., 2008). As a result,
Trp53 and miR-34a form a positive feedback loop.
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Kim and colleagues (2011) further demonstrate that TRP53 and miR-34 are
negative regulators of canonical Wnt signaling. Loss of TRP53 function by
conditional knock out, siRNA, or introduction of mutant p53 in human cell lines all
lead to increased expression of b-Catenin, WNT1 and LRP6. Loss of miR-34a by
addition of anti-miR-34a RNAs also induced Wnt activity by preventing binding of
miR-34a to its cognant sequences on Wnt1, Wnt3, Lrp6 and β-catenin (Kim et al.,
2011). These studies uncover the interaction of TRP53 and Wnt pathways by the
intermediate of miR-34a.
Therefore, we expected miR-34a to be overexpressed in the Nle1 mutants.
However, we did not find significant upregulation of miR-34a in mutant embryos
from the 16-cell stage through the hatched-blastocyst. The expression levels of
miR-34a are quite variable in this study; some cells show marked upregulation,
while others do not. It is possible that the variable expressivity we found resulted
from the inability to precisely stage each embryo. In addition, determining
differential expression of microRNAs is difficult, as they often display subtle
changes in expression (Stadler et al., 2010), which increases the difficulty of
detecting differences in expression. Furthermore, since we showed that the
transcript levels, but not the protein levels of β-catenin were downreguated, and
miR-34a most often act to inhibit translation, other mechanisms could account for
regulating the transcription of β-catenin.
Another inhibitory effect of TRP53 on β-catenin is through the ubiquitinproteasome system, which requires an active glycogen synthase kinase 3β
(GSK3β) (Sadot et al., 2001). GSK3β has been shown to phosphorylate βcatenin, thus targeting it for proteosome degradation (Wu and Pan, 2010).
Induction of wild-type TRP53 by transfection or DNA damage down-regulates βcatenin. The reduction in β-catenin levels was accompanied by abatement in the
protein amount and transcriptional activity of β-catenin due to GSK3β targeted
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proteasome degradation. Mutating the N terminus of β-catenin prevented this
effect, where the N terminus compromises degradation of β-catenin by the
proteasomes. Blocking GSK3β activity or overexpressing the dominant-negative
ΔF-β-TrCP also prevents β-catenin degradation (Sadot et al., 2001).
DNA damage (induced by camptothecin) activates the nuclear pool of GSK3β
with no activation of the cytosolic pools (Bijur and Jope, 2001). This research
group determined that TRP53 interacts with GSK3β in the nucleus following DNA
damage. Furthermore, they found that binding of TRP53 to GSK3β increases the
activity of GSK3β, and that activated GSK3β induces transcriptional activity of
Trp53 (Bijur and Jope, 2001). Under normal conditions, GSK3β regulates TRP53
levels through phosphorylation of the central domain of MDM2. For efficient
degradation of TRP53, MDM2 required this phosphorylation within the central
domain to maintain the low basal levels of TRP53 (Kulikov et al., 2005).
As previously discussed, ribosomal stress induces the release of ribosomal
proteins (RPs) from the nucleolus, allowing RPs bind to MDM2, thereby TRP53MDM2 complexes are disrupted, stabilizing TRP53 (Deisenroth and Zhang,
2011). Under these conditions, TRP53 is increased, which allows TRP53 to bind
to GSK3β, thereby resulting in increased levels of active GSK3β. When GSK3β
is activated, it phosphorylates β-catenin, leading to proteasome degradation of βcatenin. This can further mediate down-regulation of β-catenin and Wnt signaling.
To test if this model is true in our mutants, we can determine if GSK3β is
expressed at higher levels and bound to TRP53 in the nucleus of the mutants.
5.4

Altered Nucleolar Structure and p53 Activation in the Mutant

Using immunostaining with antibodies targeting Fibrillarin, we determined the
Nle1 mutant blastocysts and hatched blastocysts show nucleolar structures that
are similar to the immature nucleolar precursor bodies (NPB). The nucleolus
precursor bodies are derived from the parental nucleolar remnant and are
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established in the pronuclei after fertilization. The NPB appear as a clear sphere
delineated from the surrounding nucleoplasm (Flechon and Kopecny, 1998). The
sphere is composed of a dense meshwork of thin fibrils. In mice, the inactive
nucleolus precursor body is gradually organized into a functional nucleolus
during four- to eight-cell stages. The zygotic nucleolus is developed mainly
limited to the surface of NPB, while the core of the original NPB remains compact
and is still detectable up to the morula stage (Flechon and Kopecny, 1998;
Maddox-Hyttel et al., 2007). The fact that we detected an NPB-like structure in
mutant blastocysts indicates a potential delay in mature nucleoli formation.
In our mutant blastocysts, not all of the blastomeres display NPB-like structures.
If the L1 and L4 mutations in Nle1 can mediate abnormal nucleolar structure, and
NLE1 is expressed throughout the embryo, we would expect all of the
blastomeres to show altered nucleolar structure. However, only some of the cells
in the inner cell mass show this defect, indicating that NLE1 may not be
expressed equally in every blastomere. In addition, activated TRP53 is not
expressed uniformly throughout the mutant embryos; it is detected mainly in the
inner cell mass. This leads us speculate if abnormal nucleoli and active TPR53
are co-localized in the same blastomere.
Recently, several studies have reported that mouse blastocysts display a saltand-pepper distribution of lineage-specific transcription factors (Chazaud et al.,
2006; Kang et al., 2013; Plusa et al., 2008; Xenopoulos et al., 2012). The
emergence of the epiblast and primitive endoderm within the inner cell mass
(ICM) of a mouse blastocyst required initial co-expression of epiblast- and
primitive endoderm- specific markers in all cells of the inner cell mass. This is
followed by a mutually exclusive pattern, where cells expressing epiblast- and
primitive endoderm- specific markers are distributed in a salt-and-pepper fashion
independent of their location within the ICM. For example, the epiblast lineage
markers (NANOG, SOX2 and OCT4) and the primitive endoderm lineage
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markers (GATA4, GATA6, SOX7 and SOX17) are mutually exclusive; cells
express either epiblast markers or primitive endomerm markers, not both. (Artus
et al., 2011; Chazaud et al., 2006; Meilhac et al., 2009; Plusa et al., 2008;
Yamanaka et al., 2010). Future studies can be aimed at determining if mutations
in Nle1 disrupt detect expression of these markers in the Nle1 mutant to
determine if cell lineage decision is disrupted.
5.5

Model for Signaling Regulation in Nle1 Mutants

Based on our findings and other published studies, we developed a model to
explain how Nle1 interacts in multiple pathways that are imperative for embryonic
development (Fig. 5.2). We demonstrated that NLE1 is involved in ribosomal
biogenesis, as the Nle1 mutants show a defect in 32S/28S rRNA processing and
display abnormal nucleolar structure. Disruption in ribosomal biogenesis leads to
ribosomal stress that mediates activation of TRP53 through binding of ribosomal
proteins to MDM2 (Daftuar et al., 2013; Dai and Lu, 2004; Deisenroth and Zhang,
2011; Gilkes et al., 2006). We confirmed that TRP53 is activated in mutant
embryos, as acetyl-K378 TRP53 is expressed at higher levels in the mutants.
This acetylation can be accomplished by histone acetyltransferases, CBP and
p300 (Feng et al., 2005; Krummel et al., 2005). Activation of TRP53 induces two
mutually exclusive pathways–cell cycle arrest or apoptosis. First, we found
upregulation of Cdkn1a and down-regulation of cell cycle regulators, such as
CyclinE1 and Cdk9 at E3.5.
transition,

while

CDK9

CCNE1 (Cyclin E1) is required for the G1/S

regulates

replication

at

S

phase.

Therefore,

downregulation of CyclinE1 and Cdk9 suggests that mutant embryos are
arrested at the G1/S cell cycle transition at E3.5. This finding is consistent with
previous reports that the amount of ribosomes produced can determine G1/S
transition (Derenzini et al., 2005; Volarevic et al., 2000). When the damage
accumulates we predict that the embryo cannot recover from cell cycle arrest.
Therefore, the mutants undergo caspase-dependent apoptosis at E4.5 via
overexpression of Bax. We found that Wnt signaling is also downregulated in the

117
mutants. How WNT being misregulated is still unclear. As previously discussed, it
could be regulated by activation of TRP53, which triggers GSK3β activity and
proteasome degradation of β-catenin, leading to inhibition of the WNT signaling
(Sadot et al., 2001).
To further support our model, future studies will need to be conducted. First, we
want to determine if ribosomal proteins bind to MDM2 to activate TRP53. Second,
we want to investigate if GSK3β is the link between TRP53 and Wnt signaling in
our model. Last, we want to identify the biological function of NLE1 in ribosomal
biogenesis. We propose that NLE1 has the same function as determined in yeast
that it is responsible for the transportation of 60S ribosomal subunit from
nucleoplasm to cytoplasm via binding to MDN1 (Bassler et al., 2010).
Biochemical studies such as co-immunoprecitiation and FRET can be used to
determine this interaction.
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Figure 5.2 Proposed model for the regulatory network in Nle1 mutants
I propose mutations in NLE1 lead to ribosomal stress and activation of the RPsMDM2-p53 pathway. Activation of p53 mediates upregulation of Cdkn1a and cell
cycle arrest. When the mutants cannot recover from cell cycle arrest, they
undergo caspase-dependent apoptosis. Downregulation of the Wnt signaling
may result from activation of GSK3β via TRP53. GSK3β phosphorylates βcatenin, thus targeting β-catenin for proteosome degradation.
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